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SUMMARY 
Neurodegenerative diseases are heterogeneous disorders that share common features of progression, 
whereby vulnerable cortical regions and neuronal populations are susceptible to disease insults during 
a prolonged preclinical period. At symptom onset, it is theorised that potential compensatory 
mechanisms mediating these disease insults fail, and overt symptoms then arise. Synaptic dysfunction 
is one such pathological pathway that has been repeatedly identified in a range of neurodegenerative 
diseases, yet the initiating mechanism resulting in the dysregulation of synaptic connections has not 
been identified. Amyotrophic lateral sclerosis (ALS) is the most common form of motor neuron 
disease, and features the select vulnerability of the motor system and degeneration of motor neurons, 
for which we have no effective cures or treatments. Critical insight as to which processes may underlie 
disease onset and progression have come from studies identifying early changes to the excitability of 
the motor cortex of ALS patients, and increasingly the dysfunction of the synapse has been linked to 
these network changes. Thus there is an increased interest in the potential for early dysregulation of 
the synaptic compartment to initiate pathological disease pathways during preclinical periods. The 
primary component of characteristic disease aggregates in ALS patient tissue is the DNA/RNA-binding 
protein TDP-43; in disease states, the protein mislocalises to the nucleus and is sequestered into toxic 
inclusions within the cytoplasm. Though previous research has focused on the role of TDP-43 within 
the nuclear and cytoplasmic compartments, increasing evidence indicates the protein has normal roles 
more distally- particularly at the dendritic spine. The dendritic spine is the primary postsynaptic 
compartment of glutamatergic neurons and is essential for the regulation of neuroplasticity. Therefore, 
the aim of this thesis was to investigate how and when misprocessing of TDP-43 may impact the 
postsynaptic compartment at the dendritic spine, and how this may then impact neuroplasticity. Further, 
the fundamental features of the motor cortex were examined in order to better understand what may 
render the region vulnerable to dysfunction mediated by changes at the dendritic spine. 
The current thesis investigated the potential for misprocessed TDP-43 to mediate dendritic spine 
dysfunction by first establishing a timeline of synaptic alterations in the motor cortex of the TDP-
43A315T mouse model of ALS. The aim of this first study was to investigate whether the synapse is 
dysfunctional over a disease time course, in order to identify the earliest occurring disease events 
mediated by TDP-43 using immunohistochemical techniques. Subsequently, neuroplasticity of the 
dendritic spine was investigated within the motor cortex under normal conditions using cranial window 
surgeries in conjunction with 2-photon laser scanning microscopy (2PLSM), in order to identify 
features that may potentially underlie the vulnerability of the region to disease-linked pathology in real 
time. An additional aim of this second study was to investigate the influence of the sex hormone 
 x 
oestrogen and age on dendritic spine populations within discrete cortical regions, to better understand 
factors that may influence the incidence of disease within populations. The final study investigated 
real-time changes at the dendritic spine in the presence of the TDP-43A315T mutation, within male and 
female mice having undergone cranial window surgeries and 2PLSM. 
This thesis determined that synaptic dysfunction is a presymptomatic disease event in the TDP-43A315T
mouse, occurring specifically in the motor cortex. Dendritic spine density was significantly reduced 
prior to overt symptoms and cell loss, occuring concurrently with a hypoexcitable phenotype. These 
changes were targeted within layer V pyramidal neurons of the motor cortex at P60, prior to dendritic 
spine density changes being evident by P90 within both the motor and somatosensory cortices. These 
findings highlight the select vulnerability of the motor cortex to TDP-43-mediated dysfunction at the 
dendritic spine, and thus the features that render this region susceptible to disease were next 
investigated. This was explored investigating real-time changes in dendritic spines within the motor 
and somatosensory cortices of Thy1-YFP mice, to establish a neuroplasticity ‘signature’ for each 
region. The dendritic spines of the motor cortex were found to be highly dynamic from P60 through to 
P90 in both male mice and females experiencing baseline levels of oestrogen, whilst during cycling 
peaks of oestrogen the dendritic spines of the motor cortex were observed to be stable. Conversely, the 
somatosensory cortex displayed early stability within males, prior to higher dynamics at adulthood as 
seen in females. These findings revealed that spine dynamics were specific to brain region, and that in 
the motor cortex dependent upon cycling oestrogen. Within the motor cortex of TDP-43A315T mice at 
P60, males displayed significantly reduced dynamics, whilst high oestrogen females were associated 
with increased dendritic spine dynamics. Collectively, these findings indicate the sustained dynamics 
of the motor cortex in normal conditions may prime the region to fail in the presence of activity-
dependent pathology at the dendritic spine. The potential for cycling oestrogen to be neuroprotective 
at the dendritic spine under these conditions is evident, and highlights the need for further studies to 
explore this as a potential therapeutic pathway.  
The findings from this thesis provide strong evidence in support of the crucial role neuroplastic 
mechanisms at the dendritic spine have in response to pathology. Here, evidence is provided for the 
early dysfunction of the synapse in an ALS disease model being a key disease event within the 
presymptomatic motor cortex, a region that may be primed to fail fundamentally as a result of sustained 
activity demands at the dendritic spine. Further, the thesis supports the notion of oestrogen as being 
neuroprotective at the synapse, and indicates the transient peaks of the hormone maintain compensatory 
dynamics in the presence of misprocessed TDP-43. These results highlight the targeted nature of 
vulnerability to neurodegenerative diseases, and highlight the need to target early dysregulation of 
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neuroplasticity at the synapse to protect select cortical networks prior to neurodegeneration. 
Importantly, the identification of cycling oestrogen as being protective at the dendritic spine may be 
critical for future efforts aimed at developing new therapeutic targets in ALS and other 
neurodegenerative diseases; for this application to be viable, it is essential to investigate further the 
role for disease proteins at the dendritic spine, as well as the mechanisms through which oestrogen 
exerts neuroprotective effects.  
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1 INTRODUCTION 
Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disease that is presently 
incurable and manifests as the degeneration of the motor system (Cleveland & Rothstein 2001, Talbot 
2014) (Figure 1.1.1). The disease is characterised by the loss of cortical upper motor neurons (UMNs) 
and spinal lower motor neurons (LMNs); the deterioration of this system then leads to muscle 
weakness, disability, paralysis and eventual death (Logroscino et al 2008) . The disease strikes 2/100, 
000 people annually, with a male to female ratio of 1:5 for sporadic disease forms (Chio et al 2013). 
The mean age of onset is 55-60 years and with no treatments available to successfully halt disease 
progression, the majority of patients die within 2-5 years of diagnosis, primarily from respiratory 
failure (Al-Chalabi & Hardiman 2013, Chio et al 2013). Two drugs have been approved for the 
treatment of ALS; the first of these being Riluzole and the most recent being Edaravone (Abe et al 
2017, Bensimon et al 1994, Cruz 2018, Fang et al 2018). Riluzole is a glutamatergic antagonist, 
associated with a 35% reduction in mortality and being particularly efficacious at the later stages of 
disease (Fang et al 2018). The exact mechanism of action of edaravone treatment in ALS is still 
unknown, though therapeutic benefits may be a result of antioxidant properties (Cruz et al 2018).  
 ALS is a multifactorial disorder and this translates into vast clinical heterogeneity. Disease onset is 
focal, and patients experience fatigue in conjunction with limb onset (weakness and wasting of the 
limbs) or bulbar onset (tongue fasciculation) (Hardiman et al 2011, Turner & Swash 2015). The focal 
nature of onset then becomes something else entirely, following the systematic spread of pathology 
throughout the motor system- culminating in respiratory failure and death (de Carvalho et al 1996). 
Pathological spread from a focal point to canonical regions is indicative of common mechanisms in 
select regional vulnerability; thus to halt or prevent the spread of pathology throughout cortical regions, 
the earliest disease events need to be identified to produce therapeutic targets (Figure 1.1.2). While the 
majority of ALS cases are sporadic (sALS), with ten percent being linked to familial mutations (fALS), 
the overlap in disease presentation in both sporadic and heritable disease further indicates shared 
neurodegenerative pathways (Pochet 2017).  
In 2006 the transactive response DNA-binding protein 43 (TDP-43) was identified as the primary 
component of intracellular ubiquitinated inclusions that characterise 97% of sporadic ALS cases, and 
familial disease forms have been linked to mutations in the TARDBP gene that encodes for TDP-43 
(Geser et al 2009, Ling et al 2013, Neumann et al 2006, Umoh et al 2018). Furthermore, specific 
neuronal networks are spared in sporadic disease and even in the presence of ubiquitously expressed 
heritable mutations; cognitively, higher order executive functions, problem solving and memory are 
Figure 1.1.1 
Schematic of the motor system, selectively vulnerable in ALS. The system is composed of 
upper motor neurons in the motor cortex, and bulbar and spinal (lower) motor neurons within 
the spinal cord which innervate skeletal muscles. Reproduced from Brown, 2017. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Figure 1.1.2 
The development of ALS may begin during a prolonged pre-clinical time period. Motor 
neurons are inherently susceptible to inflammation, excitotoxicity, mitochondrial dysfunction 
and environmental risk factors. Epigenetics may also further influence sensitivity and 
susceptibility to these insults. The high activity-load of motor neurons leads to metabolic stress 
and progressive loss of motor neuron function; after a prolonged period of compensation, these 
mechanisms may then begin to fail and early presymptomatic features such as 
electrophysiological abnormalities may be detectable. By clinical manifestation of disease, the 
motor system fails and ALS becomes progressively symptomatic. Reproduced from Eisen et 
al 2014. 
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preserved, whilst bladder control and eye movement are unaffected by the pathological spread of motor 
neuron neurodegeneration (Bruijn & Cudkowicz 2014, Proudfoot et al 2016). Together, this suggests 
that not only is TDP-43 dysfunction intimately associated with ALS pathogenesis, it is also implicated 
in the differential vulnerability of cortical regions.  
1.1 EPIDEMIOLOGY AND CLINICAL MANIFESTATION  
The prevalence of ALS in Australia is thought to be 8 sufferers per 100 000, with approximately 1500 
patients living with the disease at a given time (Kiernan et al 2011). With no biomarkers or tests 
currently widely available, diagnosis of ALS is based on clinical scoring using neuropsychological 
tests and structural brain imaging (Hardiman et al 2011). Both fALS and sALS share the focal 
degeneration of motor neurons, grouped into upper populations of the motor cortex and the lower 
populations of the spinal cord and brain stem (Fogarty 2018). As these populations degenerate, the 
synaptic connectivity with target muscles is lost, leading to atrophy of the muscle and characteristic 
manifestation of disease (Brown & Al-Chalabi 2017). The loss of UMN populations induces muscle 
stiffness and spasticity, whilst LMN loss is observed through excessive excitation that induces 
fasciculations, observed as muscle spasms (Al Chalabi et al 2011). Approximately 70% of patients 
will present with limb onset, 25% with bulbar onset (speech and swallowing difficulties), and 5% with 
initial respiratory involvement that ultimately spreads to other regions (Kiernan et al 2011). Though it 
is apparent that the motor system as a whole is affected in ALS, it is still unclear as to where the initial 
pathological insult begins; multiple hypotheses attempt to cohesively understand the timing and extent 
of UMN and LMN degeneration. The ‘dying-back’ hypothesis has historically been the most accepted, 
and encompasses initial periphery neuronal loss prior to retrograde degeneration toward the cortex 
(Dadon-Nachum et al 2011, Fischer et al 2004, Williamson & Cleveland 1999). Conversely, the 
‘dying-forward’ hypothesis concerns disease initiation in the motor cortex, followed by anterograde 
neurodegeneration and loss of motor network connectivity (Eisen et al 1992). An alternative, third 
hypotheses has also gained traction in recent literature- that of independent degeneration. This theory 
suggests neurodegeneration occurs at both ends of the motor system near-simultaneously, resulting in 
bi-directional neuronal loss, and highlights the importance of treating the circuitry of the motor system 
as a whole (Dervishi & Ozdinler 2018, Grad et al 2017) (Figure 1.1.3). Contentious as these concepts 
may be, increasing evidence indicates the early dysfunction of upper motor neurons in the motor cortex 
precedes the clinical manifestation of disease prior to onset, indicating the cortex is an early site of 
pathology (Geevasinga et al 2016a, Menon et al 2015, Ozdinler et al 2011, Vucic et al 2011). 
Identifying the earliest disease mechanisms is essential for finding an efficacious cure; however, due 
to the diversity in disease manifestation it has proven incredibly difficult to identify therapeutic and 
Figure 1.1.3 
Schematic of the die-forward (green text), die-back (blue text) and independent degeneration 
(red text) hypotheses of ALS. The die-forward hypothesis posits that ALS onset begins within 
the corticomotor system, with lower motor neuron degeneration resulting later in the cascade 
due to glutamate-mediated excitotoxicity. The die-back hypothesis posits that ALS begins 
within muscles, at the neuromuscular junction. The disease cascade then travels retrogradely 
to the cell body and towards the corticomotor system. In contrast, the independent-degeneration 
hypothesis suggests both upper and lower motor neurons degenerate independently and 
concurrently within their distinct compartments. Reproduced from Vucic et al 2013. 
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neuroprotective targets, and diagnosis is often complex and delayed (Geevasinga et al 2016b) (Figure 
1.1.2). A major barrier to understanding ALS has been the inability to create viable disease models to 
understand the complex combination of pathological pathways and rare occurring de novo mutations. 
1.1.1 Familial ALS and Protein Dysfunction  
A theme common in ALS is the dysfunction and aggregation of several protein species, both mutant 
and wild-type, that undergo distinct posttranslational modifications (see Table 1.1.1). The first gene 
and protein whose mutations were identified as ALS-causing was cytosolic superoxide dismutase 
[Cu/Zn] (SOD1) (Rosen et al 1993). The majority of missense and truncation protein mutations induce 
SOD1 inclusion bodies within spinal motor neurons, with a correlation between the degree of 
conformational instability and rate of disease progression (Borchelt et al 1994, Prudencio et al 2009). 
The molecular underpinnings of SOD1 cytotoxicity disrupt an array of normal functions, partly 
associated with mechanisms of oxidative stress and the aberrant trafficking of copper and zinc; this is 
in addition to disrupted mitochondrial trafficking, impaired molecular motors and axonal transport, 
and interference with neuromuscular synapses (Beckman et al 1993, Estevez et al 1999, Morfini et al 
2013, van Zundert et al 2012, Vande Velde et al 2011). The creation of the SOD1G93A mouse model- 
expressing high levels of mutant protein- has been crucial for investigations into ALS through the 
recapitulation of pathological and clinical phenotypes observed in human cases (Gurney et al 1994).  
A major breakthrough in investigating the aggregation of ubiquitinated proteins as an early and 
canonical feature of ALS pathology came with the identification of pathological TDP-43 inclusions, 
along with mutations in the gene encoding for the protein in sALS and fALS (Neumann et al 2006). 
The protein TDP-43 has been identified as a pathological hallmark in a range of disparate 
neurodegenerative diseases, with the depletion and increase of protein levels implicated in the 
progression of both sporadic and familial ALS (D'Alton et al 2014, Gendron & Petrucelli 2011). The 
fused in sarcoma/translocated in liposarcoma protein (FUS/TLS) is an RNA-binding protein that has 
also been implicated in ALS through heritable gene mutations (Kwiatkowski et al 2009, Vance et al 
2009) (Dormann et al 2010). FUS/TLS is structurally and functionally similar to TDP-43, with 
mutations identified in a range of intracellular inclusions (Dobra et al 2018).  
An advance in identifying the genes that underlie fALS came in 2011, with the discovery of 40-50% 
of cases being attributed to mutations in the C9ORF72 gene (DeJesus-Hernandez et al 2011, Renton 
et al 2011). Normally, the C9ORF72 (Chromosome 9 Open Reading Frame 72) protein has roles in 
trafficking nuclear/endosomal membranes and autophagy, featuring a noncoding stretch of six 
nucleotides repeats up to 30 times; however, in ALS this segment is repeated hundreds to thousands 
Table 1.1.1 Adapted from Taylor et al 2016. 
Locus Gene Protein Function Mutations Proportion 
of ALS 
 Discovery 
     Familial Sporadic  
21q22.1 SOD1 Cu/Zn superoxide 
dismutase 
Superoxide 
dismutase 
>150 20% 2% Rosen et al 1993 
2p13 DCTN1 Dynactin Component of dynein 
motor complex 
10 1% <1% Puls et al 2003 
14q11 ANG Angiogenin Ribonuclease >10 <1% <1% Greenway et al 
2006 
q36 TARDBP TDP-43 RNA-binding protein >40 5% <1% Kabashi et al 
2008; 
Sreedharan et al 
2008 
16p11.2 FUS FUS/TLS RNA-binding protein >40 5% <1% Kwiatkawski et 
al 2009; Vance 
et al 2009 
9p13.3 VCP Valosin-containing 
protein 
Ubiquitin segregase 5 1-2% <1% Johnson et al 
2010 
10p15-
p14 
OPTN Optineurin Autophagy adaptor 1 4% <1% Maruyama et al 
2010 
9p21-22 C9ORF72 C9ORF72 Possible guanine 
nucleotide exchange 
factor 
Intronic 
GGGGCC 
repeat 
25% 10% De-Jesus 
Hernandez et al 
2011; Renton et 
al 2011 
Xp11.23- 
Xp13.1 
UBQLN2 Ubiquilin2 Autophagy adaptor 5 <1% <1% Deng et al 2011 
5q35 SQSTM1 p62 Autophagy adaptor 10 <1%  Fecto et al 2011; 
Teyssou et al 
2011 
17p13.2 PFN1 Profilin-1 Actin-binding protein 5 <1% <1% Wu et al 2012 
12q13.1 HNRNPA1 hnRNPA1 RNA-binding protein 3 <1% <1% Kim et al 2013; 
Liu et al 2013 
5q31.2 MATR3 Matrin3 RNA-binding protein 4 <1% <1% Johnson et al 
2014 
2q36.1 TUBA4A α-tubulin 4 a Microtubule subunit 7 <1% <1% Smith et al 2014 
22q11.23 CHCHD10 Coiled-coil-helix-coiled-
coil-helix domain 
containing 10 
Mitochrondrial 
protein of unknown 
function 
2 <1% <1% Bannwarth et al 
2014 
12q14.1 TBK1 TANK-binding kinase 1 Regulates autophagy 
and inflammation 
10 ? ? Freischmidt et 
al 2015 
16p13.3 CCNF Cyclin F Ubiquitin proteolysis 10 ? ? Williams et al 
2016 
4q33 NEK1 Never in mitosis gene A-
related kinase1 
Cell cycle control and 
cilia regulation 
4 ? ? Brenner et al 
2016; Kenna et 
al 2016 
21q22.3 C21ORF2 Cilia and flagella-
associated protein 410 
Ciliogenesis and 
DNA damage repair 
21 ? ? van Rheenan et 
al 2016; Iyer 
etal 2018 
2p13.3 TIA1 Cytotoxic granule-
associated RNA-binding 
protein 
RNA-binding 
protein, component 
of stress granules 
1 2% 0.4% Mackenzie et al 
2017 
10q22.3 ANXA11 Annexin A11 Calcium-dependent 
phospho-lipid 
binding protein 
3 ? ? Smith et al 2017 
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of times, with three mechanisms thought to induce disease state. A loss of function mechanism has 
been theorised to be caused by down-regulation of C9ORF72 gene expression (Sakkas et al 2017). 
Secondly, a gain-of-function mechanism has been associated with the sequestration of RBPs into 
intranuclear foci (Kumar et al 2017). The third proposed mechanism is that of dipeptide-repeat protein 
(DPR) production through abnormal non-AUG-dependent (RAN) translation of RNAs containing 
repeats (Freibaum et al 2015, Zhang et al 2015). While mouse models of C9ORF72 mutations 
recapitulate the molecular signature of associated ALS, most of these mice do not show a strong motor 
phenotype, with the exception of the BAC mouse model (Liu et al 2016, O'Rourke et al 2016, Peters 
et al 2015).  
Models of fALS mutations have been used to uncover a swathe of shared pathological pathways, as 
well as mutation-specific phenotypes that have broadened our knowledge of shared mechanisms that 
may be relevant across all forms of ALS. To better understand incidences of ALS outside of heritable 
mutations, research models also need to encompass sporadic pathological pathways.  
1.1.2 Sporadic insights 
Though family history in sporadic disease is absent, twin studies demonstrate heritability is still ~60% 
and mutations identified in fALS can also be found in sALS (Al-Chalabi et al 2010). This is 
confounded by fALS mutations manifesting as other neurodegenerative disorders; the intermediate 
penetrance of several fALS gene variants; and the combination of variants that may increase the risk 
of ALS through apparently sporadic mechanisms (Andersen & Al-Chalabi 2011, Cirulli et al 2015, 
Freischmidt et al 2015, Pottier et al 2015, van Blitterswijk et al 2012). Still, studies of heritability 
cannot account for all sALS cases and these are thought to be a result of undefined factors or 
environmental exposures. Studies of environmental factors have been inconclusive and are notoriously 
fraught due to the large number of possible exposures, and the temporal difficulty of identifying when 
exposures occurred. Additionally, poor prognosis is linked to reporting bias, wherein the patients who 
survive long enough to contact specialist research centres differ from those included in population 
studies (Lacorte et al 2016). Despite these issues, factors such as military service, smoking, and chronic 
exposure to heavy metals and electromagnetic fields have been associated with ALS in multiple studies 
(Beard et al 2016, Ingre et al 2015, Wang et al 2011).  
In both sALS and fALS, it is apparent that the motor system is uniquely susceptible to the disease 
mechanisms that characterise ALS. It is critical to identify the pathological pathways shared by fALS 
and sALS to understand the select vulnerability of the motor cortex to this disease.  
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1.2  THE DIFFERENTIAL VULNERABILITY OF CORTICAL REGIONS IN DISEASE 
Early synaptic dysfunction within vulnerable cortical regions has been identified across a range of 
neurodegenerative diseases (Henstridge et al 2016). The human brain constructs and functions via 
intricate large-scale neural connectomes that are critically dependent on functional feedback at the 
synapse. These discrete regions are defined by synchronous baseline activity; a unified and stepwise 
reaction to stimulation; and selective vulnerability to neurodegenerative disorders (Seeley et al 2007, 
Henstridge et al 2016). Accordingly, correlated spontaneous activity occurs within functionally related 
and spatially distinct groups of cortical and subcortical regions (Vincent et al 2007). These direct or 
indirect anatomical connections exist within intrinsic connectivity networks, as evidenced by 
functional magnetic resonance imaging (fMRI) and blood-oxygen-level-dependent (BOLD) signal 
fluctuations during sleep, and during mental effort (Fransson et al 2007, Greicius et al 2009, 
Hesselmann et al 2008, Raichle 2009). Neurodegenerative diseases induce progressive and debilitating 
dysfunction as a result of localised regional pathology, and a canonical pattern in disease is the 
misfolding of key proteins within targeted neuronal populations residing in distinct brain regions 
(Seeley et al 2009, Takalo et al 2013, Walker et al 2013). As pathology spreads throughout 
interconnected anatomical areas, synaptic connections within intrinsic networks falter and are 
accompanied by a worsening in disease manifestation (Buckner et al 2009, Greicius et al 2004, Palop 
et al 2006, Selkoe 2002).  
ALS features the exclusive dysfunction of the motor system, with pathology spreading to the frontal 
and temporal lobes in later disease stages (Brettschneider et al 2013). Within the cortex, UMNs are 
selectively lost in a unique pattern of degeneration (Nihei et al 1993); though there is increasing 
recognition of other affected neuronal subgroups in the disease, particularly after a prolonged disease 
course. While synaptic dysfunction has been increasingly implicated in the disease, a myriad of 
pathological intrinsic and extrinsic mechanisms have been identified as specifically impacting motor 
neurons during ALS progression.    
1.2.1 Motor neuron pathology  
The clinical manifestation of ALS is distinct, yet the complexity of molecular mechanisms implicated 
in this multifactorial disease underlie vast heterogeneity. Various neurochemical and molecular 
pathways of motor neurons render cells vulnerable to insults, and in ALS genetic factors, glutamatergic 
toxicity, oxidative stress and damage to specific proteins and organelles may all be important 
contributory factors (Shaw & Eggett 2000) (Figure 1.1.2; Figure 1.1.4). Motor neurons differ vastly 
Figure 1.1.4 
The pathophysiological mechanisms underlying neurodegeneration in ALS. The disease is 
multifactorial, and involves molecular and genetic pathways. Astrocytic dysfunction is 
associated with reduced glutamate uptake by excitatory amino acid transporter 2 (EAAT2) 
from the synaptic cleft, and is linked to excitotoxicity. Glutamate-induced excitotoxicity results 
in the influx of Na+ and Ca2+ ions, with neuronal death due to activation of Ca2+ enzymatic 
pathways and the generation of free radicals. Mutations in key genes such as C9ORF72, 
TARDBP and FUS induce dysregulation of RNA processing and metabolism, linked to protein 
mislocalisation and toxic cytoplasmic inclusions. SOD1 mutations increase oxidative stress 
and mitochondrial dysfunction, as well as affecting neurofilamental and axonal transport 
processes. Secretion of proinflammatory cytokines follows microglial activation. Adapted 
from Vucic et al 2014.  
 
 
 
 
 
 
 
 
 
 
 
 
 

   26  
 
from other cells in somatic diameter and the length of axonal processes; consequently, this comes with 
increased energy, metabolic and mitochondrial demands, along with a high content of neurofilament 
proteins (Gao et al 2009).  
Mitochondrial alterations have been observed in patient tissue and in animal models, with impairments 
in organelle clearance and calcium buffering, apoptosis and defective mitochondrial transport 
(Cozzolino & Carrì 2012, Cozzolino et al 2013, Palomo & Manfredi 2015). The majority of studies 
implicating mitochondrial involvement in ALS come from those on SOD1-associated disease forms 
with SOD1 mutations increasing protein accumulation in mitochondria, inducing defective function, 
mitochondrial damage and ALS-like phenotypes (Cozzolino et al 2009, Magrané et al 2009, Pickles et 
al 2016, Tafuri et al 2015). The translocation of mutated FUS to mitochondria also seems to play a 
role in this pathway, interacting with the mitochondrial chaperone HSP60 and inducing an ALS 
phenotype in Drosophila expressing disease-associated mutations (Deng et al 2015). The increased 
demands required to sustain motor neurons are clearly factors in the underlying susceptibility to 
disease, and this extends to the cytoskeletal components of the cell.   
The axonal length of motor neurons necessitates relatively high neurofilament content, with 
neurofilament (NF) proteins being the major component of the cytoskeleton (Hirokawa et al 1984, 
Oberstadt et al 2018). A feature of ALS is the abnormal assembly and accumulation of neurofilaments 
within the cell body and axons of motor neurons; though it is not known whether these events are a 
consequence of blocked axonal transport, or whether protein accumulation mediates secondary 
impairment (Hirano 1991). In human embryonic stem cells expressing a SOD1 mutation, NF 
misregulation has been found to mediate aggregation and axonal degeneration in ALS-patient derived 
motor neurons (Chen et al 2014). Aberrant neurofilaments are also found localised with ubiquitinated 
TDP-43 inclusions within the cytoplasm, with variations in the subunits of NFs (Menke et al 2015, 
Turner & Gray 2016).  
Gene mutations associated with ALS impact multiple cell types, and it is now apparent the disease 
arises partly from non-cell-autonomous mechanisms (Taylor et al 2016). Microglia are the immune 
cells of the nervous system, and are activated in ALS; indeed, microglial synthesis of mutant SOD1 is 
a determinant of rapid disease progression (Boillee et al 2006). In C9ORF72 variants of ALS, the 
inactivation of the protein encoded by C9ORF72 results in abnormal microglia and progressive 
inflammation, providing further evidence towards microglia-mediated inflammation in ALS (Burberry 
et al 2016, O'Rourke et al 2016). Astrocytes are another glial cell-type implicated in non-cell 
autonomous pathology, whereby astrocytes affected by ALS mutants are implicated in diffusible motor 
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neuron toxicity (Di Giorgio et al 2007, Re et al 2014). These cells play a critical role in governing 
neuronal transmission- responsible for neurotransmitter clearance at the synapse and critical for the 
protection of neurons from overstimulation (Malarkey & Parpura 2008, Schousboe et al 2014). The 
deregulation of glutamate metabolism and clearance has been identified through increased glutamate 
in the cerebrospinal fluid (CSF) of ALS patients, whilst studies in ALS post-mortem tissue and SOD1 
mice have identified reductions in excitatory amino acid transporters (EAAT1 and EAAT2), and in 
glutamate transporters (GLT-1) (Lin et al 1998, Pardo et al 2006, Rothstein et al 1990, Rothstein et al 
1995). Though a range of pathways are implicated here in motor neuron susceptibility in disease,  
accumulating research now suggests the dysregulation of glutamate and excitation may be critical to 
the onset and progression of neurodegenerative mechanisms.  
1.2.2 Cortical Excitability 
A well-documented aspect of ALS pathophysiology is cortical hyperexcitability- an increased neuronal 
or network response to a stimulus (Bae et al 2013, Do-Ha et al 2018). Glutamate is the principle 
excitatory neurotransmitter of the brain, with three main ionotropic receptors; N-methyl-D-aspartate 
(NMDA), α-amino-3-hydroxyl-5-methylisoxazole-4-propionic acid (AMPA) and Kainite (Meldrum 
2000). Glutamatergic transmission is essential for cortical plasticity and long-term potentiation, yet 
can also promote excitotoxic environments that can lead to neuronal loss within cortical networks 
(Kalia et al 2008). Investigating neurophysiological network features in fALS and sALS cohorts has 
shown hyperexcitability is a common pathology, and accordingly patients often display early increases 
in neural activity indicative through muscle cramping and fasciculations, months before the clinical 
diagnosis of the disease (Bae et al 2013, de Carvalho et al 2014, Mills & Nithi 1997, Vucic et al 2008, 
Wainger et al 2014). Several clinical methods can be employed to investigate changes to excitation 
within cohorts in vivo, including transcranial magnetic stimulation (TMS) (de Carvalho et al 2008). 
TMS stimulates the primary motor cortex, producing electrical currents and measurable muscle 
responses (Di Lazzaro et al 2006, Nurmikko et al 2016, Treister et al 2013). Using this technology, 
studies have shown patients in the early stages of ALS require a smaller stimulus to generate an evoked 
response, indicating a hyperexcitable motor cortex (Menon et al 2015, Vucic & Kiernan 2006). The 
drug Riluzole is known to slow ALS progression- though only by a few months- and a proposed 
pathway for efficacy is the inhibition of persistent sodium (Na+) channels, though any effects on 
hyperexcitability are transient (Geevasinga et al 2016a, Kuo et al 2005, Pieri et al 2009, Vucic et al 
2013a). Additionally, the reduction of potassium (K+) channels has been confirmed in patient cohorts, 
potentially contributing to hyperexcitability and fasciculations (Jiang et al 2005, Kanai et al 2006, 
Shibuya et al 2011).  
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The inhibitory networks of the cortex can provide further insights into cortical hyperexcitability. To 
balance excitation within neural circuitry, inhibitory interneurons utilise gamma-aminobutyric acidA  
(GABA)- the predominant inhibitory neurotransmitter in the brain (Buzsáki & Wang 2012, Owens & 
Kriegstein 2002). Applying TMS to ALS patients has shown the threshold to produce motor-evoked 
potentials is reduced following an inhibitory stimulus, particularly so in those with less severe 
symptomology. This suggests that not only is cortical excitability present early in disease, it may be 
reduced at later progressive stages (Floyd et al 2009, Vucic et al 2018, Vucic et al 2013b). Furthermore, 
specific interneuronal populations are perturbed, whereby the loss of calretinin interneurons in the 
SOD1G93A mouse and fluctuating levels of neuropeptide-Y (NPY) interneurons may reflect 
compensatory mechanisms of the motor circuitry (Clark et al 2017).  In layer V of the motor cortex, a 
decrease in interneuron populations occurs concurrently with a reduction in the frequency of GABA 
receptor-mediated postsynaptic currents, leading to cortical hyperexcitability (Nieto-Gonzalez et al 
2011).  
Hyperexcitability is associated with the exaggerated influx of calcium through AMPA receptors 
(AMPARs), and alterations to key synaptic receptors are linked to toxic alterations in calcium 
permeability (Hardingham & Bading 2010, Kawahara et al 2004, Kwak & Kawahara 2005, Lau & 
Tymianski 2010). Motor neurons express abundant glutamate receptors and as such, the cell type is 
especially vulnerable to AMPAR-mediated excitotoxicity (Carriedo et al 1996, Krieger et al 1994, Van 
Den Bosch et al 2000). The calcium permeability of AMPARs is largely mediated by the ionotropic 
glutamate receptor 2 (GluA2) subunit, and the process of post-transcriptional editing to induce calcium 
impermeability at the Gln/Arg site (Grosskreutz et al 2010, Kawahara et al 2004, Sasaki et al 2015, 
Yamashita & Kwak 2014b). The low expression of GluA2 and calcium-buffering proteins render 
motor neurons uniquely vulnerable to excitability of the cortex in ALS, though clear evidence 
indicating that it is the primary disease mechanism is lacking.  
Intriguingly, recent studies have now shown that the most vulnerable motoneuron populations lose the 
ability to fire repetitively- a signature of hypoexcitability (Devlin et al 2015, Martinez-Silva et al 
2018). These insights have challenged the notion of hyperexcitability being responsible for cell death, 
evidenced by the resilience of hyperexcitable subsets of motor neurons, and the protection of motor 
neurons from ALS-linked pathology following induction of excitability (Leroy & Zytnicki 2015, 
Saxena et al 2013). Studies utilising ALS human induced pluripotent stem cells (iPSCs) have indicated 
evidence for both hypo- and hyperexcitability; however, some light has been shed on these 
contradictory findings from a 2015 study, where a switch from initial hyperexcitability to later 
hypoexcitability was reported in motor neurons differentiated from patient-derived iPSCs harbouring 
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TARDBP and C9ORF72 gene mutations (Naujock et al 2016). The susceptibility of motor neurons to 
hypoexcitability has been further elucidated following the identification of the most vulnerable 
populations being larger motor units containing fast-contracting muscle fibers, breaking down at a 
faster rate than slower motor units. Furthermore, these large motor units display an inability to fire 
repetitively even though their neuromuscular junctions are still functional (Martinez-Silva et al 2018). 
Together, these studies suggest intrinsic hyperexcitability is unlikely to be the major cause of motor 
neuron degeneration, and that hypoexcitability may be a key player in the progression of ALS. Though 
we have evidence of changes in the excitability of neurons within the motor system, we still do not 
understand the mechanisms driving these changes; nor do we know when these insults are occurring 
over a timeline of disease. The misprocessing of the protein TDP-43 is another hallmark feature of 
ALS that is shared across the vast majority of cases, and the potential for an association between this 
and excitability may be key to identifying early disease mechanisms. 
1.3 THE FUNCTIONS OF TDP-43 
The hallmark characteristic of ALS is the aggregation and mislocalisation of TDP-43. The protein is 
an auto-regulating and widely expressed RNA-binding protein (RBP) localised to the neuronal 
nucleus, able to shuttle into the cytoplasm to perform functions in both compartments (Ayala et al 
2008, Neumann et al 2006). The protein features two RNA-recognition motifs (RRM1 and RRM2), an 
N-terminal domain (NTD) and a glycine-rich C-terminal domain (CTD) (Neumann et al 2006). RRM1 
has a crucial role in the binding affinity between TDP-43 and single stranded RNA (ssRNA), and both 
RRMs are essential for the regulation of transcription and RNA-splicing (Maurel et al 2018). The NTD 
encompasses the nuclear localisation signal and RRM1, and this domain is highly conserved between 
species (Kuo et al 2014, Mompean et al 2017, Yang et al 2010a)(Figure 1.1.5). Physiologically, the 
NTD is able to reversibly assemble full-length TDP-43, enhancing the functions of the CTD by raising 
the local concentration of these disordered domains (Mompeán et al 2017). The CTD is essential for 
protein-protein interactions, enabling liquid-liquid phase separation and aggregation (Buratti et al 
2005, Conicella et al 2016, Kato et al 2012, Kuo et al 2009). The domain also facilitates reversible 
RNA granule assembly and soluble protein aggregation (Han et al 2012).  
The structure of TDP-43 is essential for other roles in the regulation of mRNA splicing, translation 
and transport (Alami et al 2014, Bose et al 2011, Liu-Yesucevitz et al 2014, Polymenidou et al 2011, 
Tollervey et al 2011); the processing of micro RNAs via Drosha and Dicer complexes (Kawahara & 
Mieda-Sato 2012, Ling et al 2010); the assembly of stress granules to protect mRNA (Aulas & Vande 
Velde 2015, Liu-Yesucevitz et al 2010); and the trafficking of RNA granules to distal processes (Alami 
Figure 1.1.5 
The structure of TDP-43 and ALS-linked mutations. TDP-43 consists of a nuclear localisation 
sequence (NLS) and a nuclear export sequence (NES), two RNA recognition motifs (RMM1, 
RMM2) and a glycine-rich, low complexity sequence C-terminal domain (LCD). The 
mutations identified in TDP-43 in sporadic and familial ALS patients are primarily localised 
within the LCD. The mutation studied in the current thesis is highlighted in red (A315T).  
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et al 2014, Coyne et al 2015, Gopal et al 2017, Liu-Yesucevitz et al 2014). Upon stimulation, TDP-43 
colocalises and co-purifies with other RBPs such as Staufen, and localised to dendrites within RNA-
granules containing target mRNAs (Freibaum et al 2010, Yu et al 2012). The number of TDP-43-
containing granules increases following neuronal activation and the protein is translocated to dendritic 
spines, establishing TDP-43 as a neuronal activity-response factor, particularly as a component of these 
granules (Alami et al 2014, Wang et al 2008a). Distal TDP-43 localisation is further supported by 
identification of the protein at the presynaptic membrane of neuromuscular junction (NMJ); a synaptic 
connection formed between motor neurons and muscle fibers (Narayanan et al 2013). Knowledge of 
these roles is critical for understanding how either the loss of or the gain of protein function underpins 
disease pathogenesis, and is achievable only through our ability to model TDP-43-mediated toxicity.  
1.3.1 Investigating TDP-43 Toxicity 
The pathological accumulation of TDP-43 was first identified in post-mortem patient tissue in 2006, 
yet the role of this pathology is still poorly understood in the context of human clinical features, 
outcomes and underlying molecular mechanisms. Autopsy cohorts have provided an unmatched 
opportunity to investigate clinical associations with aggregate pathology, and give further insights into 
the toxicity of TDP-43 misprocessing. The burden of insoluble TDP-43 has been associated with a 
greater severity of cognitive changes and a reduction in cortical thickness, affecting regions outside of 
the motor system by end stage (Brettschneider et al 2014, Ferraro et al 2018, Geser et al 2009, 
McCluskey et al 2009). The distinct aggregate patterning of TDP-43 has also been associated with 
disease phenotypes, whereby cortical dystrophic neurites indicate a poorer prognosis - despite the less 
severe loss of lower motor neurons (Takeuchi et al 2016). Interestingly, the burden of TDP-43 in the 
hypoglossal nucleus has been shown to discriminate ALS patients from other disorders with 98% 
accuracy, whilst TDP-43 burden in layer V pyramidal neurons in the anterior cingulate cortex is 
specifically linked with sporadic ALS, connecting regional protein pathology with distinct clinical 
phenotypes (Braak & Del Tredici 2018, Braak et al 2017, Tan et al 2015).  
Though post-mortem tissue has proven an invaluable resource, the caveat remains that these cases are 
analysed at the end of the ALS disease course, and cannot shed light on the early or initiating 
mechanisms if the disease. The ability to generate human iPSCs from somatic cells allows the analysis 
of individual human phenotypes within a physiological context (Dimos et al 2008, Takahashi et al 
2007). Derived motor neurons from both fALS and sALS patients demonstrate these cells are able to 
functionally mature, and recapitulate key disease aspects such as neuronal degeneration and insoluble 
protein accumulation (Burkhardt et al 2013, Egawa et al 2012, Guo et al 2017). Nucleocytoplasmic 
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deficits have been identified under conditions of misprocessed TDP-43 in the presence of C9ORF72 
mutations, and sporadic lines have been used to identify mitochondrial involvement in disease; thus 
demonstrating the use for iPSCs to delineate pathogenic events in ALS (Alves et al 2015, Burkhardt 
et al 2013, Zhang et al 2016). Interestingly, regardless of genotype TARDBP and C9ORF72 mutations 
display initial hyperexcitability followed by progressive reductions in action potential outputs and 
synaptic activity, further supporting the early dysfunction of excitability as a common mechanism 
underlying motor neuron death in ALS (Devlin et al 2015).   
While human tissue and iPSCs provide new pathways through which to investigate ALS and TDP-43-
mediated pathology, animal models are still a widely used resource aimed at establishing pathological 
links between TDP-43 and ALS. These models facilitate investigations into early disease mechanisms 
that cannot be elucidated from post-mortem tissue, within mammalian nervous systems that are unable 
to be replicated in a dish. To uncover the mechanistic disease role of TDP-43 and the cell type in which 
misprocessed proteins act to drive pathological cascades, promotors have been used to drive varying 
expression levels of wild-type (WT) and mutant protein forms in murine models (Ash et al 2010, 
Kabashi et al 2010, Wegorzewska et al 2009, Xu et al 2011). The overexpression of wild-type TDP-
43 under the control of different promotors - prion (Prp), Thy1, or calcium/calmodulin-dependent 
kinase (CaMKII) - results in transgenic animals with a range of phenotypes and exogenous protein 
expression patterns. Wild-type human TDP-43 (WT-hTDP-43) exerts toxicity in a dose-dependent 
manner, and induces diverging disease manifestations depending on variables such as the promoter 
used (Da Cruz & Cleveland 2011). Driven by Prp, a 2.5 fold WT-hTDP-43 increase in mice induces 
motor dysfunction, cytoplasmic protein expression, TDP-43 posttranslational modifications and 
abnormal molecular trafficking along neuronal processes, mimicking signatures of ALS (Stallings et 
al 2010, Xu et al 2011). However, in comparable studies the same promotor driving hTDP-43 
expression has been shown to produce no overt phenotype, whilst a range of motor features occur in 
different combinations in mice expressing the protein under Thy1 or CAMKII promotors (Igaz et al 
2011, Wils et al 2010). Conversely, the complete knockout of the TARDBP gene is embryonically 
lethal, and knockout post-natally results in metabolic defects and rapid death (Chiang et al 2010, 
Kraemer et al 2010, Mitchell et al 2015, Sephton et al 2010, Wu et al 2010). Establishing the effects 
of varying expression levels of TDP-43 has been beneficial for understanding protein functions, and it 
is evident these changes lead to TDP-43-mediated toxicity in the central nervous system (CNS).  
Mutations in the TARDBP gene have been utilised to create models of ALS phenotypes in the presence 
of misprocessed TDP-43, with the majority of mutations located in the CTD of the protein (Gitcho et 
al 2008, Sreedharan et al 2008). The A315T mutation of TDP-43 induces autosomal dominant disease 
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and the accumulation of dysfunctional protein at ~3 fold overexpression as compared to endogenous 
levels (Gitcho et al 2008). Transgenic models with the mutation undergo the loss of layer V pyramidal 
neurons in the motor cortex and lower motor neurons in the spinal cord at the onset of motor deficits, 
recapitulating ALS clinical manifestation (Herdewyn et al 2014). The hyperactivity of somatostatin 
interneurons has been shown to inhibit layer V pyramidal neurons in the presence of the TDP-43A315T 
mutation early in disease, contributing to overall excitotoxicity in the motor cortices and further 
recapitulating the excitability of discrete cortical networks (Zhang et al 2016). Concurrent with 
comprised motor abilities, TDP-43A315T mice develop deficits in spatial memory and disinhibition; 
intriguingly, the suppression of the TDP-43 mutant in these animals for a week has the propensity to 
rescue motor and behavioural deficits (Ke et al 2015).  
Two other key mutations of TARDBP that promote toxicity in the CNS are the M337V and Q331K 
mutants (Rutherford et al 2008). Both mutations provoke age-dependent, progressive axonal 
degeneration and neurodegeneration, gait and motor disturbances, and enhance TDP-43 splicing 
functions for some RNA-targets, but a loss-of-function for others (Arnold et al 2013, Bilican et al 
2012, Xu et al 2011). TDP-43Q311K models have been shown to develop early synaptic disturbances 
alongside an ALS phenotype, whereby excitatory synaptic inputs and dendritic spine densities are 
increased presymptomatically (Fogarty et al 2016). The most crucial finding from models of TARDBP 
mutations and altered protein expression in ALS is that aggregation appears to be a secondary, rather 
than a primary pathological mechanism (Janssens et al 2013). The vast majority of disease mechanisms 
identified in these models are recognisable in human cases of ALS, and each mutation induces the 
clinical and molecular manifestation of disease; but without widespread TDP-43 aggregation. It may 
well be that the aggregation of TDP-43 is a late-stage disease signature, or even an attempt by the 
cortex to compensate for earlier insults. Whatever may be established as the initiating pathology 
mediated by TDP-43, it is apparent the misprocessing of the protein is a lynch pin in the disease 
cascade that becomes ALS.   
1.3.2 TDP-43-mediated pathology in Amyotrophic Lateral Sclerosis 
The caveat of our understanding of ALS is that we have yet to definitively demonstrate whether TDP-
43 misfolding induces the disease cascade or if indeed, aggregation is a result of earlier insults (Arnold 
et al 2013). To effectively tailor therapeutic interventions, it is essential to develop a detailed 
understanding of TDP-43 functions and explore the toxic effects of protein dysfunction on these roles. 
A diverse range of cellular stresses - including osmotic stress, endoplasmic reticulum stress, heat stress 
and, as aforementioned, oxidative stress - induce TDP-43 incorporation into stress granules, and the 
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protein directly binds to proteins associated with stress granule recruitment in vitro and in human tissue 
from ALS patients  (Anderson & Kedersha 2009, Barmada et al 2014, Dewey et al 2011, Liu-
Yesucevitz et al 2010, McDonald et al 2011). While the regulated aggregation of RBPs into stress 
granules is normally reversible, under conditions of chronic neuronal stress, stress granules may act to 
spread the pathological transformation of TDP-43; and intriguingly, TDP-43 within stress granules is 
detergent resistant (King et al 2012, Meyerowitz et al 2011).  
 
Translocation from the nucleus, to the cytoplasm, and to association with RNA granules is a common 
process for RBPs, and TDP-43 has been identified as an integral protein functioning to 
compartmentalise and traffic mRNAs from the cell body to distal sites for localised protein translation 
(Batista & Monday 2016, Elvira et al 2006). Translation of mRNAs is repressed during transport until 
arrival at a pre-destined site, where these mRNA packages are specifically targeted to and translated 
at activated synapses (Steward et al 1998, Steward & Worley 2001). Within dendrites, the TDP-43A315T 
mutant increases the size of neuronal RNA-granules and reduces movement and mobility along the 
axon; disrupting the arrival of key synaptic mRNAs at distal regions such as the synapse (Alami et al 
2014). Taken together, these findings indicate a pathological role for TDP-43 outside of the soma and 
within neuronal processes.  
 
RNA granules- along with other non-membrane-bound organelles enriched in RNA and proteins- show 
liquid droplet properties, such as rapid dissolution and assembly (Hyman et al 2014, Patel et al 2015). 
The structure of TDP-43 facilitates this process, possessing RRMs and a low complexity CTD (LCS) 
(Bolognesi et al 2016). The LCS drives self-assembly of RNA granules through a process that has been 
termed liquid-liquid phase separation (Han et al 2012, Li et al 2018, Murakami et al 2015, Patel et al 
2015). ALS-linked TDP-43 mutations are known to disrupt the self-assembly or phase separation 
ability, with dysfunction intrinsically linked to the protein’s cellular environment (Conicella et al 2016; 
Li et al 2018). The roles for TDP-43 as a component of various granules travelling to distal regions 
are indicative of functions outside of the classical nucleus-cytoplasm shuffling, aggregation-prone 
properties, and crucial roles for TDP-43 directly at the neuronal synapse. 
1.4 TDP-43 AT THE SYNAPSE  
The transport of mRNA and RNA to synapses is fundamental to the maintenance of neuronal activity 
and plasticity (Swanger & Bassell 2011). Specific RNAs depleted following TDP-43 knockdown are 
physiologically required for encoding proteins involved in synaptic activity and function 
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(Polymenidou et al 2011; Tollervey et al 2011). These include the subunit 2A of NMDARs; the 
ionotropic glutamate receptor 6 (GluA6); the calcium activated potassium channel alpha (Kcnma1); 
the voltage dependent calcium channel (Cacna1c); and synaptic cell-adhesion molecules neurexin 1 
and 3 (Nrxn1, Nrxn3), with crosslinking immunoprecipitation sequencing (CLIP-seq) identifying 
glutamate transport 1 (Glt1) as an in vivo RNA target (Polymenidou et al 2011). In patient tissue, 
changes to TDP-43 binding of individual transcripts have been identified in Nrxn3, as well as the 
excitatory amino acid transporter-2, essential for synaptic glutamate clearance; these transcript 
expression changes are proportional to the binding capacity of TDP-43 (Tollervey et al 2011). TDP-
43 may also be involved in directly regulating local translation at the synapse; the protein is actively 
relocated to the synapse following potassium chloride (KCl) stimulation of rat hippocampal neurons 
(Wang et al 2008). At the translational level, TDP-43 specifically targets and regulates 
futsch/microtubule-associated protein 1b (MAP1B), and Ras-related C3 botulinum toxin substrate 1 
(Rac1) (Godena et al 2011, Majumder et al 2012). Both of these proteins are essential for the structure 
of synaptic compartments, suggesting TDP-43 dysregulation and misprocessing may be linked to 
synaptic dysfunction (Ratti & Buratti 2016). 
1.4.1 TDP-43 at the presynapse  
Synaptic transmission is mediated by the regulated release of neurotransmitters from the pre-synaptic 
compartment (Binotti et al 2016). At the pre-synapse, efficient trafficking of mRNA for local protein 
synthesis is vital to maintaining transmission within cortical circuitry (Alami et al 2014). Following 
TDP-43 silencing, pre-synaptic targeted proteins found to be differentially upregulated within primary 
cortical neurons include syntaxin-1A (Stx1A), vesicle-associated membrane protein 1 (VAMP1) and 
synaptotagmin 17 (Syt17); all essential for synaptic function and structure (Honda et al 2013). 
Furthermore, at disease onset whole brain protein homogenates from hTDP-43 mice display a 44% 
decrease in synaptophysin levels, a pre-synaptic protein often used as a marker of synaptic density 
(Medina et al 2014). Accordingly, TDP-43 is localised to the presynaptic mouse NMJ, concentrated at 
the motor nerve terminal (Godena et al 2011; Narayanan 2013). 
The NMJ is a specialised cholinergic synapse that is particularly vulnerable in ALS, and facilitates 
signalling between muscles and nerves required for skeletal muscle function (Campanari et al 2016). 
Impairment of the NMJ is manifested through muscle weakness or paralysis, key features of ALS, and 
these symptoms have been recapitulated in a range of animal models (Ciura et al 2013, Fischer et al 
2004, Magrané et al 2009). In Drosophila, TDP-43 mutations alter the organisation of the NMJ, 
correlating with reduced levels of the protein futsch/MAP1B-essential for microtubule assembly of the 
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cytoskeleton (Godena et al 2011). TDP-43Q331K mutant mice display defective fusion and release of 
synaptic vesicles, with aberrant NMJ innervation; this occurs prior to symptom onset, indicative of a 
failure of the NMJ to remodel in response to activity (Chand et al 2018). Indeed, accumulating studies 
indicate TDP-43 may have a crucial role in maintaining the structural integrity of the NMJ and the pre-
synaptic compartment and increasingly, the protein is linked to both the normal function and 
pathological dysfunction of the synapse (Estes et al 2013, Feiguin et al 2009, Romano et al 2014). 
1.4.2 TDP-43 at the postsynapse  
TDP-43 reaches the post-synaptic compartment following neuronal depolarisation, and via RNA 
granules (Wang et al 2008; Liu-Yesucivitz et al 2014). The protein has been shown to be vital for 
regulation of the Rho family of GTPases, including RhoA1, Rac1 and Cdc42, suggesting roles in actin 
cytoskeletal dynamics and neurite outgrowth (Koh 2006, Stankiewicz & Linseman 2014). Under 
normal conditions, TDP-43 inhibits Rac1 through a pathway mediated by the fragile X mental 
retardation protein (FMRP). TDP-43 binds to Rac1 mRNA, recruits an FMRP complex and interacts 
with eukaryotic translation initiation factor (eIF4E) to inhibit translational initiation of Rac1 mRNA 
(Majumder et al 2016). Thus, protein misprocessing induces dysregulation of Rac1 expression, 
inhibiting the function of a key post-synaptic protein within a structural pathway. The depletion of 
TDP-43 also increases levels of essential post-synaptic MAP1B and ionotropic glutamate receptor 1 
(GluA1) mRNA, but only in conjunction with the depletion of FMRP (Majumder et al 2016), 
indicating RNA-regulatory roles as mediated by the ability of TDP-43 to bind to other proteins.  
TDP-43 has been further linked to the expression levels of post-synaptic proteins involved in synaptic 
organisation and transmission regulation (Wang et al 2008; Majumder et al 2012; Honda et al 2013; 
Majumder et al 2016). The src-like adaptor protein (Slap) is differentially upregulated following TDP-
43 knockdown and is recruited at the post-synaptic membrane in conjunction with NMDARs, 
indicating the potential for TDP-43 misprocessing to impact this key activity-dependent process 
(Semerdjieva et al 2013). NMDAR regulation is potentially disrupted by TDP-43 silencing, as 
evidenced by the alternative splicing of the CAMK2A and KCNIP genes. These genes are essential 
for long-term potentiation and plasticity through roles in regulating NMDARs, AMPARs and Kv4-
transient potassium channels (Birnbaum et al 2004, Mathie et al 1998, Stephenson et al 2017).  
Additional evidence for TDP-43 functions in synaptic receptor regulation comes from investigations 
into AMPA receptors. At AMPARs, the expression level of TDP-43 directly correlates with subunits 
GluA1 and GluA2, essential for the retention of long-term potentiation (LTP) and regulating calcium 
permeability (Gulino et al 2015, Isaac et al 2007, Lee et al 2003). GluA2 pre-mRNA is subject to RNA 
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editing at the glutamine/arginine (Q/R) site, where adenosine is converted to inosine (A-to-I 
conversion) becoming GluA2R (Kawahara et al 2004). Failure of Q-to-R conversion results in 
increased excitation of neurons, and in the spinal motor neurons of sporadic ALS patients, RNA editing 
at this site is inefficient or abnormal (Hideyama et al 2012, Higuchi et al 2000, Kawahara et al 2004). 
The levels of the enzyme adenosine deaminases that act on RNA (ADAR2) have been linked to 
expression of the GluA2Q subunit, and in sALS, pathological TDP-43 aggregates have been identified 
in the spinal cord in the presence of low ADAR2 levels (Aizawa et al 2010, Hideyama et al 2012, 
Yamashita et al 2012). Furthermore, assays probing abnormal cleavage of TDP-43 indicate that calpain 
is activated through increased calcium permeability of AMPARs, thus inducing fragmentation and 
abnormal localisation of TDP-43 at the post-synapse (Yamashita & Kwak 2014a). These findings 
provide intriguing evidence for the potential of TDP-43 to induce dysfunction at the post-synapse; 
though it is yet to be determined whether these events may occur and what processes are initiating 
factors. The regulation of neuronal excitability is intimately linked the health of cells, and associated 
with mechanisms at the primary post-synaptic structure: the dendritic spine.  
1.5 THE ROLE OF DENDRITIC SPINES  
Few studies have yet to explore how changes in connectivity in ALS may be linked to the post-synaptic 
structure responsible for network plasticity. The majority of excitatory synapses reside at the dendritic 
spine as small, dynamic protrusions from the shaft of dendrites (Harris & Kater 1994, Lu & Zuo 2017). 
The dendritic spine contains the postsynaptic molecular machinery that enables synaptic transmission 
and plasticity, functionally compartmentalising intracellular chemical and electrical signalling (Bourne 
& Harris 2008, Nishiyama & Yasuda 2015, Sheng & Kim 2011). Dendritic spines are highly activity-
dependent and exhibit a wide range of sizes and shapes within a single dendritic section, varying 
among neuronal type (Bosch & Hayashi 2012, Nimchinsky et al 2002). Three primary spine types are 
recognised; long, thin spine types are immature, transient and highly motile, the mature, strong spine 
types exhibit a predominantly mushroom shape, and the other stable spine type is known as a stubby 
spine (Alvarez & Sabatini 2007, Holtmaat et al 2005) (Figure 1.1.6). The size and morphology of the 
spine head is associated with the number of pre-synaptic vesicles docked there and the number of post-
synaptic receptors; thus, it is also associated with the strength of synaptic currents (Arellano et al 2007, 
Yuste & Bonhoeffer 2001). In the post-synaptic membrane of dendritic spines, the number of 
AMPARs at the spine head in particular is correlated with the maturity and stability of the synapse 
(Matsuzaki et al 2001). AMPARs are highly dynamic and are laterally trafficked to and from the cell 
surface; as such, changes in AMPAR numbers at the synapse facilitate alterations to synaptic 
Figure 1.1.6 
Morphological subsets of dendritic spines. The function of dendritic spines is tightly linked to 
morphology, as indicated by the ratio head diameter (blue dashed lines) to neck diameter (green 
dashed lines), as well as the overall size of the structure (red dashed lines). Filopodium and 
thin spine types constitute immature synapses, and display a low head:neck ratio. Stubby spines 
are a stable spine type, whilst mushroom spines constitute the most mature dendritic spine 
morphology, with a large head:neck ratio.  
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transmission (Nishimune et al 1998, Shi et al 2001). Accordingly, a reduction in post-synaptic 
scaffolding proteins such as PSD-95 decreases the number of receptors at the spine head as well as 
miniature excitatory postsynaptic current (mEPSC) amplitude (MacGillavry et al 2013, Nair et al 
2013). The diffusional exchange of AMPARs between the synaptic membrane and peri-synaptic 
regions enables neurons to intricately regulate short-term plasticity; rapid exchange allows AMPARs 
to recover from desensitisation to glutamate (Heine et al 2008, Lisman & Raghavachari 2006).  
The continual emergence, morphological alteration and retraction of dendritic spines in different brain 
regions reflect turnover and formation of synapses (Chen et al 2014, Fu & Zuo 2011, Holtmaat & 
Svoboda 2009). Dendritic spine dynamics are influenced spatially by cortical region and cortical layer, 
and the inputs discrete regions receive. While little research has looked into region-specific 
comparisons of dendritic spine turnover, innate functional differences suggests neuronal plasticity and 
circuitry mediated by dendritic spines may vary (Benavides-Piccione et al 2002, Holtmaat et al 2005, 
Zuo et al 2005). Activity-dependent mechanisms have repeatedly been associated with regional 
vulnerability in neurodegeneration (Bero et al 2011, de Haan et al 2012, Seeley et al 2009, Zhou et al 
2012). The intricate relationship between dendritic spines and neuronal network activity may thus play 
a role in determining the regional susceptibility of neuronal populations in neurodegenerative disease. 
Synaptic plasticity is attributed to structural changes in the number and shape of dendritic spines, 
dependent on the cortical environment, with changes occurring within minutes that may endure for 
spans of weeks to months (Fu & Zuo 2011, Lendvai et al 2000, Yang et al 2009). Understanding 
fundamental dendritic spine plasticity and the factors influencing this within specific cortical regions 
is essential for targeting the mechanisms that may perturb synaptic function in disease states.   
1.5.1 Dendritic spines in disease states 
Neurodegenerative diseases feature the progressive loss of synapses and neurons in distinct anatomical 
networks, resulting in hallmark clinical phenotypes; yet the events initiating synaptic loss are still 
unknown. Pathological changes in dendritic spines at the post-synapse can be categorised as alterations 
in distribution and alterations of structure (Fiala et al 2002). Distribution pathology refers to increases 
and decreases in dendritic spine density, and to morphological changes such as altered spine size, shape 
and subtype; it is this measure that provides information as to the overall function of neuroplastic 
mechanisms within a cortical region (Penzes et al 2011). A decreased density of dendritic spines can 
be linked to axonal loss and deafferentation and is most evident in forms of mental retardation and 
epilepsy - these conditions have decreased neuronal numbers, suggesting density loss is associated 
with a decline in available axonal inputs and stimulation (Huttenlocher 1991, von Bohlen Und Halbach 
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2010, Wong & Guo 2013). Conversely, increased spine density is much less associated with disease 
and instead can be observed during critical developmental time periods, following environmental 
enrichment and in fluctuations of the oestrus cycle (Berman et al 1997, Huttenlocher & Dabholkar 
1997, Munoz-Cueto et al 1990). An overabundance of dendritic spines has however been identified in 
Fragile-X Syndrome and in some cases of Sudden Infant Death Syndrome (SIDS), thought to be a 
product of defective dendritic spine pruning during development (Irwin et al 2001, Takashima et al 
1994). Dendritic spine morphology on the other hand depends not only inputs received, but also on the 
functionality of the structure and localised protein synthesis (Fiala et al 2002, Lendvai et al 2000).  
A number of possible causes have been linked to dendritic spine pathology, yet no single disease 
pathway has been identified. Changes in spine density can be linked to altered presynaptic inputs, 
compensation for the loss of afferents, autonomous neuronal functions-such as NMDAR activation, 
disrupted dendritic transport and aberrant protein synthesis-or due to extraneuronal factors (Coleman 
& Riesen 1968, Hasbani et al 2001, Keck et al 2008, Tolino et al 2012). In ALS there is an increasing 
focus on the effect dendritic spine aberrations have on vulnerable networks. In a mouse model of 
mutated ubiquilin 2 (UBQLN2) - a mutation associated with ALS- aggregation of proteins within the 
spine head occurs concurrently with a decrease in dendritic spine density and synaptic dysfunction 
(Gorrie et al 2014). Conversely, familial ALS mutations in the actin-binding protein profilin 1 have 
been shown to increase dendritic spine density, highlighting the complex nature of disease-mediated 
alterations at the post-synaptic structure (Brettle et al 2015). In ALS there is an acknowledged lengthy 
pre-symptomatic period, during which dysregulated cortical excitability is thought to be integral to 
disease onset (Joyce & Carter 2013, Menon et al 2017, van Zundert et al 2012, Vucic et al 2008). 
While evidence for TDP-43 mediating both physiological dendritic spine function and disease-state 
dysfunction accumulates, questions still remain as to whether protein dysfunction is a direct cause or 
consequence of dendritic spine alterations. Additionally, there is yet to be a cohesive understanding as 
to how and when dendritic spine alterations result in pre-symptomatic functional pathology within 
vulnerable cortical regions, with a need to understand fundamental changes that occur at the dendritic 
spine within these regions.  
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1.6 THESIS HYPOTHESIS AND AIMS 
Early synaptic dysfunction and perturbed neuroplasticity has increasingly been implicated in the onset 
and progression of ALS, yet our understanding of the relationship between TDP-43 and neuroplastic 
mechanisms at the dendritic spine is wanting. The complexity of mechanisms occurring at the dendritic 
spine contributes to the lack of understanding as to normal roles, as well as how dendritic spines are 
affected in disease states. Roles for TDP-43 at the post-synaptic structure have been identified under 
normal conditions, but how protein misprocessing at the dendritic spine impacts susceptible neuronal 
populations in ALS has yet to be elucidated. To understand how TDP-43 may contribute to the select 
vulnerability of the motor system, early dysfunction at the synapse in ALS will be investigated at the 
dendritic spine within a mouse model of mutated TDP-43.  
Aim 1: Investigate whether the synapse is dysfunctional over a disease time course in the Thy1-
YFP:prpTDP-43A315T mouse model of ALS. Hypothesis 1: Dysfunction at the post-synaptic dendritic 
spine is an early disease mechanism mediated by misprocessed TDP-43, central to disease 
progression.   
A range of experiments support the notion of early, subtle cellular events occurring distally at the 
synaptic extremity, preceding neuronal death. However, investigations into the major regulators of 
synaptic plasticity- dendritic spines- in disease states have yet to determine whether these events are 
upstream of a disease cascade, or a consequence of protein pathology. The first aim of this thesis will 
be focused on identifying synaptic alterations at defined stages of early disease progression in a model 
of the ALS that recapitulates key features of disease manifestation. Mice will be probed for synaptic 
markers and dendritic spine alterations at a juvenile stage; presymptomatically; and at disease onset.  
Aim 2: Determine whether cortical region, age and sex influence dendritic spine changes in the 
Thy1-YFP mouse model. Hypothesis 2: Dendritic spine turnover and morphological subsets have a 
unique pattern of dynamics depending on cortical region, sex and age.  
To identify why the dendritic spine is vulnerable to pathological changes in disease, there needs to be 
a better understanding of fundamental dendritic spine dynamics. Between cortical regions, dendritic 
spine maturation fine-tunes specific cortical networks as a function of differences in activity-dependent 
mechanisms. The second aim of this thesis will be to investigate how dendritic spine dynamics change 
over time from developmental stages to adulthood within two distinct cortical regions of mice 
expressing yellow fluorescent protein. To capture the dynamic processes of dendritic spines, cranial 
window surgeries will be used in conjunction with 2-photon microscopy (2PLSM) to determine 
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alterations in spine dynamics in real time. These changes will be compared between males and females, 
in order to determine the role of the sex hormone oestrogen in dendritic spine regulation.  
Aim 3: Investigate dendritic spine plasticity in real-time in the Thy1-YFP:prpTDP-43A315T mouse 
model of ALS. Hypothesis 3: Misprocessed TDP-43 will affect the dynamics of dendritic spine 
turnover and perturb neuronal plasticity.  
In ALS, distinct cortical regions are progressively impacted by the degeneration of neuronal networks. 
The maturation and turnover of dendritic spines is a key regulator of neuronal network plasticity and 
dysfunction of the structure may have vast implications for cortical circuitry in disease. To establish 
the potential impact of a disease linked TDP-43 mutation on the synaptic compartment, cranial window 
surgeries will be used in conjunction with 2PLSM to establish dendritic spine activity in the male and 
female motor cortices. These experiments will be undertaken at a presymptomatic time point to further 
build upon the timeline of synaptic dysfunction determined in Aim 2, utilising the Thy1-YFP:prpTDP-
43A315T mouse model of ALS.  
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2 MUTANT TDP-43 MEDIATES EARLY SYNAPTIC DYSFUNCTION  
2.1 INTRODUCTION 
The cytoplasmic aggregation of misprocessed TDP-43 is a key pathological feature of a range of 
neurodegenerative disorders and the discovery of intracellular TDP-43 inclusions in over 95% of 
heritable and sporadic forms of ALS implicates a shared pathological pathway for both disease forms. 
Molecularly, neurons depleted of TDP-43 or expressing a dominant mutation show morphological and 
molecular changes that indicate neuronal and synaptic dysfunction. Furthermore, being a component 
of transporting RNA granules provides a pathway for the protein to be directly involved in regulating 
synaptic strength through localised translation-the underlying mechanism of synaptic plasticity (Bliss 
& Collingridge 1993). Given the evidence for TDP-43 binding to RNA targets critical for synaptic 
function, as well as mediating dendritic spine maturation, it is entirely conceivable the protein may 
regulate synaptic plasticity through processes such as RNA transport, local translation and dendritic 
spinogenesis (Majumder et al 2012, Narayanan et al 2013, Sephton et al 2010, Wang et al 2008a, Xiao 
et al 2011). However, even with hints of TDP-43 functioning at the synaptic compartment, there is yet 
to be a cohesive understanding of what these roles encompass-let alone of how these roles may be 
perturbed in disease states. Potentially, in ALS the modulation of synaptic plasticity by misprocessed 
TDP-43 may induce synaptic deficits that in turn, are a critical turning point in the progression and 
onset of neurodegeneration (Bellucci et al 2012, Palop et al 2006, Sephton & Yu 2015, Sheng & Cai 
2012). Dendritic spines are the major regulators of synaptic plasticity, yet it is still to be determined as 
to whether alterations at the postsynaptic structure are upstream of disease events, or a consequence of 
disease pathology. Among recent findings, a theme emerges whereby TDP-43-mediated synaptic 
mechanisms are significantly altered by misprocessed protein forms, potentially at early stages of the 
disease cascade. To understand how these insults are situated within the context of disease progression, 
a timeline of TDP-43-mediated synaptic dysfunction is essential.    
To address these research questions, this Chapter aimed to establish a timeline of TDP-43 mediated 
synaptic alterations in the cortex of the TDP-43A315T mouse model of ALS (Wegorzewska et al 2009). 
These mice express a human TDP-43 construct containing the missense mutation Ala-315-Thr 
(A315T) seen in familial disease (Gitcho et al 2008), and driven by the mouse prion protein promotor 
at 3-fold overexpression (Wegorzewska et al 2009). Previously, TDP-43A315T mice died spontaneously 
before full disease expression due to an enteric phenotype resulting in intestinal obstruction; however, 
a high fat/low fibre diet abolishes sudden death, allowing a pronounced disease phenotype to develop 
and exhibiting a greater loss of upper and lower motor neurons (Herdewyn et al 2014). These mice are 
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born without a disease phenotype, and appear normal until ~3 months of age, when they first develop 
gait abnormalities. By 4-5 months of age, TDP-43A315T mice begin losing weight and develop 
characteristic motor deficits, whereby they are unable to hold their bodies off of the ground but can 
still propel themselves forward using their limbs (Wegorzewska et al 2009). Additionally, mouse 
models of the A315T mutation also exhibit cognitive deficits such as impaired spatial memory 
acquisition and retention, increased disinhibition and hyperactivity, associated with the expression and 
deposition of dysfunctional TDP-43 (Ke et al 2015).  
Ubiquitinated aggregates are a defining feature of TDP-43 pathology, found in the brains and spinal 
cords of ALS patients (Leigh et al 1991). Sufferers of ALS exhibit the degeneration of the layer v 
pyramidal neurons within the motor cortex- cells essential for integrating sensory cues and controlling 
motor output (Agosta et al 2012). Despite the universal expression of the Prp TDP-43A315T transgene 
within all cortical layers, TDP-43A315T mice only display cytoplasmic accumulation of ubiquitinated 
proteins in layer v cortical neurons- further demonstrating the benefits of using this mouse to 
investigate cortical pathology and highlighting the select vulnerability of excitatory neurons. Due to 
the previously observed spontaneous death of mice before full disease expression, the TDP-43A315T 
model has been poorly utilised, and the potential for identifying early disease events in the cortex is 
yet to be fully explored.  
The potential for synaptic dysfunction to be a key, early disease event was probed by determining 
alterations at the dendritic spine at defined timepoints, establishing a time-course of disease in the 
TDP-43A315T mouse. The TDP-43A315T mouse is crossed with Thy1-YFPH mice, preferentially 
fluorescing excitatory LV motor and sensory neurons- enabling the visualisation of regions of interest 
under pathological conditions. Immunohistochemistry is used to determine TDP-43 localisation and 
global expression of synaptic proteins. Specialised dendritic spine analysis software is used to assess 
changes in dendritic spine density as a whole and within morphological subsets. To elucidate the 
functional outcomes of any alterations, electrophysiology is used to determine the viability of the 
synapse. The current Chapter aimed to investigate whether the synapse is dysfunctional over a disease 
time-course in the Thy1-YFP:prpTDP-43A315T  mouse model of ALS, to elucidate whether this may be 
an early disease mechanism mediated by misprocessed TDP-43. 
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2.2 METHODS 
2.2.1 Animals 
Thy1-YFP transgenic mice [B6.Cg-Tg (Thy1-YFP-H)16Jrs/J) (Feng et al. 2000; Porrero et al. 
2010)] and TDP43A315T transgenic mice [B6.Cg-Tg (Prnp-TARDBPxA315T)95Balo/J 
(Wegorzewska et al. 2009; Herdewyn et al. 2014)] were purchased from the Jackson Laboratory 
and maintained on a C57BL6 background, with these strains crossed to create the novel Thy1-
YFP:prpTDP-43A315T. Thy1-YFP positive littermates were used as controls. These mice demonstrate 
an approximate 3-fold increase in expression of human TDP-43A315T in comparison to endogenous 
TDP-43 levels, driven on the prion promoter; this drives high expression within the brain and spinal 
cord, as well as at lower levels in most other tissues (Wegorzewska et al. 2009). Animals were 
housed in ventilated cages at 20oC, on a 12 hour light-dark cycle, with access to food and water ad 
libitum. All procedures were approved by the Animal Ethics Committee of the University of 
Tasmania and conducted in accordance with the Australian Code of Practice for the Care and Use 
of Animals for Scientific Purposes, 2013. 
2.2.2 Genotyping 
Mice were genotyped at the time of weaning (28 day post-natal) using a clipping from the top portion 
of the ear, which was removed and stored at -20°C until DNA extraction was undertaken. DNA was 
extracted using an Extract-N-Amp Tissue PCR tissue kit (Sigma-Aldrich, Australia) according to 
manufacturer’s instructions and stored at -4°C. TDP-43A315T PCR amplification was performed using 
an 11µl reaction containing 50-100g of DNA (~1µl), and the following primers (GeneWorks, 
Australia):1µl oIMR 8744 internal positive control forward (5’-CAA ATG TTG CTT GTC TGG TG-
3’); 1µl oIMR 8745 internal positive control reverse (5’-GTC AGT CGA GTG CAC AGT TT-3’); 1µl 
transgene forward (5’-GGA TGA GCT GCG GGA GTT CT-3’); and 1µl transgene reverse (5’ TGC 
CCA TCA TAC CCC AAC TG-3’). Amplification occurred under the following conditions: 94°C for 
3 minutes; 94°C for 30 seconds; 60°C for 30 seconds; 72°C for 30 seconds; steps two-four repeated 
for 30 cycles; 72°C for 30 seconds; 4°C on infinite hold.  
Thy1-YFP PCR amplification was performed using a 10µ reaction containing 50-100g of DNA (~1µl) 
and the following primers (GeneWorks, Australia): 1µl oIMR 7338 internal positive control forward 
(5’-CTA GGC CAC AGA ATT GAA AGA-3’); 1µl oIMR 7339 internal positive control reverse (5’-
GTA GGT GGA AAT TCT AGC ATC ATC C-3’); 1µl transgene forward (5’-TCT GAG TGG CAA 
AGG ACC TTA G-3’); and 1 µl transgene reverse (5’-TGA ACT TGT GGC CGT TTA CG-3’). 
Amplification occurred under the following conditions: 95°C for 1 minute; 95°C for 15 seconds; 58°C 
for 15 seconds; 72°C for 30 seconds; steps two-four repeated for 35 cycles; 72°C for 7 minutes; 11°C 
on infinite hold.   
2.2.3 Tissue preparation 
This part of chapter 2  has been removed for
copyright or proprietary reasons.
It has been published as: Handley, E. E., . Pitman, K. A., Dawkins, E., 
Young, K. M., Clark, R. M., Jiang, T. C., Turner, B. J., Dickson, T. C., 
Blizzard, C. A., 2017. Synapse dysfunction of layer V pyramidal neurons 
precedes neurodegeneration in a mouse model of TDP-43 proteinopathies, 
Cerebral cortex, 27(7), 3630–3647
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3 THE DIFFERENTIAL NEUROPLASTICITY OF CORTICAL REGIONS 
3.1 INTRODUCTION 
The development of techniques facilitating the imaging of living structures has provided new ways to 
understand dendritic spine structure and function; yet there remain unknowns as to how real-time 
changes at synaptic compartments are influenced by factors such as cortical region, age and sex 
hormones. The cortical control of motor function in the mouse involves the activity of pyramidal 
neurons in the motor /frontal cortex, constituting a higher order processing level projecting to major 
subcortical motor systems, and this organisation is recapitulated within the human cortex, as 
demonstrated by longitudinal MRI (Bergmann et al 2016, Keller 1993, Schieber 2001)qiu(Qiu et al 
2018). Understanding how the hierarchical activity of the cortex influences specific regional activity 
at the synapse is crucial for elucidating the mechanisms of activity-dependent vulnerability, as seen in 
neurodegenerative disease. The current Chapter aims to determine the biological basis for the increased 
susceptibility of the motor cortex to synaptic dysfunction in pathological conditions, and to better 
understand how to target potential for therapeutic interventions aimed at maintaining appropriate 
synaptic connections.  
A lack of consideration has been given to the role played by sex hormones in the formation and 
regulation of cortical networks, both in clinical human studies and in research using animal models to 
investigate the synapse and disease conditions (Zárate et al 2017). A range of pathologies have a clear 
sex differences in their prevalence, including ALS, yet the precise roles played by hormonal cues in 
determining disease dimorphism remain to be clarified (Arevalo et al 2015). Women experience ALS 
onset significantly later in life than men- corresponding to the post-menopausal period, during 
declining oestrogen levels (Curtis et al 2017, McCombe & Henderson 2010). Furthermore, while 
incidence rates occur at a ratio of 3:2 between males and females overall, this diminishes to a ratio of 
1:1 with advancing age and decreased oestrogen levels in females (Blasco et al 2012, Manjaly et al 
2010, McCombe & Henderson 2010). Gonadal hormone fluctuations during the oestrous cycle have 
well-established impacts on a range of cognitive functions in the female brain (Alexander et al 2018, 
Srivastava et al 2008). Delivery of estradiol- an estrogen agonist- rapidly improves discrimination 
learning in female mice, and within the hippocampus has been shown to dramatically and rapidly 
increase dendritic spine and synaptic density (Murakami et al 2006, Spencer et al 2008, Srivastava et 
al 2013). 
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Dendritic spines are also influenced by the brain region in which they reside and the stage of 
development the cortex is undergoing. Regional dendritic variation is extensive, with crucial 
implications for cortical processing, as a larger dendritic field is associated with increased spine 
numbers and input sampling across cortical systems (Elston & Rosa 1998, Elston et al 1996, Oga et al 
2017).  Spines within the frontal cortex undergo pruning during adolescence and developmental 
periods across a variety of species, including humans and mice (Johnson et al 2016, Petanjek et al 
2011). In layer V pyramidal neurons of the frontal cortex, these changes are also mediated by pubertal 
development, with sex-specific changes identified in rats (Drzewiecki et al 2016). The development 
of stable dendritic spines and synaptic connections can also be mediated by specific cortical regions 
through network-wide activity- though there has yet to be comprehensive comparisons of inter-
regional dendritic spine dynamics (Antonini et al 1999). Intriguingly, cortical regions involved in early 
stages of processing exhibit less complex dendritic spine turnover than those involved in later 
processing stages, reflecting spine-dense neurons at higher association levels integrating a greater 
range of synaptic input than those at lower processing levels (Jacobs et al 2001).  
Classic studies demonstrate time periods of heightened neuronal plasticity- critical periods in which 
the development of the nervous system is able to be rapidly modulated by experience (Hubel et al 
1977, Lichtman & Colman 2000, Shatz & Stryker 1978). However, the structural bases and dynamics 
underlying the transition from plasticity to stability are still poorly understood. Dendritic spines are 
widely accepted as specialised, distinct compartments, and their morphology is optimised for 
excitatory transmission and the formation of functional brain circuitry (Bloodgood & Sabatini 2007, 
Maiti et al 2015, Sala & Segal 2014). The dimensions of the spine head and neck dictate function, 
including the abundance of neurotransmitters; small molecule diffusion; independent regulation of 
biochemical and electrical machinery; and calcium compartmentalisation (Harris & Kater 1994). As 
the morphogenesis of dendritic spines that supports these processes is impaired in a range of disorders, 
understanding the factors influencing synaptic plasticity is critical for elucidating dysfunction in the 
face of neurodegeneration. 
The ability to monitor neuronal connectivity in real time has provided new understanding of the 
mechanisms underlying the development of neuronal circuitry and connections- and why these 
networks may be primed to fail in neurodegenerative states (Okabe 2013). Two-photon laser scanning 
microscopy (2PLSM) facilitates the monitoring of brain structures such as dendritic spines in vivo, 
capturing changes in neuronal connectivity mediated by cognitive functions, as well as in pathological 
states (Yang et al 2010b). To repeatedly and reliably image the same region of interest over time, open-
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skull windows facilitate optimised resolution and comparable spine turnover between groups when 
undergoing standardised procedures, and further protocol optimisation includes using immune 
suppressants such as a dexamethasone, to reduce glial activation and promote physiological conditions 
for spine turnover (Keck et al 2008, Park et al 2015).  
To address gaps in the knowledge of fundamental dendritic spine dynamics within specific cortical 
regions, the second aim of this thesis was to determine whether cortical region, age and sex influence 
dendritic spine changes in the Thy1-YFP mouse. The Thy1-YFP mouse selectively expresses yellow 
fluorescent protein within layer V pyramidal neurons of motor and sensory regions, facilitating 
visualisation of the basal and apical dendrites of the primary motor and somatosensory cortices within 
a high density of cells, increasing the statistical power of analyses by providing a larger sample size 
for quantification (Feng et al 2000). This enables capturing the neuronal population susceptible to 
disease insult in ALS, to identify specific changes occurring under normal conditions that may 
perturbed in disease. Cranial window surgeries in conjunction with 2PLSM provide real-time 
quantification of dendritic spine changes over three imaging sessions within regions of interest, 
identifying the same dendritic process with each subsequent round. NeurolucidaÔ software is used to 
asses changes in morphology and spine turnover as a measure of baseline gain and loss rates. The 
experimental paradigm will be used to answer three key research questions, 1) being do sex hormones 
influence neuroplasticity at the dendritic spine; 2) are there regional differences in dendritic spine 
changes; and 3) are these specific dendritic spine changes altered over time, from adolescence to 
adulthood? These questions will be used to form a fundamental basis for dendritic spine changes that 
may underlie the select vulnerability of discrete cortical regions to neurodegenerative disease and early 
synaptic dysfunction.  
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3.2 METHODS 
3.2.1 Animals 
Experimental procedures utilised both male and female mice and were approved by the Animal Ethics 
Committee of the University of Tasmania, performed in accordance with the Australian Code of 
Practice for the Care and Use of Animals for Scientific Purposes. Animals were housed in ventilated 
cages at 20°C on a 12 hour light-dark cycle, with access to food and water ad libitum. Thy1-YFP 
transgenic mice [B6.Cg-Tg (Thy1-YFP-H) 16Jrs/J) (Feng et al 2000, Porrero et al 2010)] were 
purchased from the Jackson Laboratory and maintained on a C57BL6 background. Thy1-YFPH mice 
express high levels of yellow fluorescent protein in the motor and sensory neurons of cortical layer V 
(LV) (Feng et al 2000; Porrero et al 2010).  
3.2.2 Genotyping 
Mice were genotyped at the time of weaning (28 day post-natal) using a clipping from the top portion 
of the ear, which was removed and stored at -20°C until DNA extraction was undertaken. DNA was 
extracted using an Extract-N-Amp Tissue PCR tissue kit (Sigma-Aldrich, Australia) according to 
manufacturer’s instructions and stored at -4°C.  
Thy1-YFP PCR amplification was performed using a 10 µl reaction containing 50-100g of DNA (~1µl) 
and the following primers (GeneWorks, Australia): 1 µl oIMR 7338 internal positive control forward 
(5’-CTA GGC CAC AGA ATT GAA AGA-3’); 1 µl oIMR 7339 internal positive control reverse (5’-
GTA GGT GGA AAT TCT AGC ATC ATC C-3’); 1 µl transgene forward (5’-TCT GAG TGG CAA 
AGG ACC TTA G-3’); and 1 µl transgene reverse (5’-TGA ACT TGT GGC CGT TTA CG-3’). 
Amplification occurred under the following conditions: 95°C for 1 minute; 95°C for 15 seconds; 58°C 
for 15 seconds; 72°C for 30 seconds; steps two-four repeated for 35 cycles; 72°C for 7 minutes; 11°C 
on infinite hold.   
3.2.3 Oestrus cycle tracking 
In mice, the oestrus cycle is divided into 4 stages (proestrus, oestrus, metestrus and diestrus) and 
repeats every 4-5 days unless interrupted by pregnancy, pseudopregnancy or anestrus (Byers et al 
2012) (Figure 3.2.1). The oestrus stage in which female mice underwent 2PLSM was assessed in two 
steps; a preliminary visual observation of the vaginal opening of each mouse, and verification by 
vaginal cytology. To evaluate oestrus cycle stage visually, mice were restrained and vaginal opening 
evaluated based on standard criteria (Byers et al 2012, Champlin et al 1973). (Figure 3.2.2 Ai-iv). A 
Figure 3.2.1 
Schematic of the relative time period and proportion of each cell type present during the four 
stages of the oestrus cycle, with the transition from each stage delineated. The size of each 
quadrant is an approximate length of each oestrus stage, with the total cycle taking 4-6 days. 
(A) Leukocytes are the predominant cell type during diestrus; both nucleated and cornified 
epithileal cells during proestrus and metestrus; and predominantly cornified epithileal cells 
during estrus. (B) Oestrogen levels peak during estrus for 24-48 hours, before lowering for 24 
hours during metestrus. Oestrogen hits baseline levels during diestrus for ~48-72 hours, before 
rising for 14 hours during proestrus. Adapted from Byers et al 2012. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
OESTRUS
Figure 3.2.2  
Representative images of the four stages of oestrus identified by vaginal cytology (A) and 
visual appearance (B) (Byers et al 2012; McLean et al 2012). (A) Three cell types were 
identified after collecting a vaginal swab, and cells transferred to a dry glass slide to be stained 
with toluidine blue. The stage of the oestrus cycle was determined based on the presence or 
absence of leukocytes, cornified epithelial and nucleated epithelial cells. Proestrus is 
determined by the primary presence of nucleated epithelial cells (Ai, Bi); estrus determined by 
the primary presence of cornified epithelial cells (Aii, Bii); metestrus determined by the 
combined presence of leukocytes, nucleated epithelial cells and cornified epithelial cells (Aiii, 
Ciii); and diestrus determined by the primary presence of leukocytes (Aiv). 
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vaginal swab was collected using a cotton tipped swab, wetted with room temperature saline. The swab 
was inserted into the opening of the vagina of the restrained mouse and rolled against the vaginal wall. 
Cells were transferred to a dry glass slide (Livingstone, Australia) by rolling the swab across the slide. 
Slides were then air-dried and stained with toluidine blue (0.l25% toluidine blue in 0.l25% acetic acid) 
(Sigma Aldrich, Australia) for 10 minutes. The slides were then rinsed with water, overlaid with a 
cover-slip using fluorescent PermaFluor™ mounting medium (Thermo-Fisher Scientific, Australia) 
and viewed immediately at 200x magnification under bright-field illumination using an Olympus 
CKX31 Inverted Microscope (Olympus Australia Pty. Ltd., Australia). The stage of oestrus cycle was 
determined based on the presence or absence of leukocytes, cornified epithelial, and nucleated 
epithelial cells (Felicio et al 1984) (Figure 3.2.2 Bi-iv). 
3.2.4 Tissue preparation  
For tissue collection mice were terminally anaesthetised with an overdose of sodium pentobarbital, 
and transcardially perfused with 4% (w/v) paraformaldehyde (PFA) in 0.01 M phosphate-buffered 
saline (PBS) at postnatal day (P) 30 (n = 5), P60 (n = 5), and P90 (n = 5). Dissected cortical tissue was 
postfixed overnight in 4% PFA and stored at 4°C in 0.01 M PBS containing 0.1% (w/v) sodium azide 
(Sigma Aldrich, Australia). The brain was cut at Bregma – 4.00mm, and the anterior portion embedded 
in 5% (w/v) molecular grade agarose (Bioline Australia Pty Ltd, Australia) dissolved in 0.01 M PBS. 
Coronal vibratome sections (20µm) were generated using a Leica VT1000S vibratome (Biosystems 
Australia Pty Ltd, Australia) and collected onto slides (Livingstone, Australia). 20 µm sections were 
processed immediately for immunohistochemistry.  
3.2.5 Immunolabelling 
For cortical analyses, the primary motor and somatosensory cortices were identified by anatomical 
landmarks referring to the appearance of the lateral ventricles, the shape of the third ventricle and the 
appearance of the anterior commissure and corpus callosum (Paxinos & Franklin 2012). For dendritic 
spine density analysis, sections on slides (20 µm) were exposed to a primary antibody solution 
containing 0.3% triton-X-100 (Sigma Aldrich, Australia) and anti-GFP (1:1000), which detects 
endogenous YFP for 24 hours at room temperature and agitated. Sections were then washed three times 
in PBS and incubated with an Alexa Fluor® conjugated secondary antibody (Thermo-Fisher Scientific, 
Australia) for 2 hours at room temperature. Sections were washed three times with PBS for 10 minutes 
prior to drying in the dark. Slides were mounted in fluorescent mounting medium (Thermo-Fisher 
Scientific, Australia). No primary controls were included in immunohistochemical experiments.    
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3.2.6 Confocal microscopy 
Immunofluorescence was captured using a Zeiss LSM 510 Duo-scan confocal microscope (Carl Zeiss 
Microscopy, Germany) running ZEN software and equipped with Ar488 and HeNe543 lasers. For cell 
body analysis in the motor and somatosensory cortices, an EC Plan Neofluar 10x/0.3 air objective 
(Carl Zeiss Microscopy, Germany) was used to acquire z-plane images with 0.7 µm intervals through 
12 µm of the tissue depth. Eight sections were imaged per cortical region, per mouse. To image the 
basal and apical dendrites of layer V pyramidal neurons, a Plan-Apochromat 63x/1.4 oil objective 
(Nikon, USA) was used to acquire z-plane images with 0.9 µm intervals through 18 µm of tissue. Four 
images were collected from eight sections per cortical region per time point (960 stacks in total).  
3.2.7 Cranial window surgeries 
An open-skull cranial window was surgically implanted over either the motor or somatosensory 
cortices of mice at P50, following the protocol previously described by Holtmaat et al. (2009) (Figure 
3.2.3). This timeline enables 10 days of recovery prior to imaging at P60, whereupon ~80% of cranial 
windows were successful. Experimental mice underwent isoflurane (Henry Schein®, USA) induction 
(4%, ~0.5 litre min-1 O2), were given a sub-cutaneous (s.c.) injection of the long-acting general 
analgesic Temgesic (buprenorphine 300mg/ml dosed at 0.1mg/kg) (Ilium, Troy Laboratories, 
Australia) and heads shaved to prevent foreign particles entering the surgical site. Mice were then 
placed into a stereotaxic frame and isoflurane maintained at 1.5-2%, ~0.5 litre min-1 O2. The cranium 
was cleaned with three rotations of a cotton swab with the disinfectant Microshield® chlorhexidine 
(Schulke Pty. Ltd., Australia) and after drying, swabbed again with ethanol (Sigma Aldrich, Australia). 
Viscotears® liquid eye gel (Novartis Pharmaceuticals, Australia) was applied and the mouse injected 
s.c. with the local analgesic bupivacaine (bupivacaine hydrochloride 0.5% dosed at 0.025%) (Pfizer 
Ltd., Australia) and the anti-inflammatory Metacam (meloxicam 5 mg/ml dosed at 1 mg/kg) (Ilium, 
Troy Laboratories, Australia).  
Using scissors, a circular flap of skin (~1 cm2) was removed from the skull, and the periosteum 
removed by gently scraping the skull with sharpened forceps. Vetbond™ (cyanoacrylate 3M™, USA) 
tissue adhesive was applied to the temporalis muscle and wound margins to prevent seepage of 
serosanguinous fluid, sparing the trepanation area. The cortical regions of interest were identified 
according to bregma, in order to accurately locate the correct coordinates for the motor cortex (-1.0 
mm posterior from bregma, -0.8 mm lateral) and the somatosensory cortex (1.5 mm from bregma, 3.0 
mm lateral) (Figure 3.2.3 A, B). A circular groove was drilled around the area of interest (~3 mm in 
diameter) and cortex buffer (125 mM NaCl, 5 mM KCl, 10 mM glucose, 10 mM HEPES, 2 mM CaCl2, 
Figure 3.2.3 
Schematic of the cranial window procedure and identification of regions of interest. (A) The 
motor and somatosensory cortices are identified according to coordinates from Bregma. (B) 
A circular flap of skin is removed to reveal the cranium, the sutures of the cranium and 
the temporalis muscle. (C) A 3mm bone island is removed from the trabecular bone over 
the region of interest using a titanium drill. (D) A 5mm glass coverslip is placed over the 
exposed dura membrane, and the cranium, wound margins and the lip of the coverslip sealed 
using dental cement. A titanium steel bar with screws holes is embedded to facilitate 
fastening under the 2-photon laser scanning microscope. (E) Surgeries were undertaken at 
post-natal day 50 (P50) and 10 days of post-surgical monitoring and oestrus cycle tracking 
elapsed prior to 2PLSM at P60. At P60, imaging sessions occurred once every 3 days, ~24 
hours apart.  
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2 mM MgSO4) regularly applied to avoid heating. A bone island was left intact, dampened with buffer 
and sharp angle-tipped forceps inserted into the trabecular bone exposed on the side of the groove to 
expose the dura. Dexapent (dexamethasone sodium phosphate 5 mg/ml dosed at 4 mg/ml) (Ilium, Troy 
Laboratories, Australia) was topically applied to the surface of the exposed dura to act as an 
immunomodulator and prevent regrowth of neomembrane (Figure 3.2.3 C). A circular coverglass (4 
mm diameter, #1 thickness) was placed over the dura flush with the skull and Loctite® adhesive 
(Henkel Adhesives, Australia) applied around the window edges to prevent seepage under the 
coverslip. The cranial window was sealed with dental cement (Paladur, Kulzer Australia Pty. Ltd., 
Australia), covering the exposed cranium, the wound margins and the lip of the coverglass. A titanium 
steel bar (Central Science Laboratory, University of Tasmania, Australia) with screw holes was 
embedded in the dental acrylic over the intact hemisphere for animal stabilisation during imaging 
sessions (Figure 3.2.3 D).  
Post-surgery, the mouse received a 1 ml s.c. injection of saline and was placed back into the home 
cage on a heat pad for ~30 minutes of recovery. The mouse was considered fully recovered after 
observation of grooming, eating and normal movement and reflexes. Monitoring was undertaken twice 
a day for 4 days, then once a day for 6 days, prior to the first imaging round (Figure 3.2.3 E).  
3.2.8 Two-photon scanning laser microscopy 
To image dendritic spine dynamics in real time, a 2PLSM (Scientifica, UK) equipped with a MaiTai 
laser (Spectra-Physics, NewSpec Pty. Ltd., Australia) and running custom MATLAB® software 
(MathWorks, Australia) was used over 3 consecutive imaging sessions, 24 hours apart to image the 
motor and somatosensory cortices. The MaiTai laser was run at 910 nm by a 10 W solid state laser 
(Spectra-Physics, Australia). The mouse was anaesthetised following an intraperitoneal (i.p.) injection 
of a 12:1 mixture of Ketamine (ketamil 100mg/ml) (Ilium, Troy Laboratories, Australia) and Xylazine 
(xylazil 20mg/ml) (Ilium, Troy Laboratories, Australia) at a recommended dosage of 5 µl of working 
solution per gram (0.12 mg/g ketamine to 0.01 mg/g xylazine, approximate dose of 100 µl for a 20 g 
mouse), which wore off after 45-60 minutes. Once no reflexes were detected, mice were placed on a 
heat-pad maintained at 37°C under the microscope, with head immobilised by screwing the titanium 
bar of the cap to a stable, adjustable arm and eye gel applied.  
An EC Plan-Neofluar 10x/0.3 air objective (Nikon, USA) was used to image the vasculature of a region 
of interest (ROI), illuminated by white light, and captured using XCAP Image Processing Software 
(EPIX Incorporated, USA) (Figure 3.2.4 Ai). Once a region of interest was identified, the z-plane 
coordinate was saved and the objective changed to a W Plan-Apo 40x/1.0 water immersion objective 
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(Nikon, USA). The same z-plane coordinate was initiated and a higher-powered region of interest 
captured to find the same position during consecutive imaging sessions (Figure 3.2.4 Aii). The MaiTai 
laser was used to capture blue/green emissions (Channel 1 PMT 550-565 nm) at 910 nm/1700 mW of 
power at a maximum percentage of 25%, equivalent to 70 mW (Mainen et al 1999). The apical tuft 
dendrites of LV neurons were captured in Z-stacked images (20 µm) of cortical layers II-III (slices 1 
µm apart) at a minimum depth of 210 µm from the cranial surface to a maximum depth of 350 µm 
(Figure 3.2.4 B). Landmark dendrites were identified during the initial imaging session, and returned 
to in the following sessions in order to capture the same region of interest and identify the same 
dendritic spines on a given dendritic segment (Figure 3.2.4 C). The xyz-coordinates of every ROI were 
stored relative to the vasculature pattern initially captured. To verify all structures were detected, 
excitation was increased to ensure no additional spines were revealed and signal fluorescence intensity 
was different from noise. Imaging sessions lasted for ~30 minutes p/mouse and during imaging the 
respiratory rate of the mouse was monitored at 10 minute intervals. Post-imaging the mouse was 
injected with 1 ml of saline s.c. and placed back into the transfer cage on a heat pad for recovery, until 
fully ambulant.  
3.2.9 Quantification of dendritic spine density  
For dendritic spine density quantitation, Z-stack images of the basal and apical dendrites within the 
motor and somatosensory cortices were analysed using Neurolucida™ software (MBF Bioscience, 
USA). Dendritic compartments were located using the location of the processes; apical dendrites are 
found extending throughout layers II/III and IV, whilst basal dendrites are located within layer V. 
Image files were renamed and analysed while completely blinded; dendrites were traced through stacks 
with spines marked, and images then exported to Neurolucida™ Explorer 11 (MBF Bioscience, USA) 
for spine quantitation. Branched structure analysis was used to analyse the number of dendritic spines 
per µm and density of spine morphologies. Spines were classified as mature or immature according to 
neck length and spine head size, referring to established functional parameters (Harris et al 1992, 
Holtmaat et al 2009). Approximately 10 dendrites from each dendritic compartment per animal were 
quantified, per group- Mature spines are those with a larger head to neck ratio, and consist of stable, 
stronger synaptic connections; conversely, immature spines are those with less distinction between the 
spine head and neck, and consist of transient populations (Holtmaat et al 2009) (Figure 2.2.2 A-D).  
3.2.10 Quantification of dendritic spine turnover 
Z-stacked images were taken in real time of LV apical tuft dendrites residing in layers II/III of the 
motor and somatosensory cortices at 3 times points, 24 hours apart (Figure 3.2.5 A, B). To quantify 
Figure 3.2.4  
(A) Representative images illustrate the vasculature of the surface of the brain, used to locate 
the same region of interest for subsequent imaging rounds at 10x magnification (Ai, scale bar 
= 500µm) and 40x magnification (Aii, scale bar = 5µm). (B) Representative z-stacked image 
captured in real time of YFP-positive layer V apical tuft dendrites residing in layer II-III of the 
cortex. Scale bar = 5µm (C) Dendritic segments were selected for quantification based on 
clarity and evident spine morphologies. Dendritic spines were annotated over three consecutive 
imaging rounds using a 2-photon laser scanning microscope as gained (yellow) lost (red), 
morphological matured (purple) and stable (blue). Scale bar = 1µm 
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the turnover of dendritic spines, images for a given segment of dendrite from each round were opened 
in Neurolucida™ and spines annotated along the segment as being morphologically thin, stubby or 
mushroom shaped. The analysed segments were uploaded into Neurolucida Explorer™ and density 
quantified to validate representation of a given cohort. For each animal, ~2 dendrites were analysed 
for each cohort; P60 MC males (369 spines), baseline oestrus (406 spines) and high oestrus (350 
spines); SSC males (449 spines), baseline oestrus (360 spines) and high oestrus (390 spines); P90 MC 
males (382 spines), baseline oestrus (293 spines) and high oestrus (404 spines); and P90 SSC males 
(545 spines), baseline oestrus (422 spines) and high oestrus (578 spines).  Spines were only measured 
if they clearly emanated laterally from the dendritic shaft-those protruding below or above the dendrite 
could not be reliably quantified in the axial dimension. Spines for each round were quantified in 
comparison to the preceding round as being gained, lost or exhibiting a morphological change-with 
morphological subtypes being classed as mature (mushroom and stubby morphologies) and immature 
(thin morphology). Spines were considered lost if they disappeared between imaging rounds; gained 
if they newly protruded between rounds; and considered to exhibit morphological changes if the head 
to neck ratio was clearly altered between rounds (Figure 3.2.5 C). The baseline turnover gain and loss 
rates of spine subtypes was calculated as TR = Nt/Nl or Ng, where TR is the turnover rate; Nt is the total 
number of spines for a single mouse; Nl is the number of spines lost; and Ng is the number of spines 
gained, as a ratio from the total number of dendritic spines and dendritic spine changes. This formula 
was used to calculate the total gain and loss rate of all spines for a single mouse, as well as the specific 
gain and loss rates of mature, and of immature spines-where Nlm and Ngm is equal to the number of 
lost and gained mature spines, and Nli and Ngi is equal to the number of lost and gained immature 
spines (Attardo et al 2015, Frank et al 2018).  
3.2.11 Statistical analysis 
Student’s t-tests, one-way and two-way analysis of variance (ANOVAs) were performed in GraphPad 
(USA) Prism. Post-hoc comparisons were performed using Bonferroni’s correction for multiple 
comparisons. A p-value of <0.05 was considered significant.   
   67  
 
3.3 RESULTS 
3.3.1 Dendritic spine density peaks at P60 in the Thy1-YFP mouse cortex 
Pyramidal neurons are structurally typified by a skirt of basal dendrites and a single vertical apical 
dendrite emerging from the soma (Bianchi et al 2013). Generally, apical dendrites extend throughout 
cortical layers (Major et al 2013); in contrast, basal dendrites make localised intralayer synaptic 
connections (Nevian et al 2007). The previous Chapter of this thesis identified specific changes in 
dendritic spine density at adolescent P60 in a mouse model of ALS; to establish the overall density of 
dendritic spines at this time point under normal conditions across basal and apical dendritic 
compartments, spine density was also investigated using the Thy1-YFP mouse (Figure 3.3.1 A) at post-
natal day 30 (P30, juvenile mouse), P60 (young adult) and P90 (adult). The Thy1-YFP mouse expresses 
YFP in layer V pyramidal neurons (Feng et al 2000) enabling the basal and apical dendrites of the 
primary motor and somatosensory cortices (Figure 3.3.1 B) to be clearly identified at all time points 
(Figure 3.3.1 C). Basal and apical dendritic spine density was quantified (spines per millimetre) in 
layer V of the motor cortex (MC) and the somatosensory cortex (SSC).  
Within the motor cortex, the dendritic spine density of both basal and apical compartments were found 
to be significantly (p < 0.0001, two-way ANOVA, Tukey’s multiple comparisons test) increased 
between P30 and P60 (619.88 ± 91.02 p/nm P30 MC basal, 966.64 ± 63.44 p/nm P60 MC basal) 
(650.48 ± 107.52 p/nm P30 MC apical, 1098.16 ± 167.81 p/nm P60 MC apical) (Figure 3.1 D). By 
P90, dendritic spine density was significantly (p < 0.0001, two-way ANOVA, Tukey’s multiple 
comparisons test) reduced compared to P60 across both dendritic compartments within the motor 
cortex (188.50 ± 25.68 p/nm P90 MC basal) (206.34 ± 29.88 p/nm P90 MC apical) (Figure 3.3.1 D). 
A similar pattern emerges over time within the somatosensory cortex, whereby there was a significant 
(p < 0.0001, two-way ANOVA, Tukey’s multiple comparisons test) increase in dendritic spine density 
between P30 to P60 (604.52 ± 144.05 p/nm P30 SSC basal, 848.30 ± 29.13 p/nm P60 SSC basal) 
(592.26 ± 120.71 p/nm P30 SSC apical, 948.86 ± 111.69 p/nm P60 SSC apical), before significantly 
decreasing by P90 (190.25 ± 17.16 p/nm P90 SSC basal) (190.43 ± 18.69 p/nm P90 SSC apical) 
(Figure 3.3.1 E). Basal and apical dendritic spine density was also significantly reduced at P90 in 
comparison to P30 in both cortical regions. Increases in spine density are thought to reflect the capacity 
of a network to undergo heightened neuroplasticity during periods of development and learning 
(Nakamura et al 1999; Hensch et al 2005; Alvarez et al 2007). These results demonstrate that the 
adolescent P60 time point- where synaptic dysfunction is first observed in the TDP-43A315T mouse- is 
Figure 3.3.1 
Time course of dendritic spine density in the Thy1-YFP cortex. (A) Whole brain image of the 
Thy1-YFP mouse, with the motor and somatosensory cortices outlined in white. (B) A YFP-
positive pyramidal neuron, demonstrating the position and morphology of basal and apical 
dendrites. (C) Representative images show basal and apical dendritic spine density over a time 
course at 30 days, 60 days and 90 days (P30, P60, P90) in the motor and somatosensory 
cortices of Thy1-YFP mice. (D, E) The graphs show the quantification of spine density in the 
basal and apical dendrites of the motor and somatosensory cortices from n = 5 mice per time 
point. Bars show mean ± SEM. *p = <0.05. Scale bar (C) = 10µm, (E) = 6µm 
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a period of heightened dendritic spine density under normal conditions within the Thy1-YFP cortex, 
and that this is consistent across dendritic compartments and cortical regions.  
3.3.2 Dendritic spine of the male Thy1-YFP motor cortex are highly dynamic at P60 
To further establish the changes occurring at the dendritic spine in real time at the P60 time point, the 
current chapter employed 2PLSM in conjunction with cranial window surgeries to investigate dendritic 
spine changes occurring in the maturing cortex, during a time point where synaptic connections are 
being alternately strengthened and pruned (Boivin et al 2018). Individual apical tuft dendrites of layer 
V pyramidal neurons were followed over three consecutive days, in the motor (MC) and 
somatosensory (SSC) cortices of Thy1-YFP male (M) (n = 6) and female (F) mice (n = 8 p/group). 
Snapshots of dendritic spines were taken at each imaging round for comparison of dendritic spines 
over the three rounds. To establish the overall spine activity within different cortical regions between 
the sexes, the total proportion of stable and dynamic spines was quantified within each cohort. 
Dynamic populations were classified as mature or immature spine types, with a new spine considered 
‘gained’ and the absence of a spine in a subsequent imaging round considered ‘lost’ (Figure 3.3.2).  
At the time point of P60, the male motor cortex displays a significantly (p < 0.001, Unpaired t-test) 
increased proportion of dynamic spines as compared to stable (37.84% ± 0.09 M SSC stable, 62.16% 
± 0.09 M MC dynamic) (Figure 3.3.3 A). When split into the gain and loss of mature and immature 
spine types, the gain of mature spines was significantly (p < 0.0001, one-way ANOVA, Tukey’s 
multiple comparison’s test) greater than both the gain and the loss of immature spines (31.42% ± 0.05 
M MC mature gain, 20.42% ± 0.03 M MC immature gain, 11.20% ± 0.04 M MC immature loss). 
Furthermore, the loss of mature spines also occurred at a significantly greater rate than the gain or loss 
of immature spine types (23.20% ± 0.06 M MC mature loss), indicative of specific mature spine 
turnover within the highly dynamic male motor cortex at P60 (Figure 3.3.3 B). Comparatively, in the 
male somatosensory cortex the proportion of stable spine types is significantly (p < 0.001, Unpaired t-
test) greater than dynamic populations at this time point (69.75% ± 0.12 M SSC stable, 32.25% ± 0.10 
M SSC dynamic) (Figure 3.3.3 C), with no significant differences in mature and immature spine 
turnover (Figure 3.3.3 D).  
3.3.3 Cycling oestrogen stabilises dendritic spines within the motor cortex of female Thy-YFP 
mice at P60 
To investigate the proportions of stable and dynamic spines within the female Thy1-YFP cortex, mice 
were split into groups experiencing either high or baseline oestrus levels, as determined by vaginal 
Figure 3.3.2 
(A, B) Representative images of dendritic spine dynamics in the 60 day (A) and 90 day (B) 
Thy1-YFP cortex, with turnover events defined as a gain (i); a loss (ii); and morphological 
maturation or dematuration (iii) over the 3 consecutive imaging sessions. Stable spine types (A 
iv) were those unchanged from each imaging round. Scale bar = 1µm. 
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Figure 3.3.3 
Comparisons of stable and dynamic populations of dendritic spines within the Thy1-YFP male 
and female motor and somatosensory cortices at P60. Stable spines were quantified as those 
unchanged over the three imaging rounds, while dynamic spines underwent a gain, loss or 
morphological change event from the first imaging round to the last. (A, C) The graphs show 
the proportion of stable and dynamic dendritic spines within the male somatosensory and motor 
cortices. (B, D) The graphs show the turnover rate of mature and immature spines within the 
male (n  = 5) motor and somatosensory cortices. (E, G) The graphs show the proportion of 
stable and dynamic dendritic spines within the female motor and somatosensory cortices during 
high (n  = 4) and baseline (n = 4) levels of oestrogen. (F, H) The graphs show the turnover rate 
of mature and immature spines within the female motor and somatosensory cortices during 
high and baseline levels of oestrogen. MC = motor cortex, SSC = somatosensory cortex. Bars 
show mean ± SEM. *p = <0.05. 
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lavage (Figure 3.2.1 Ai-v). At each imaging round, a snapshot was taken of morphology and the 
presence or absence of dendritic spines during either high oestrogen levels or during baseline levels.  
When experiencing high levels of the sex hormone oestrogen, mice displayed no significant 
differences between stable and dynamic dendritic spine proportions within the motor cortex; however, 
during baseline levels of oestrogen, there was a significant (p < 0.02, two-way ANOVA, Tukey’s 
multiple comparisons test) increase in the dynamic proportion (27.40% ± 0.10 F baseline MC, 72.6% 
± 0.10 F high MC) (Figure 3.3.3 E). Within the dynamic population, baseline oestrus induced 
significantly (p < 0.05, two-way ANOVA, Tukey’s multiple comparisons test) increased mature spine 
gain as compared to immature gain during baseline oestrus (24.30% ± 0.06 F baseline MC mature 
gain, 7.00% ± 0.03 F baseline MC immature gain), and mature gain during high oestrus (10.60% ± 
0.06 F high MC mature gain). The loss of mature spine types during baseline oestrus was also 
significantly greater than that of immature spine loss (22.00% ± 0.07 F baseline MC mature loss, 6.80% 
± 0.02 F baseline MC immature loss) (Figure 3.3.3 F), and suggests that turnover during baseline 
oestrogen is similar to the increased turnover of mature spines within the male Thy1-YFP motor cortex 
at P60. There were no significant differences between stable and dynamic proportions of dendritic 
spines within the somatosensory cortex regardless of oestrogen levels (Figure 3.3.3 G). However, 
within the dynamic spine proportion both high and baseline oestrus states undergo significantly (p < 
0.0001, two-way ANOVA, Tukey’s multiple comparisons test) greater loss of mature spine types 
compared to the loss of immature spine types (26.70% ± 0.06 F high SSC mature loss, 8.40% ± 0.06 
F high SSC immature loss, 28.60% ± 0.11 F baseline SSC mature loss, 8.00% ± 0.01 F baseline SSC 
immature loss) (Figure 3.3.3 H). These findings highlight the role cycling of oestrogen plays in 
regulating the ratio of stable and dynamic dendritic spine proportions, with greater stability evident 
during high oestrogen.  
3.3.4 Dendritic spines of the male Thy1-YFP motor cortex are more dynamic than the 
somatosensory cortex at P60 
To further elucidate region-specific dendritic spine dynamics regulating neuronal networks, the motor 
and somatosensory cortices were compared within male and female Thy1-YFP mice at P60. Within the 
male Thy1-YFP cortex, the motor cortices display significantly (p < 0.001, Unpaired t-test) reduced 
stable populations as compared to the somatosensory cortex (37.84% ± 0.09 M MC stable, 69.75% ± 
0.13 M SSC stable) (Figure 3.3.4 A) and a significantly (p < 0.008, Unpaired t-test) greater dynamic 
proportion (62.16% ± 0.32 M MC dynamic, 32.22% ± 0.10 M SSC dynamic) (Figure 3.3.4 B). Within 
the dynamic dendritic spine population of males, the gain and loss rates of mature spine types was 
Figure 3.3.4 
Comparisons of stable and dynamic populations of dendritic spines between the motor 
and somatosensory cortices of male and female Thy1-YFP mice at P60. (A, D, G) The 
graphs show the proportions of stable dendritic spines within the male (n = 5), high 
oestrogen female (n = 4) and baseline oestrogen (n = 4) motor and somatosensory cortices. 
(B, E, H) The graphs show the proportions of stable dendritic spines within the male, 
high oestrogen female and baseline oestrogen motor and somatosensory cortices. (C, F, I) 
The graphs show the gain and loss rates of mature and immature spines within the male high 
oestrogen female and baseline oestrogen motor and somatosensory cortices. MC = motor 
cortex, SSC = somatosensory cortex. Bars show mean ± SEM. *p = <0.05. 
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significantly (p < 0.0001, two-way ANOVA, Tukey’s multiple comparisons test) greater in the motor 
cortex compared to the somatosensory cortex (31.40% ± 0.05 M MC mature gain, 11.20% ± 0.05 M 
SSC mature gain, 23.2% ± 0.06 M MC mature loss, 13.00% ± 0.04 M SSC mature loss). The gain rates 
of immature spines within the dynamic dendritic spine population of males was also higher than that 
of the somatosensory cortex (20.40% ± 0.03 M MC immature gain, 8.70% M SSC immature gain) 
(Figure 3.3.4 C).  
No significant differences in stable dendritic spine populations were observed in the female Thy1-YFP 
motor and somatosensory cortices (Figure 3.3.4 D, G). However, during high oestrus states the 
somatosensory cortex has a significantly (p < 0.02, Unpaired t-test, Tukey’s multiple comparisons test) 
greater dynamic population of dendritic spines as compared to the motor cortex (51.91% ± 0.80 F high 
MC dynamic, 79.56% ± 0.14 F high SSC dynamic) (Figure 3.3.4 E). This may be attributed to the 
significantly (p < 0.0001, two-way ANOVA, Tukey’s multiple comparisons test) increased gain rate 
of mature spines in the somatosensory cortex compared to the motor cortex (10.60% ± 0.06 F high MC 
mature gain, 24.30 ± 0.06 F high SSC mature gain) (Figure 3.3.4 D). No significant differences were 
identified between the motor and somatosensory cortices in the dynamic population and turnover of 
dendritic spines during baseline oestrogen (Figure 3.3.4 H, I). In accordance with the results above, 
these inter-regional comparisons further support the finding of greater mature spine turnover within 
the male motor cortex and suggest a role for oestrogen levels in the maturation of dendritic spines.  
3.3.5 Dendritic spines of the female Thy1-YFP somatosensory cortex are more dynamic than 
the male Thy1-YFP motor cortex at P60 
It is well established that gonadal hormones exert a critical influence on the structure and function of 
the brain during development and adulthood, and the sex hormone oestrogen has specifically been 
identified as a robust modulator of dendritic spine density (Alexander et al 2018, Brinton 2008, Gould 
et al 1990, Srivastava et al 2013, Woolley et al 1990). The findings thus far from the current chapter 
indicate sex-specific changes at the dendritic spine; to further investigate the role of sex, stable and 
dynamic dendritic spines proportions were compared between males and females experiencing high 
and baseline oestrus levels.  
Within the motor cortex, there were no significant differences in the proportion of stable spines 
between groups (Figure 3.3.5 A). However, baseline levels of oestrogen in females resulted in a 
significantly (p < 0.05, two-way ANOVA, Tukey’s multiple comparisons test) increased dynamic 
population of dendritic spines compared to females during high oestrogen, with no significance 
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compared to males (51.91% ± 0.12 F high MC dynamic, 72.62% ± 0.10 F baseline MC dynamic) 
(Figure 3.3.5 B). Within the dynamic proportions of dendritic spines, the gain rate of mature spines 
was significantly (p < 0.0001, two-way ANOVA, Tukey’s multiple comparisons test) reduced during 
high oestrogen when compared to females during baseline oestrogen and male Thy1-YFP mice 
(10.60% ± 0.06 F high MC mature gain, 24.30% ± 0.06 F baseline MC mature gain, 31.9% ± 0.05 M 
MC mature gain). During high oestrus the gain of immature spines was also significantly less than that 
of the male motor cortex (3.40% ± 0.02 F high MC immature gain, 20.30% ± 0.04 M MC immature 
gain) (Figure 3.3.5 C).  
Within the somatosensory cortex male mice display a significantly (p < 0.0001, one-way ANOVA, 
Tukey’s multiple comparisons test) higher proportion of stable spine types compared to females 
experiencing both high and baseline levels of oestrogen (20.44% ± 0.14 F high SSC stable, 14.01% ± 
0.09 F baseline SSC stable, 69.75% ± 0.12 M SSC stable) (Figure 3.3.5 D). Accordingly, the proportion 
of dynamic spine populations in the male somatosensory cortex was significantly reduced compared 
to females (79.56% ± 0.14 F high SSC dynamic, 86.00% ± 0.09 F baseline SSC dynamic, 32.25% ± 
0.10 M SSC dynamic) (Figure 3.3.5 E). Within dynamic proportions, high oestrogen levels are 
associated with significantly (p < 0.0001, two-way ANOVA, Tukey’s multiple comparisons test) 
higher mature spine gain as compared to the male somatosensory cortices (29.10% ± 0.11 F high SSC 
mature gain, 10.00% ± 0.05 M SSC mature gain), whilst baseline oestrogen levels are associated with 
significantly higher mature spine loss as compared to male somatosensory cortices (28.80% ± 0.09 F 
baseline SSC mature loss, 12.70% ± 0.05 M SSC mature loss) (Figure 3.3.5 F). These findings 
highlight the dynamics of the male motor cortex as compared to the stability of the male somatosensory 
cortex, and the increased dynamics of the female somatosensory cortex, further establishing sex-
specific dendritic spine changes within cortical regions at P60. 
3.3.6 Dendritic spines of the male Thy1-YFP motor and somatosensory cortices are highly 
dynamic at P90 
To address one of the key research questions of this Chapter and to understand how development into 
adulthood may alter dendritic spines in the male and female Thy1-YFP motor and somatosensory 
cortices, 2PLSM was undertaken at P90. The same protocol was performed as described above (Figure 
3.3.2). At P90, there were no significant differences between stable and dynamic populations of 
dendritic spines within the male motor cortex (Figure 3.3.6 A). However, within the dynamic dendritic 
spine proportion there was a significant (p < 0.0006, one-way ANOVA, Tukey’s multiple comparisons 
test) increase in mature spine gain rates compared to the overall turnover of immature spines (23.29% 
Figure 3.3.5 
Comparisons of stable and dynamic populations of dendritic spines between male and female 
Thy1-YFP motor and somatosensory cortices at P60. Stable spines were quantified as those 
unchanged over the three imaging rounds, while dynamic spines underwent a gain, loss or 
morphological change event from the first imaging round to the last. (A, D) The graphs show 
the proportion of stable dendritic spines within the motor and somatosensory cortices of male 
(n = 5) mice and female mice experiencing high (n = 4) and baseline (n = 4) levels of oestrogen. 
(B, E) The graphs show the proportion of dynamic dendritic spines within the motor and 
somatosensory cortices of male and female mice experiencing high and baseline levels of 
oestrogen. (C, F) The graphs show the turnover of mature and immature spines within the motor 
and somatosensory cortices male and female mice experiencing high and baseline levels of 
oestrogen. MC = motor cortex, SSC = somatosensory cortex. Bars show mean ± SEM. *p = 
<0.05. 
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± 0.02 M MC mature gain, 5.52% ± 0.03 M MC immature gain, 8.45% ± 0.05 M MC immature loss) 
(Figure 3.3.6 B). The loss of mature spines was also significantly increased, occurring at a greater rate 
than the overall turnover of immature spines (27.53% ± 0.02 M MC mature loss) (Figure 3.3.6 B). 
Within the male somatosensory cortices at P90, the dynamic dendritic spine proportion was 
significantly (p < 0.006, Unpaired t-test) greater than that of the stable dendritic spine proportion 
(37.35% ± 0.12 M SSC stable, 62.65% ± 0.12 M SSC dynamic) (Figure 3.3.6 C). Within the dynamic 
dendritic spine proportion, there was a significant (p < 0.003, one-way ANOVA, Tukey’s multiple 
comparisons test) increase in mature spine gain compared to the overall turnover of immature spines 
(26.88% ± 0.08 M SSC mature gain, 8.60% ± 0.1 M SSC immature gain, 7.56% ± 0.03 M SSC 
immature loss) (Figure 3.3.6 D). The loss of mature spines was also significantly increased, occurring 
at a greater rate than the overall turnover of immature spines (22.05% ± 0.04 M SSC mature loss) 
(Figure 3.3.6 D). These findings highlight the maintained high dynamics of the motor cortex, as well 
as the potentially increased dynamics of the somatosensory cortex. 
3.3.7 Dendritic spines of the female Thy1-YFP somatosensory cortex are highly dynamic and 
mature spine turnover influenced by cycling oestrogen at P90 
At P90 in the female Thy1-YFP motor cortex, high oestrus mice display a significantly (p < 0.0015, 
two-way ANOVA, Tukey’s multiple comparisons test) greater stable dendritic spine population than 
female mice during baseline oestrogen (45.60% ± 0.11 F high MC stable, 23.80% ± 0.02 F baseline 
MC stable). Females experiencing baseline oestrogen levels have a greater dynamic dendritic spine 
population than stable dendritic spine population (54.30% ± 0.11 F high MC dynamic, 75.3% ± 0.01 
F baseline MC dynamic), and a higher dynamic dendritic spine population than females experiencing 
high oestrogen levels (Figure 3.3.6 E). Within the dynamic proportions, females experiencing both 
high and baseline levels of oestrogen display a significantly (p < 0.0002, two-way ANOVA, Tukey’s 
multiple comparisons test) greater gain rate of mature spines as compared to the gain rate of immature 
spines (26.20% ± 0.09 F high MC mature gain, 6.70% ± 0.05 F high MC immature gain, 33.70% ± 
0.12 F baseline MC mature gain, 7.50% ± 0.08 F baseline MC immature gain), as well as a greater loss 
rate of mature spines compared to the loss rate of immature spines (24.10% ± 0.03 F high MC mature 
loss, 4.60% ± 0.02 F high MC immature loss, 65.00% ± 0.09 F baseline MC mature loss, 5.30% ± 0.02 
F baseline MC immature loss) (Figure 3.3.6 F).  
Within the P90 female Thy1-YFP somatosensory cortex, the proportion of dynamic spines is 
significantly (p < 0.0001, two-way ANOVA, Tukey’s multiple comparisons test) greater than that of 
stable spines regardless of oestrogen levels (35.20% ± 0.06 F high SSC stable, 64.8% ± 0.06 F high 
Figure 3.3.6 
Comparisons of stable and dynamic populations of dendritic spines within the Thy1-YFP 
male and female motor and somatosensory cortices at P90. (A, C) The graphs show the 
proportion of stable and dynamic dendritic spines within the male somatosensory and motor 
cortices. (B, D) The graphs show the turnover rate of mature and immature spines within the 
male (n  = 5) motor and somatosensory cortices. (E, G) The graphs show the proportion of 
stable and dynamic dendritic spines within the female motor and somatosensory cortices 
during high (n  = 3) and baseline (n = 3) levels of oestrogen. (F, H) The graphs show the 
turnover rate of mature and immature spines within the female motor and somatosensory 
cortices during high and baseline levels of oestrogen. MC = motor cortex, SSC = 
somatosensory cortex. Bars show mean ± SEM. *p = <0.05. 
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SSC dynamic, 13.00% ± 0.05 F baseline SSC stable, 87.00% ± 0.05 F baseline SSC dynamic) (Figure 
3.3.6 G). Between high and baseline oestrogen levels, there was a significantly higher proportion of 
stable spines at high oestrus than those during baseline oestrus; conversely, during baseline oestrus the 
dynamic dendritic spine populations were greater than those at high oestrus (Figure 3.3.6 G). Within 
the dynamic proportions during baseline oestrogen, there was significantly (p < 0.0001, two-way 
ANOVA, Tukey’s multiple comparisons test) greater overall turnover of mature spines compared to 
immature spines (30.80% ± 0.16 F baseline SSC mature gain, 8.30% ± 0.01 F baseline SSC immature 
gain, 34.10% ± 0.08 F baseline SSC mature loss, 8.50% ± 0.03 F baseline SSC immature loss) (Figure 
3.3.6 H). When considered as a whole, the data suggests that at P90, cycling oestrogen is associated 
with the alternating proportion of stable and dynamic spines within the motor and somatosensory 
cortices. 
3.3.8 Baseline levels of oestrogen are associated with regional dendritic spine changes in the 
female Thy1-YFP cortex at P90 
To elucidate region-specific activity by adulthood, dendritic spine dynamics of the motor and 
somatosensory cortices were compared within male and female Thy1-YFP mice at P90. No significant 
differences were identified in the stable and dynamic proportions of dendritic spines within the male 
cortex, nor of that in the female cortex during high oestrogen (Figure 3.3.7 A, B, C, D, E, F). However, 
during baseline oestrus dendritic spines in the motor cortex were significantly (p < 0.05, Unpaired t-
test) more stable than those within the somatosensory cortex (23.79% ± 0.02 F baseline MC stable, 
12.96% ± 0.05 F baseline SSC stable) (Figure 3.3.7 G). Accordingly, the somatosensory cortex was 
significantly (p < 0.01, Unpaired t-test) more dynamic than the motor cortex during baseline oestrogen 
(75.31% ± 0.00 F baseline MC dynamic, 87.04 ± 0.05 F baseline SSC dynamic) (Figure 3.3.7 H). 
Intriguingly, within the dynamic populations of the female Thy1-YFP cortex during baseline oestrus, 
the motor cortex displays a significantly (p < 0.05, two-way ANOVA, Tukey’s multiple comparisons 
test) increased rate of mature spine loss (65.00% ± 0.09 F baseline MC mature loss, 34.10% ± 0.08 F 
baseline SSC mature loss) (Figure 3.3.7 I). This finding has also been observed at P60 as detailed 
above, and may indicate oestrogen-regulated activity at mature dendritic spines. 
To address sex-specific dendritic spine changes in the adult cortex, stable and dynamic populations 
were compared between females experiencing high and baseline oestrus states, and male YFPH mice. 
Within the motor cortex, no significant differences in stable dendritic spine populations were identified 
between high oestrus females and males; however, female mice experiencing baseline oestrogen 
displayed a significantly (p < 0.05, one-way ANOVA, Tukey’s multiple comparisons test) reduced 
Figure 3.3.7 
Comparisons of stable and dynamic populations of dendritic spines between the motor and 
somatosensory cortices of male and female Thy1-YFP mice at P90. Stable spines were 
quantified as those unchanged over the three imaging rounds, while dynamic spines underwent 
a gain, loss or morphological change event from the first imaging round to the last. (A, D, G) 
The graphs show the proportions of stable dendritic spines within the male (n = 5), 
high oestrogen female (n = 3) and baseline oestrogen (n = 3) motor and somatosensory 
cortices. (B, E, H) The graphs show the proportions of stable dendritic spines within 
the male, high oestrogen female and baseline oestrogen motor and somatosensory cortices. 
(C, F, I) The graphs show the gain and loss rates of mature and immature spines within the 
male high oestrogen female and baseline oestrogen motor and somatosensory cortices. MC = 
motor cortex, SSC = somatosensory cortex. Bars show mean ± SEM. *p = <0.05. 
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proportion of stable spines when compared to male Thy1-YFP mice at P90 (23.79% ± 0.02 F baseline 
MC stable, 54.24% ± 0.13 M MC stable) (Figure 3.3.8 A). No significant differences in dynamic 
dendritic spine proportions were observed between the sexes (Figure 3.3.8 B). However, within 
dynamic populations the loss of mature spines during baseline oestrogen in females was significantly 
(p < 0.0001, two-way ANOVA, Tukey’s multiple comparisons test) greater than at high oestrus, or 
within males (24.1% ± 0.3 F high MC mature loss, 65.00% ± 0.09 F baseline MC mature loss, 27.5% 
± 0.02 M MC mature loss) (Figure 3.3.8 C). The proportion of stable spines was also comparatively 
reduced during baseline oestrogen levels, being significantly (p < 0.05, two-way ANOVA, Tukey’s 
multiple comparisons test) lower than that of the male somatosensory cortex (14.01% ± 0.09 F baseline 
SSC stable, 37.35 ± 0.12 M SSC stable) (Figure 3.3.8 D). A significantly higher dynamic population 
of dendritic spines was also observed during baseline oestrogen when compared to high oestrus levels 
and males (64.78% ± 0.05 F high SSC dynamic, 87.04% ± 0.05 F baseline SSC dynamic, 62.65% ± 
0.12 M SSC dynamic) (Figure 3.3.8 E). No significant differences were identified in overall dendritic 
spine turnover within the dynamic spine proportions between the sexes (Figure 3.3.8 F).  
3.3.9 Dendritic spines of the male Thy1-YFP somatosensory cortex are increasingly dynamic 
during maturation 
The aforementioned findings highlight specific alterations to mature spines at adulthood in the Thy1-
YFP mouse model, with sex associated with differential dynamic and stable dendritic spine populations 
at P90. To determine the influence of ageing, dendritic spine changes within the motor and 
somatosensory cortices were compared between male and female mice at P60 and at P90.  
Within the male motor cortex, no differences in the proportion of stable and dynamic dendritic spines 
were identified between P60 and P90 (Figure 3.3.9 A). However, within dynamic spine populations 
there was a significant (p < 0.0001, two-way ANOVA, Tukey’s multiple comparisons test) reduction 
in the gain rate of immature spines from P60 to P90 (20.4% ± 0.03 P60 M MC immature gain, 5.5% ± 
0.03 P90 M MC immature gain) (Figure 3.3.9 B). Within the somatosensory cortices, there was a 
reversal of dynamic and stable proportions between the two age groups, where by P90 there was a 
significant (p < 0.0001, two-way ANOVA, Tukey’s multiple comparisons test) reduction in stable 
populations (69.8% ± 0.13 P60 M SSC stable, 37.5% ± 0.12 P90 M SSC stable) and a significant 
increase in dynamics populations (32.2% ± 0.10 P60 M SSC dynamic, 62.6% ± 0.12 P90 M SSC 
dynamic) as compared to those at P60 (Figure 3.3.9 C). Within the dynamic dendritic spine proportion, 
there was a significant (p < 0.001, two-way ANOVA, Tukey’s multiple comparisons test) increase in 
the gain of mature spines from P60 to P90 in the male somatosensory cortex (11.2% ± 0.05 P60 M 
Figure 3.3.8 
Comparisons of stable and dynamic populations of dendritic spines between male and female 
Thy1-YFP motor and somatosensory cortices at P90. (A, C) The graphs show the proportion 
of stable dendritic spines within the motor and somatosensory cortices of male (n = 5) mice 
and female mice experiencing high (n = 3) and baseline (n = 3) levels of oestrogen. (B, D) 
The graphs show the turnover of mature and immature spines within the motor and 
somatosensory cortices male mice and female mice experiencing high (n = 3) and baseline (n 
= 3) levels of oestrogen. MC = motor cortex, SSC = somatosensory cortex. Bars show mean 
± SEM. *p = <0.05. 
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Figure 3.3.9 
Comparisons of stable and dynamic populations of dendritic spines between male Thy1-YFP 
motor and somatosensory cortices from P60 to P90. (A, C) The graphs show the proportion 
of stable dendritic spines within the motor and somatosensory cortices of male (n = 5) mice at 
P60 and at P90. (B, D) The graphs show the turnover of mature and immature spines within 
the motor and somatosensory cortices male (n = 5) mice at P60 and P90. MC = motor cortex, 
SSC = somatosensory cortex. Bars show mean ± SEM. *p = <0.05. 
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SSC mature gain, 26.9% ± 0.08 P90 M SSC mature gain) (Figure 3.3.9 D). These findings suggest that 
within the somatosensory cortex of male YFPH mice, the proportion of stabilisation and dynamic 
events of neuronal circuits is altered over time. Conversely, dynamics are maintained over time in the 
motor cortex, with evidence of maturation in the increased gain of mature spines within the 
somatosensory cortex and the reduced growth of immature spines in the motor cortex.  
3.3.10 Cycling oestrogen influences increased mature spine turnover in the female Thy1-YFP 
motor cortex between P60 and P90 
Between P60 and P90, there were no significant differences in the dynamic and stable dendritic spine 
proportions of the female motor and somatosensory cortices regardless of oestrogen levels (Figure 
3.3.10 A, C, E, G). However, during high oestrogen levels the dynamic proportion of dendritic spines 
within the motor cortices displayed a significantly (p < 0.0001, two-way ANOVA, Tukey’s multiple 
comparisons test) increased gain rate of mature spines at P90 as compared to P60 (10.6% ± 0.06 P60 
MC F high mature gain, 26.2% ± 0.09 P90 MC F high mature gain) (Figure 3.3.10 B). Conversely, 
during baseline levels of oestrogen there was a significant (p < 0.0001, two-way ANOVA, Tukey’s 
multiple comparisons test) increase in mature spine loss within the motor cortex at P90 as compared 
to P60 (22.00% ± 0.07 P60 F baseline MC mature loss, 65.00% ± 0.09 P90 F baseline MC mature loss) 
(Figure 3.3.10 D). No significant differences were identified in turnover within the dynamic 
populations of the somatosensory cortex during high or baseline oestrogen levels (Figure 3.3.10 H). 
Thus the motor cortex displays age-dependent changes at mature dendritic spine types, while within 
the female somatosensory cortex dendritic spine populations are maintained from P60 to P90.   
 
 
 
 
 
 
 
 
Figure 3.3.10 
Comparisons of stable and dynamic populations of dendritic spines between female Thy1-YFP 
motor and somatosensory cortices during high and baseline oestrogen levels from P60 to P90. 
(A, C) The graphs show the proportion of stable dendritic spines within the motor cortices of 
female (n = 5) mice at P60 and at P90 during high and baseline oestrogen levels. (B, D) The 
graphs show the turnover of mature and immature spines within the motor cortices of female 
(n = 5) mice at P60 and P90 during high and baseline oestrogen levels. (E, G) The graphs 
show the proportion of stable dendritic spines within the somatosensory cortices of female (n 
= 5) mice at P60 and at P90 during high and baseline oestrogen levels. (F, H) The graphs 
show the turnover of mature and immature spines within the somatosensory cortices of female 
(n = 5) mice at P60 and P90 during high and baseline oestrogen levels. MC = motor cortex, 
SSC = somatosensory cortex. Bars show mean ± SEM. *p = <0.05.
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3.4 DISCUSSION 
The formation and modulation of the CNS relies upon precisely regulated synaptic circuits to function 
correctly. These cortical networks are assembled during development within discrete, yet 
interconnected regions through the formation and remodelling of dendritic spines (Katz & Shatz 1996). 
The current study aimed to determine whether cortical region, age and sex influence dendritic spine 
changes in the Thy1-YFP mouse model, and whether these may underlie differential susceptibility to 
disease. It was hypothesised that changes in dendritic spine populations and turnover have a unique 
pattern depending on these factors. Here, an increase in dendritic spine density is identified at P60 in 
both the motor and somatosensory cortices, indicative of a previously uncharacterised peak in 
neuroplastic capacity during adolescence. During this stage, male and female Thy1-YFP mice display 
a higher turnover of dendritic spines in the motor cortex, with peaks of high oestrogen associated with 
transient stability. The high dynamics of the male motor cortex are maintained into adulthood, as are 
the oestrogen-mediated changes in the female motor cortex. Within the somatosensory cortex, a switch 
between stability and dynamics is observed in males over time, whilst females sustain their relatively 
high proportions of dynamic dendritic spine populations (Figure 3.4.1).   
3.4.1 Peaks of neuronal plasticity in the maturing cortex 
Although there is evidence for changes in overall dendritic spine density throughout cortical 
development, little is still known regarding the specific changes that occur at the highly motile 
postsynaptic structure in the mouse cortex over time, as influenced by sex (Bhatt et al 2009, Zuo et al 
2005). Peaks in spine density during critical periods and adolescence are well-documented in both 
mammalian models and in humans, whereby global spine density reductions facilitate the formation 
of viable connections (Arikkath 2012, Bourne & Harris 2008, Gonzalez-Burgos et al 2015, Knott et al 
2006, Poon 2018, Selemon 2013). Compared to the adult cortex, developing networks display higher 
plasticity during a time window where both environmental and genetic factors can shape the 
development of cortical circuits (Hensch 2005, Maffei et al 2010, Maffei & Turrigiano 2008). In this 
Chapter, the density of dendritic spines is increased at P60 - a previously undefined developmental 
period in the adolescent mouse cortex - prior to pruning at adult P90, a process essential for the fine-
tuning of synaptic connections (Boivin et al 2018, Flurkey et al 2007, Johnson et al 2016, Koss et al 
2014, Petanjek et al 2011). Knowledge of when these periods of increased capacity for plasticity occur 
are essential for targeting early stages during which activity-dependent insults may be impacting 
cortical regions. Though measures of density provide insight into the availability of viable synaptic 
compartments, they do not capture the structural plasticity of dendritic spines within a network. To 
Figure 3.4.1 
The schematic represents the relative proportions of dynamic (waved line) and stable (straight 
line) dendritic spine populations of the motor (A) and somatosensory (B) cortices, within male 
(red) and female mice experiencing high (green) or baseline (blue) levels of oestrogen. The 
axis represents the relative proportions of dynamic and stable dendritic spine populations from 
adolescent P60 to adult P90.  
Low oestrogen
High oestrogen
Male
Motor cortex
Somatosensory cortex
A
B
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better appreciate the distinct roles of dendritic spines within circuits, the quantification of gain, loss 
and morphological alterations can be used to further elucidate the neuroplastic processes of a cortical 
region (Berry & Nedivi 2017).  
3.4.2 The male motor cortex maintains high dynamic populations of dendritic spines  
The constant rewiring of neural networks is in part mediated through structural plasticity at the 
dendritic spine, and is a fundamental mechanism for learning. The motor cortex is intricately connected 
to frontal regions of the brain in mice, and in both mice and humans constitutes a higher order region 
(Barthas & Kwan 2017, Brecht 2011, Kolb et al 2012, Lein et al 2006, Meunier et al 2009). 
Accordingly, the primary motor cortex has been implicated in a range of functions outside of typical 
motor behaviours, and is increasingly recognised as being responsible for higher order tasks such as 
planning, orientation, angular coordinates during turning tasks and movement anticipation (Brecht 
2011, Erlich et al 2011, Hill et al 2011, Sreenivasan et al 2016). The involvement in executive functions 
as well as motor coordination suggests the region may have higher activity dependent demands, 
reflected here in the increased turnover of dendritic spines at adolescent P60 and sustained dynamic 
spine proportions by adulthood (Figure 3.4.1). 
Within the male motor cortex, the findings here indicate mature spines undergo higher rates of gain 
and loss than immature spines. Classically, mature spine types have been considered a stable dendritic 
spine morphology-however, more recent studies have shown that while spines undergoing dynamic 
events are likely to be slightly smaller, they can be of all sizes and morphological subtypes (Holtmaat 
et al 2005, Keck et al 2008, Villa et al 2016). Indeed, increased turnover of spines is the initial step for 
stabilisation that determines integration into a local circuit (Attardo et al 2015, Hayashi-Takagi et al 
2015, Sanders et al 2012). The increased turnover of mature spine types within the motor cortex may 
be a reflection of increased activity within higher order cortical regions, where mature spines in these 
regions require more synaptic inputs to stabilise AMPA receptors at the post-synaptic density (Lambert 
et al 2017, Taft & Turrigiano 2014). Intriguingly, other in vivo studies have demonstrated the 
stabilisation of networks is largely driven by mature or stable spine elimination, implicating the spine 
type in a range of activity dependent processes underlying circuit formation (Knott & Holtmaat 2008, 
MacDonald et al 2017). A reduction of thin spine gain in the male motor cortex by adulthood is further 
indicative of regional maturation, with these spines having the lowest ratio of AMPA to NMDA 
receptors, and the least capacity for post-synaptic machinery (Holtmaat et al 2005, Majewska et al 
2006). These specific alterations in the turnover rates of dendritic spine types may reflect the 
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maturation of motor cortex circuitry in male mice, with decreases in immature turnover and increases 
in mature turnover underlying the sustained dynamic nature of the region.  
3.4.3 Cycling oestrogen regulates the stable:dynamic ratio of dendritic spines of the Thy1-YFP 
motor cortex at P60 
An intriguing result from the current Chapter is how cycling oestrogen regulates the proportion of 
stable and dynamic dendritic spine populations. During baseline levels of oestrogen, females display 
similarly high proportions of dynamic spines as males; however, during peaks of oestrogen, dynamic 
proportions are reduced and dendritic spines within the region are stabilised (Figure 3.41). Oestrogen 
exerts its effects at the synapse through receptors within the post-synaptic density, with the classical 
subtypes- alpha and beta- observed to have roles in promoting memory consolidation and spine density 
that vary depending on cortical region and age (Hara et al 2015, MacLusky et al 2005, Milner et al 
2005, Murakami et al 2006, Phan et al 2011, Srivastava et al 2011). Receptors for oestrogen are widely 
distributed throughout the brain, and the cortex in particular has been shown to undergo increases in 
dendritic spine density in relation to higher oestrogen levels (Chen et al 2009, Khan et al 2013, Kinsley 
et al 2006, Tang et al 2014, Wallace et al 2006). Observed increases in dendritic spine density 
following heightened oestrogen are likely to be associated with the formation and stabilisation of 
dendritic spines, and the association between high oestrogen and the stabilisation has been suggested 
to be regulated via the oestrogen receptor b (ERb) (Alexander et al 2018, Wang et al 2018). While 
increases in overall dendritic spine density following peaks of oestrogen may reflect the neuroplastic 
capacity of the cortex, these findings do not provide insights into the strength and stability of synaptic 
connections being formed and maintained during these stages.  
At the level of the dendritic spine, oestrogen increases synaptic proteins, promotes F-actin-dependent 
spine assembly and activates changes to the ratios of AMPA and NMDA receptors (Babayan & Kramár 
2013, Kramár et al 2009, Lee et al 2003, Woolley & McEwen 1994). Previous studies have identified 
increased binding for specific NMDA receptors at the dendritic spine membrane, with no overall effect 
on AMPA receptors (Cyr et al 2001, Gureviciene et al 2003, Woolley et al 1997). However, more 
recent research has found specifically targeting ERb has profound effects on AMPA recruitment at the 
spine head, particularly that of GluA1 and GluA2 – essential for activity-dependent delivery of AMPA 
receptors to the synapse and calcium permeability respectively (Lee et al 2003, Shi et al 2001, Waters 
et al 2009). It may be that cycling peaks of oestrogen regulate the transient stabilisation of dendritic 
spines through the ERb-dependent recruitment of AMPA subunits to the spine head, further inducing 
F-actin to promote mature spine growth and greater post-synaptic machinery. Further evidence for this 
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comes from the specific regulation of mature spine gain and loss by oestrogen fluctuations as identified 
in this Chapter, indicating the hormone is crucial for the formation and regulation of strong synaptic 
connections.   
3.4.4 The somatosensory cortex displays sex-dependent trajectories of maturation 
The manipulation of inputs and stimulation differentially affect the rate of spine dynamics in a circuit-
specific manner, and reflect region and cell types (Berry & Nedivi 2017). While the motor cortex 
appears to normally be highly dynamic, with spine stability regulated by oestrogen, the somatosensory 
cortex in this Chapter displays sex-specific changes at the dendritic spine. Females maintain high 
dynamics within the somatosensory cortex over time, whilst males display a developmental switch; 
during adolescence, dendritic spines in the motor cortex of male mice are more stable, whereas by 
adulthood they become more dynamic (Figure 3.4.1). This dynamic population appears to be driven 
primarily by the gain of mature spine types-the morphological subset most likely to form stable 
synaptic connections. Previous studies of dendritic spine turnover within the somatosensory cortex 
have identified increased stability as mice mature; however, these findings have been at differing time 
points to the ones utilised in this Chapter (Holtmaat et al 2005; Zuo et al 2005). Further, an increased 
capacity for turnover has been identified in the somatosensory cortex compared to other cortical 
regions by adulthood, indicative of a greater plastic capacity (Holtmaat et al 2005). Primarily, these 
findings come from male mice only, or mixed cohorts; there is less evidence for the effects sex 
hormones may have over these developmental time periods. Evidence for sex-dependent development 
of cortical networks has largely come from longitudinal MRI, demonstrating global changes in the size 
of cortical regions dependent on sex during development; yet the specific events underlying the 
formation of networks during this time remain largely unknown (Qiu et al 2018, Raznahan et al 2010). 
The distinct difference in stability vs dynamics between males and females at adolescence within this 
region may reflect unique timelines for hierarchical cortical development, whereby the somatosensory 
cortex is evidenced to mature earlier in females than in males (Boivin et al 2018, Munoz-Cueto et al 
1990). As aforementioned, the increased dynamic proportions of females over time and that of males 
by adulthood may reflect the maturing cortex; rather than dynamics being a sign of instability, these 
populations may instead be contributing to the continual stabilisation of cortical networks through 
neuroplasticity (Attardo et al 2015, Hayashi-Takagi et al 2015, Lambert et al 2017, Taft & Turrigiano 
2014).  
As opposed to the motor cortex, where oestrogen exerts differential effects on stable and dynamics 
spine populations, here dynamic proportions remain elevated through to adulthood regardless of 
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oestrogen fluctuations. This suggests not only a functionally mature region, but also indicates 
mechanisms underlying learning, memory and activity-dependent processes remain stable across the 
oestrus cycle. Evidence for this comes from studies of dendritic spine density on layer V pyramidal 
neurons of the somatosensory cortex, where steady-state conditions result in dendritic spines being 
unaffected by oestrus cycle, and comparable to that of males at adulthood (Alexander et al 2018). 
However, it appears the ability of layer V neurons in this region to respond to sensory-evoked structural 
plasticity may indeed be influenced by oestrus, displaying higher turnover rates during high oestrus 
(Alexander et al 2018). Together, these findings indicate that while dendritic spines of the female 
somatosensory cortex maintain high dynamics over time, circuitry is still regulated by oestrogen 
cycling during learning events. To continue gaining an understanding of how oestrogen mediates 
dendritic spine activity, it is vital to investigate how functional output from a region is tied to the 
machinery at the post-synapse that may interact with or be influenced by the sex hormone. 
3.4.5 Conclusions 
Dendritic spines are highly motile regulators of the processes underlying neuroplasticity, influenced 
by a range of factors. The finely-tuned balance of stable and dynamic dendritic spine populations is 
essential for the appropriate functioning of discrete cortical regions, and underlies the ability to respond 
to activity demands. This Chapter provides insights into how the neuroplasticity of discrete cortical 
regions is influenced by age and sex. Within the motor cortex, males and females demonstrate 
sustained high proportions of dynamic spines, yet females also experience higher stability during peaks 
of cycling oestrogen. Conversely, within the somatosensory cortex males display a switch whereby 
adolescence is marked by stable spine populations, whilst by adulthood these populations have become 
more dynamic. Females display sustained somatosensory dynamic populations from adolescence to 
adulthood. Gaining a greater understanding of the potential for cortical regions to differentially 
respond to activity and modulate neuroplasticity is essential for understanding why certain circuits are 
primed to fail in disease. Here, the increased dynamic needs of the male motor cortex suggest that the 
region may be specifically susceptible to altered neuroplasticity due to an inability to regulate activity 
physiologically. It is crucial to investigate the mechanisms underlying interactions between sex, age 
and region to elucidate how these factors influence neuroplasticity at the dendritic spine both normally 
and in disease.  
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4 THE TDP-43A315T MUTATION ALTERS DENDRITIC SPINE DYNAMICS   
4.1 INTRODUCTION 
Neuroplasticity is the phenomenon describing molecular changes that constitute learning and memory, 
and is partly regulated by changes in the shape and number of dendritic spines within networks (Fu & 
Zuo 2011). Changes at the dendritic spine are critical for the appropriate function of cortical regions, 
and in the current thesis the dendritic spines of the motor cortex have been identified as innately 
dynamic. However, the region has also been identified as being susceptible to early dysfunction at the 
postsynaptic structure mediated by misprocessed TDP-43. It is crucial to identify how the normal 
processes of neuroplasticity may be perturbed in the presence of a disease-linked protein mutation, in 
order to establish early pathological events that may provide therapeutic targets. 
TDP-43 has been implicated in the growth and maturation of dendritic spine through a number of 
cellular pathways, including the Rho GTPase Rac1 pathway of spinogenesis (Hayashi & Majewska 
2005, Luo 2000, Zhang et al 2010). Activity of Rac1 induces AMPAR clustering at the spine head- 
responsible for strengthening and maturation of synapses- which is facilitated by the trafficking of 
synaptic mRNAs to and from the synaptic membrane, essential for localised protein synthesis 
(Grienberger et al 2015, Haditsch et al 2009, Matsuzaki et al 2004, Sutton & Schuman 2006). TDP-43 
is a negative regulator of this pathway both in vitro and in vivo, and changes in protein expression 
result in aberrant spine formation (Majumder et al 2012). TDP-43 forms a complex with the FMRP 
protein to regulate the mRNA of both Rac1 and GluA1 proteins, both requiring activity-dependent 
localised protein synthesis to perform functions at the dendritic spine (Majumder et al 2016). The role 
of TDP-43 in this pathway may be essential for cortical plasticity under normal conditions, and thus 
protein misprocessing has vast implications for the ability of susceptible cortical regions to modulate 
and respond to activity. After establishing changes at the dendritic spine under normal conditions as 
influenced by age, sex and region, the third aim of this thesis was to investigate dendritic spine 
plasticity in real time in the TDP-43A315T mouse model of ALS. 
The sex hormone oestrogen has been implicated in synaptic regulation at the dendritic spine, 
facilitating fast excitatory postsynaptic potentials, long-term potentiation and increase dendritic spine 
density (Arevalo et al 2015, Babayan & Kramár 2013, Frankfurt & Luine 2015, Luine & Frankfurt 
2013). Intriguingly, oestrogen has also been identified as a potential cortical neuroprotective agent 
within mammalian models and humans, where decreased hormone levels as a result of ovariectomy or 
other means increases brain damage under neurodegenerative conditions (Behl 2002, Carswell et al 
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2005, Scott et al 2012, Tang et al 1996, Zhang et al 2014). Furthermore, the magnitude of the insult is 
thought to be mediated by fluctuating oestradiol levels during the oestrous cycle (Behl 2002, Berman 
et al 1997, Erickson et al 2005, Scott et al 2012). In ALS, the incidence of disease is higher among 
men than women at 4:1 when the age of onset is the second decade, but this rises to a 1:1 ratio at ages 
above 60 years – when the vast majority of women have undergone menopause and have greatly 
reduced oestrogen levels (Haverkamp et al 1995, Suzuki et al 2007). Furthermore, women who do 
develop ALS later in life have often experienced earlier onset of menstruation and menopause; 
indicative of an involvement of sex hormones in both the onset and progression of the disease (Chiò 
et al 1991, McCombe & Henderson 2010, Suzuki et al 2007).  
The findings from the current thesis have established specific sex-dependent changes at the dendritic 
spine within the motor cortex, where cycling oestrogen promotes transient stability. Understanding the 
complex interactions between the synaptic roles for oestrogen within cortical regions, neuroprotective 
mechanisms, and the progression of ALS may give clues as to what processes modify the disease. To 
investigate real-time region- and sex-dependent dendritic spine changes in disease states, male and 
female Thy1-YFP:prpTDP-43A315T  (TDP-43A351T) mice underwent cranial window surgeries at P50. 
Prior to 2PLSM imaging, the oestrus cycle of female mice was recorded, and these mice then assigned 
to ‘baseline oestrogen levels’ or ‘high oestrogen levels’ cohorts for imaging. The gain, loss, and 
morphological maturation of dendritic spines was quantified in the motor cortices of TDP-43A315T mice, 
and compared to that of Thy1-YFPH controls to establish whether TDP-43 misprocessing or sex 
influenced the dynamics of dendritic spines within the motor cortex. MATLAB and NeurolucidaTM 
software were utilised for the acquisition and quantification of images. These experimental paradigms 
will be used to determine the bases for specific susceptibility of the motor cortex to TDP-43 
misprocessing at the dendritic spine, and the potential for oestrogen to modulate ALS progression 
within the motor cortex at the post-synaptic compartment. 
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4.2 METHODS 
4.2.1 Animals 
Experimental procedures utilised both male and female mice and were approved by the Animal Ethics 
Committee of the University of Tasmania, performed in accordance with the Australian Code of 
Practice for the Care and Use of Animals for Scientific Purposes. Animals were housed in ventilated 
cages at 20°C on a 12 hour light-dark cycle, with access to food and water ad libitum. Thy1-YFP 
transgenic mice [B6.Cg-Tg (Thy1-YFP-H) 16Jrs/J) (Feng et al 2000; Porrero et al 2010)] and TDP-
43A315T transgenic mice [B6.Cg-Tg (Prnp-TARDBP*A315T) 95Balo/J (Wegorzewska et al 2009; 
Herdewyn et al 2014)] were purchased from the Jackson Laboratory and maintained on a C57BL6 
background. Thy1-YFPH mice express high levels of yellow fluorescent protein in the motor and 
sensory neurons of cortical layer V (LV) (Feng et al 2000; Porrero et al 2010). The TDP-43A315T mouse 
demonstrates an approximate 3-fold increase in expression of human TDP-43A315T, in comparison to 
endogenous TDP-43 levels, driven on the prion promotor (Wegorzewska et al 2009). These mouse 
lines were intercrossed to generate the Thy1-YFP::TDP-43A315T transgenic mice. Thy1-YFP transgenic 
littermates were used as controls.  
4.2.2 Genotyping 
Mice were genotyped at the time of weaning (28 day post-natal) using a clipping from the top portion 
of the ear, which was removed and stored at -20°C until DNA extraction was undertaken. DNA was 
extracted using an Extract-N-Amp Tissue PCR tissue kit (Sigma-Aldrich, Australia) according to 
manufacturer’s instructions and stored at -4°C. TDP-43A315T PCR amplification was performed using 
an 11 µl reaction containing 50-100 g of DNA (~1µl), and the following primers (GeneWorks, 
Australia):1µl oIMR 8744 internal positive control forward (5’-CAA ATG TTG CTT GTC TGG TG-
3’); 1µl oIMR 8745 internal positive control reverse (5’-GTC AGT CGA GTG CAC AGT TT-3’); 1µl 
transgene forward (5’-GGA TGA GCT GCG GGA GTT CT-3’); and 1µl transgene reverse (5’ TGC 
CCA TCA TAC CCC AAC TG-3’). Amplification occurred under the following conditions: 94°C for 
3 minutes; 94°C for 30 seconds; 60°C for 30 seconds; 72°C for 30 seconds; steps two-four repeated 
for 30 cycles; 72°C for 30 seconds; 4°C on infinite hold.  
Thy1-YFP PCR amplification was performed using a 10 µl reaction containing 50-100 g of DNA 
(~1µl) and the following primers (GeneWorks, Australia): 1µl oIMR 7338 internal positive control 
forward (5’-CTA GGC CAC AGA ATT GAA AGA-3’); 1µl oIMR 7339 internal positive control 
reverse (5’-GTA GGT GGA AAT TCT AGC ATC ATC C-3’); 1µl transgene forward (5’-TCT GAG 
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TGG CAA AGG ACC TTA G-3’); and 1µl transgene reverse (5’-TGA ACT TGT GGC CGT TTA 
CG-3’). Amplification occurred under the following conditions: 95°C for 1 minute; 95°C for 15 
seconds; 58°C for 15 seconds; 72°C for 30 seconds; steps two-four repeated for 35 cycles; 72°C for 7 
minutes; 11°C on infinite hold.   
4.2.3 Oestrus cycle tracking 
In mice, the oestrus cycle is divided into 4 stages (proestrus, oestrus, metestrus and diestrus) and 
repeats every 4-5 days unless interrupted by pregnancy, pseudopregnancy or anestrus (Byers et al 
2012) (Figure 3.2.1). The oestrus stage in which female mice underwent 2PLSM was assessed in two 
steps; a preliminary visual observation of the vaginal opening of each mouse, and verification by 
vaginal cytology. To evaluate oestrus cycle stage visually, mice were restrained and vaginal opening 
evaluated based on standard criteria (Champlin et al 1973; Byers et al 2012) (Figure 3.2.2 Ai-iv). A 
vaginal swab was collected using a cotton tipped swab, wetted with room temperature saline. The swab 
was inserted into the opening of the vagina of the restrained mouse and rolled against the vaginal wall. 
Cells were transferred to a dry glass slide (Livingstone, Australia) by rolling the swab across the slide. 
Slides were then air-dried and stained with toluidine blue (0.l25% toluidine blue in 0.l25% acetic acid) 
(Sigma Aldrich, Australia) for 10 minutes. The slides were then rinsed with water, overlaid with a 
cover-slip using fluorescent PermaFluor™ mounting medium (Thermo-Fisher Scientific, Australia) 
and viewed immediately at 200x magnification under bright-field illumination using an Olympus 
CKX31 Inverted Microscope (Olympus Australia Pty. Ltd., Australia). The stage of oestrus cycle was 
determined based on the presence or absence of leukocytes, cornified epithelial, and nucleated 
epithelial cells (Felicio et al 1984) (Figure 3.2.2 Bi-iv). 
4.2.4 Cranial window surgeries 
An open-skull cranial window was surgically implanted over either the motor or somatosensory 
cortices of mice at P50, following the protocol previously described by Holtmaat et al. (2009) (Figure 
3.2.3). This timeline enables 10 days of recovery prior to imaging at P60, whereupon ~80% of cranial 
windows were successful. Experimental mice underwent isoflurane (Henry Schein®, USA) induction 
(4%, ~0.5 litre min-1 O2), were given a sub-cutaneous (s.c.) injection of the long-acting general 
analgesic Temgesic (buprenorphine 300 mg/ml dosed at 0.1 mg/kg) (Ilium, Troy Laboratories, 
Australia) and heads shaved to prevent foreign particles entering the surgical site. Mice were then 
placed into a stereotaxic frame and isoflurane maintained at 1.5-2%, ~0.5 litre min-1 O2. The cranium 
was cleaned with three rotations of a cotton swab with the disinfectant Microshield® chlorhexidine 
(Schulke Pty. Ltd., Australia) and after drying, swabbed again with ethanol (Sigma Aldrich, Australia). 
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Viscotears® liquid eye gel (Novartis Pharmaceuticals, Australia) was applied and the mouse injected 
s.c. with the local analgesic bupivacaine (bupivacaine hydrochloride 0.5% dosed at 0.025%) (Pfizer 
Ltd., Australia) and the anti-inflammatory Metacam (meloxicam 5 mg/ml dosed at 1 mg/kg) (Ilium, 
Troy Laboratories, Australia).  
Using scissors, a circular flap of skin (~1 cm2) was removed from the skull, and the periosteum 
removed by gently scraping the skull with sharpened forceps. Vetbond™ (cyanoacrylate 3M™, USA) 
tissue adhesive was applied to the temporalis muscle and wound margins to prevent seepage of 
serosanguinous fluid, sparing the trepanation area. The cortical regions of interest were identified 
according to bregma, in order to accurately locate the correct coordinates for the motor cortex (-1.0 
mm posterior from bregma, -0.8 mm lateral) and the somatosensory cortex (1.5 mm from bregma, 3.0 
mm lateral) (Figure 3.2.3 A, B). A circular groove was drilled around the area of interest (~3 mm in 
diameter) and cortex buffer (125 mM NaCl, 5 mM KCl, 10 mM glucose, 10 mM HEPES, 2 mM CaCl2, 
2 mM MgSO4) regularly applied to avoid heating. A bone island was left intact, dampened with buffer 
and sharp angle-tipped forceps inserted into the trabecular bone exposed on the side of the groove to 
expose the dura. Dexapent (dexamethasone sodium phosphate 5 mg/ml dosed at 4 mg/ml) (Ilium, Troy 
Laboratories, Australia) was topically applied to the surface of the exposed dura to act as an 
immunomodulator and prevent regrowth of neomembrane (Figure 3.2.3 C). A circular coverglass (4 
mm diameter, #1 thickness) was placed over the dura flush with the skull and Loctite® adhesive 
(Henkel Adhesives, Australia) applied around the window edges to prevent seepage under the 
coverslip. The cranial window was sealed with dental cement (Paladur, Kulzer Australia Pty. Ltd., 
Australia), covering the exposed cranium, the wound margins and the lip of the coverglass. A titanium 
steel bar (Central Science Laboratory, University of Tasmania, Australia) with screw holes was 
embedded in the dental acrylic over the intact hemisphere for animal stabilisation during imaging 
sessions (Figure 3.2.3 D).  
Post-surgery, the mouse received a 1ml s.c. injection of saline and was placed back into the home cage 
on a heat pad for ~30 minutes of recovery. The mouse was considered fully recovered after observation 
of grooming, eating and normal movement and reflexes. Monitoring was undertaken twice a day for 4 
days, then once a day for 6 days, prior to the first imaging round.  
4.2.5 Two-photon scanning laser microscopy 
To image dendritic spine dynamics in real time, a 2PLSM (Scientifica, UK) equipped with a MaiTai 
laser (Spectra-Physics, NewSpec Pty. Ltd., Australia) and running custom MATLAB® software 
(MathWorks, Australia) was used over 3 consecutive imaging sessions, 24 hours apart to image the 
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motor and somatosensory cortices. The MaiTai laser was run at 910 nm by a 10 W solid state laser 
(Spectra-Physics, Australia). The mouse was anaesthetised following an intraperitoneal (i.p.) injection 
of a 12:1 mixture of Ketamine (ketamil 100 mg/ml) (Ilium, Troy Laboratories, Australia) and Xylazine 
(xylazil 20 mg/ml) (Ilium, Troy Laboratories, Australia) at a recommended dosage of 5 µl of working 
solution per gram (0.12 mg/g ketamine to 0.01 mg/g xylazine, approximate dose of 100 µl for a 20 g 
mouse), which wore off after 45-60 minutes. Once no reflexes were detected, mice were placed on a 
heat-pad maintained at 37°C under the microscope, with head immobilised by screwing the titanium 
bar of the cap to a stable, adjustable arm and eye gel applied.  
An EC Plan-Neofluar 10x/0.3 air objective (Nikon, USA) was used to image the vasculature of a region 
of interest (ROI), illuminated by white light, and captured using XCAP Image Processing Software 
(EPIX Incorporated, USA) (Figure 3.2.4 Ai). Once a region of interest was identified, the z-plane 
coordinate was saved and the objective changed to a W Plan-Apo 40x/1.0 water immersion objective 
(Nikon, USA). The same z-plane coordinate was initiated and a higher-powered region of interest 
captured to find the same position during consecutive imaging sessions (Figure 3.2.4 Aii). The MaiTai 
laser was used to capture blue/green emissions (Channel 1 PMT 550-565ƞm) at 910 nm/1700 mW of 
power at a maximum percentage of 25%, equivalent to 70 mW (Mainen et al 1999). The apical tuft 
dendrites of LV neurons were captured in Z-stacked images (20µm) of cortical layers II-III (slices 1µm 
apart) at a minimum depth of 210 µm from the cranial surface to a maximum depth of 350 µm (Figure 
3.2.4 B). Landmark dendrites were identified during the initial imaging session, and returned to in the 
following sessions in order to capture the same region of interest and identify the same dendritic spines 
on a given dendritic segment (Figure 3.2.4 C). The xyz-coordinates of every ROI were stored relative 
to the vasculature pattern initially captured. To verify all structures were detected, excitation was 
increased to ensure no additional spines were revealed and signal fluorescence intensity was different 
from noise. Imaging sessions lasted for ~30 minutes p/mouse and during imaging the respiratory rate 
of the mouse was monitored at 10 minute intervals. Post-imaging the mouse was injected with 1ml of 
saline s.c. and placed back into the transfer cage on a heat pad for recovery, until fully ambulant.  
4.2.6 Quantification of dendritic spine turnover 
Z-stacked images were taken in real time of LV apical tuft dendrites residing in LII/III of the motor 
and somatosensory cortices at 3 times points, 24 hours apart (Figure 3.2.3 A, B). To quantify the 
turnover of dendritic spines, images for a given segment of dendrite from each round were opened in 
Neurolucida™ and spines annotated along the segment as being morphologically thin, stubby or 
mushroom shaped. The analysed segments were uploaded into Neurolucida Explorer™ and density 
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quantified to validate representation of a given cohort. For each animal, ~2 dendrites were quantified 
for each cohort; P60 MC males (369 spines), baseline oestrus (406 spines) and high oestrus (350 
spines), and P60 TDP-43 males (361), baseline oestrus (384) and high oestrus (272). Spines were only 
measured if they clearly emanated laterally from the dendritic shaft-those protruding below or above 
the dendrite could not be reliably quantified in the axial dimension. Spines for each round were 
quantified in comparison to the preceding round as being gained, lost or exhibiting a morphological 
change-with morphological subtypes being classed as mature (mushroom and stubby morphologies) 
and immature (thin morphology). Spines were considered lost if they disappeared between imaging 
rounds; gained if they newly protruded between rounds; and considered to exhibit morphological 
changes if the head to neck ratio was clearly altered between rounds (Figure 3.2.3 C). The baseline 
turnover gain and loss rates of spine subtypes was calculated as TR = Nt/Nl or Ng, where TR is the 
turnover rate; Nt is the total number of spines for a single mouse; Nl is the number of spines lost; and 
Ng is the number of spines gained, as a ratio from the total number of dendritic spines and dendritic 
spine changes. This formula was used to calculate the total gain and loss rate of all spines for a single 
mouse, as well as the specific gain and loss rates of mature, and of immature spines-where Nlm and 
Ngm is equal to the number of lost and gained mature spines, and Nli and Ngi is equal to the number of 
lost and gained immature spines (Attardo et al 2015, Frank et al 2018).  
4.2.7 Statistical analyses 
Student’s t-tests, one-way and two-way analysis of variance (ANOVAs) were performed in GraphPad 
(USA) Prism. Post-hoc comparisons were performed using Bonferroni’s correction for multiple 
comparisons. A p-value of <0.05 was considered significant. 
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4.3 RESULTS  
4.3.1 The male TDP-43A315T motor cortex displays altered proportions of stable and dynamic 
dendritic spine populations compared to Thy1-YFP controls at P60 
The structure and localisation of dendritic spines are carefully regulated, and abnormalities are a 
hallmark of several neurological and neurodegenerative disorders (Fiala et al 2002). To investigate the 
potential for misprocessed TDP-43 to pathologically alter dendritic spine dynamics in ALS, individual 
apical tuft dendrites of layer V pyramidal neurons residing in layer II/III were followed over three 
consecutive days, in the motor (MC) cortices of TDP-43A315T male (M) (n = 6) and female (F) (n = 7) 
mice at P60. To establish the overall spine activity within different cortical regions between the sexes, 
the total proportion of stable and dynamic spines was quantified within each cohort. Dynamic 
populations were classified as mature or immature spine types, with a new spine considered ‘gained’ 
and the absence of a spine in a subsequent imaging round considered ‘lost’.  
In the male motor cortex at P60, TDP-43A315T mice did not display a significant difference between 
stable and dynamic populations of dendritic spines compared to controls, nor were there any significant 
differences within dynamic populations of mature or immature gain or loss turnover rates (Figure 4.3.1 
B). However, within the female motor cortex there was a significantly (p < 0.05, two-way ANOVA, 
Bonferroni post-hoc) higher proportion of dynamic spine populations than stable during both high and 
baseline oestrogen stages (19.30% ± 0.10 F high MC stable, 80.70% ± 0.10 F high MC dynamic, 
24.60% ± 0.13 F baseline MC stable, 75.60% ± 0.13 F baseline MC dynamic) (Figure 4.3.1 F). Within 
the dynamic proportion of dendritic spines of the TDP-43 A315T female motor cortex during high 
oestrogen, the loss of mature spine types was significantly (p < 0.05, two-way ANOVA, Bonferroni 
post-hoc) greater than the overall turnover of immature spines (21.2% ± 0.07 F high MC mature loss, 
7.00% ± 0.01 F high MC immature gain, 3.00% ± 0.01 F high MC immature loss) while the gain of 
mature spines was significantly greater than immature loss (17.6% ± 0.08 F high MC mature gain) 
(Figure 4.3.1 H). There was no significant difference between mature gain and immature gain. These 
results indicate the male TDP-43A315T does not display dendritic spine changes between stable and 
dynamic populations, whilst females display an overall dynamic motor cortex independent of 
oestrogen levels.    
4.3.2 Dynamic dendritic spine changes are increased in the female TDP-43A315T motor cortex 
during high oestrogen at P60 
Figure 4.3.1 
(A, C, E, G) The graphs show the stable and dynamic proportions of dendritic spines, and the 
turnover of dynamic spine populations of the motor cortex, in Thy1-YFP male and 
females experiencing high and baseline levels of oestrogen as presented in the previous 
chapter. (B, D, F, H) Comparisons of stable and dynamic populations of dendritic spines 
within the TDP-43A315T male (n  = 5) and female motor cortices at P60. Stable spines 
were quantified as those unchanged over the three imaging rounds, while dynamic 
spines underwent a gain, loss or morphological change event from the first imaging round to 
the last. (B) The graph shows the proportion of stable and dynamic dendritic spines within the 
male motor cortex. (D) The graph shows the turnover rate of mature and immature spines 
within the male motor cortex. (F) The graph shows the proportion of stable and dynamic 
dendritic spines within the female motor cortex during high (n  = 3) and baseline (n = 3) 
levels of oestrogen. (H) The graph shows the turnover rate of mature and immature spines 
within the female motor cortex during high and baseline levels of oestrogen. MC = motor 
cortex. Bars show mean ± SEM. *p = <0.05. 
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As demonstrated in the previous chapter, sex has an influential role on the neuroplasticity of specific 
cortical regions. Converging research indicates a neuroprotective role for oestrogen in a range of 
experimental models of cognitive disorders and brain injury (Li et al 2014, Prokai & Simpkins 2007, 
Sohrabji 2015, Zhang et al 2014). To establish the influence of oestrogen on neuroplasticity at the 
dendritic spine in the TDP-43A315T motor cortex at P60, female mice were imaged at diestrus/metestrus 
(baseline oestrogen) (n = 4) or proestrus/estrus (high oestrogen) (n = 4). The relative proportions of 
stable and dynamic dendritic spines were quantified, and changes occurring within the dynamic 
population were measured and compared between males and females. The male TDP-43A315T motor 
cortex at P60 had a significantly (p < 0.05, one-way ANOVA, Tukey’s multiple comparisons test) 
greater proportion of stable spines compared to females experiencing high oestrogen levels (19.30% ± 
0.24 F high MC TDP stable, 72.30% ± 0.53 M MC TDP stable) with no other significant differences 
in overall stable populations, nor in dynamic populations (Figure 4.3.2 B, D). 
Within the dynamic proportion of dendritic spines, females experiencing high oestrogen levels 
displayed significantly (p < 0.05, two-way ANOVA, Tukey’s multiple comparisons test) increased 
gain and loss rates of mature spine types compared to males (17.60 ± 0.07 F high MC TDP mature 
gain, 5.70% ± 0.02 M MC TDP mature gain, 21.20% ± 0.07 F high MC TDP mature loss, 8.70% ± 
0.02 M MC TDP mature loss). No other significant differences in turnover rates of dynamic spines 
were identified between males and females (Figure 4.3.3 F). Together, these results suggest high 
oestrogen levels are mediating transiently increased rates of mature dendritic spine turnover in the 
TDP-43A315T motor cortex, compared to the relative stability of the TDP-4343A315T male motor cortex.  
4.3.3 Dendritic spine dynamics are reduced in the male TDP-43A315T motor cortex compared to 
Thy1-YFP mice at P60 
To quantify changes to TDP-43-mediated dendritic spine changes at P60, the stable and dynamic 
proportions of dendritic spines in the male and female TDP-43A315T motor cortex were compared to 
those of the Thy1-YFP control cortex (Figure 4.3.3). Male TDP-43A315T mice displayed significantly 
(p < 0.05, unpaired t-test) increased proportions of stable spines compared to male Thy1-YFP mice 
within the motor cortex (37.84% ± 0.09 M MC control stable, 72.30% ± 0.30 M MC TDP-43 stable) 
(Figure 4.3.3 A), with no significant differences between dynamic proportions (Figure 4.3.3 B). Within 
the dynamic proportion of spines, male TDP-43A315T mice displayed significantly (p < 0.001, two-way 
ANOVA, Tukey’s multiple comparisons test) reduced rates of mature gain (31.40% ± 0.50 M MC 
control mature gain, 5.70% ± 0.02 M MC TDP-43 mature gain), mature loss (23.20% ± 0.06 M MC 
control mature loss, 8.70% ± 0.02 M MC TDP-43 mature loss), and immature gain (20.40% ± 0.03 M 
Figure 4.3.2 
Comparisons of stable and dynamic populations of dendritic spines between male and female 
TDP-43A315T motor cortex at P60. (A, C, E) The graphs show the stable and dynamic 
proportions of dendritic spines, and the turnover of dynamic spine populations of the motor 
cortex, between Thy1-YFP male and females experiencing high and baseline levels 
of oestrogen for a visual comparison to dendritic spines of the TDP-43A315T motor cortex. (B) 
The graph shows the proportion of stable dendritic spines within the motor cortex of male (n 
= 5) mice and female mice experiencing high (n = 3) and baseline (n = 3) levels of oestrogen. 
(D) The graph shows the proportion of dynamic dendritic spines within the motor cortex of 
male and female mice experiencing high and baseline levels of oestrogen. (F) The graph 
shows the turnover of mature and immature spines within the motor and somatosensory 
cortices male mice and female mice experiencing high and baseline levels of oestrogen. MC 
= motor cortex. Bars show mean ± SEM. *p = <0.05. 
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MC control immature gain, 4.80% ± 0.01 M MC TDP-43 immature gain) as compared to male Thy1-
YFP mice (Figure 4.3.3 C).   
4.3.4 Oestrogen peaks rescue the dynamics of the motor cortex in the female TDP-43A315T motor 
cortex compared to controls at P60 
Oestrogen has varied pathways through which it exerts neuroprotective influences, and hormone levels 
mediate functions in cognition and recovery from insult. To investigate the potential for oestrogen to 
interact with neuroplasticity at the dendritic spine in the presence of TDP-43 misprocessing, the stable 
and dynamic proportions of dendritic spines within female TDP-43A315T mice experiencing baseline or 
high levels of oestrogen were compared to Thy1-YFP counterparts. No significant differences were 
identified in the proportion of stable spines during baseline or high levels of oestrogen, nor in the 
proportion of dynamics spines during baseline oestrogen levels (Figure 4.3.3 D, G, H). However, the 
dynamic proportion of spines was significantly (p < 0.02, unpaired t-test) increased during high 
oestrogen in TDP-43A315T female mice population compared to Thy1-YFP females (51.91% ± 0.80 F 
high MC control dynamic, 80.71% ± 0.10 F high MC TDP-43 dynamic) (Figure 4.3.3 E). Within the 
dynamic dendritic spine proportion, no differences in turnover rates were identified during high 
oestrogen levels (Figure 4.3.3 F); however, TDP-43A315T mice experiencing baseline oestrogen levels 
displayed a significant (p < 0.0.5, two-way ANOVA, Tukey’s multiple comparisons test) reduction in 
the rate of mature spine gain compared to Thy1-YFP females at P60 (24.30% ± 0.06 F baseline MC 
control mature gain, 13.70% ± 0.03 F baseline MC TDP-43 mature gain) (Figure 4.3.3 I). The data 
indicates transient peaks of oestrogen may be directly associated with increased dynamics of the female 
TDP-43A315T motor cortex, compensating for TDP-43-mediated dysfunction at the synapse.  
 
 
 
 
 
 
 
 
Figure 4.3.3 
 Comparisons of stable and dynamic populations of dendritic spines within the male and female 
Thy1-YFP and TDP-43A315T motor cortices. (A, D, G) The graphs show the stable proportions 
of dendritic spines between Thy1-YFP and TDP-43A315T motor cortices within males (A), 
females experiencing high oestrogen (D) and females experiencing baseline oestrogen (G). (B, 
E, H) The graphs show the dynamic proportions of dendritic spines between Thy1-YFP and 
TDP-43A315T motor cortices within males (B), females experiencing high oestrogen (E) and 
females experiencing baseline oestrogen (H).  (C, F, I) The graphs show the gain and loss of 
mature and immature spine types within dynamic dendritic spine proportions between Thy1-
YFP and TDP-43A315T motor cortices within males (C), females experiencing high oestrogen 
(F) and females experiencing baseline oestrogen (I). MC = motor cortex. Bars show mean ±
SEM. *p = <0.05.
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4.4 DISCUSSION 
Disturbances in the structure and function of dendritic spines have been associated with the onset and 
progression of a number of neurodevelopmental, psychiatric, and degenerative disorders; though when 
and how these changes impact disease has yet to be elucidated. Dendritic spines are a key regulator of 
neuroplasticity, and their viable function is crucial to the ability of cortical networks to respond to and 
modulate activity. Changes at the dendritic spine are influenced by the cortical region in which they 
reside, age and sex, and it is essential to understand how these factors may influence the structure in 
both normal conditions and in disease states. The findings of this thesis implicate dysregulated 
neuroplasticity at the dendritic spine as being an early disease event, specifically affecting the motor 
cortex in a model of ALS. In addition, the observation of increased neuroplasticity during high 
oestrogen in the presence of a TDP-43 mutation suggests the sex hormone may be a viable treatment 
pathway to restore dendritic spine function. The current chapter investigated dendritic spine plasticity 
in real time in the TDP-43A315T mouse model of ALS, to ascertain how early synaptic dysfunction may 
impact neuroplasticity at the postsynaptic structure.  
4.4.1  The heightened dendritic spine turnover of the motor cortex may confer select 
vulnerability in the presence of the TDP-43A315T mutation 
A reduction in the normal high dynamics of the male motor cortex was identified in the presence of 
TDP-43 misprocessing at a presymptomatic time point. The motor cortex represents a higher order 
cortical region in the mammalian brain, including humans, featuring immense storage capability and 
modifiable networks controlled by broad activity patterns within local, intercortical and subcortical 
circuits (Auer et al 2018, Duncan & Owen 2000, Sanes & Donoghue 1997). The region has been shown 
to rapidly establish dynamic and adaptive synaptic connections in response to activity, which may be 
indicative of a greater need for dynamic synaptic reorganisation to respond to inputs and modulate 
large circuits (Chen et al 1998, Ziemann et al 1998). Accordingly, the motor cortex is involved in 
activity beyond roles strictly associated with upper motor neuron function and is activated during 
executive functions and cognition, with high neuroplastic demands (Kukleta et al 2016, Wexler et al 
1997). This need for dynamic synaptic plasticity may result in an increased susceptibility to activity-
dependent insult in diseases such as ALS.  
Pathological alterations in ALS are thought to occur long before symptom manifestation, yet thus far 
interactions between synaptic plasticity and protein aggregation have only been associated with disease 
onset (Arendt et al 1998, Picconi et al 2012, Stephan et al 2002, Tampellini et al 2009). Here, TDP-
43-mediated changes in neuroplasticity at the dendritic spine are evident presymptomatically in the
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male motor cortex. Furthermore, this presymptomatic time point has been identified as being a period 
of increased spine density, indicative of a greater capacity for neuroplasticity. During these periods, 
cortical regions are especially susceptible to extrinsic insults; the higher activity demands of the motor 
cortex at this time may thus render the region innately vulnerable to dysfunction at the synapse (Purves 
et al 1988, Schaefers & Teuchert-Noodt 2016).  
It is still unclear as to whether the reduction in dendritic spine dynamics as identified in the current 
Chapter is due to a loss of connectivity, or to compensation of over-activity within the network. A 
range of hypotheses have been proposed in regards to network-related neurodegeneration, and these 
include nodal stress, where regions undergo activity-related traffic inducing ‘wear and tear’; trophic 
failure, where disruption of normal connectivity undermines neuronal support; and shared 
vulnerability, where regions featuring a specific pattern of protein expression exhibit evenly distributed 
susceptibility throughout the network (Appel 1981, Buckner et al 2009, Salehi et al 2006, Saxena & 
Caroni 2011). With evidence for early alterations to neuroplasticity mediated by TDP-43, it is essential 
to understand how other factors may be influencing synaptic function at the dendritic spine in disease 
states within the motor cortex.  
4.4.2 High oestrogen is associated with high dendritic spine dynamics in the presence of the 
TDP-43A315T mutation 
Compared to the decreased dendritic spine dynamics of the male TDP-43A315T motor cortex, females 
display an overall heightened dynamic population of dendritic spines within this region. Additionally, 
cycling peaks of high oestrogen are associated with heightened dynamics in the presence of TDP-
43A315T as opposed to greater stability in control mice. This may be associated with compensatory 
mechanisms, whereby in disease states synaptic alterations have been shown to initially compensate 
for activity-dependent insult by rapidly reorganising synaptic connections- yet how dendritic spines 
respond during these conditions has not been established (Enciu et al 2011, Schaefers & Teuchert-
Noodt 2016, Zhou et al 2012). The increased dynamics of dendritic spines during high oestrogen in 
TDP-43A315T females may therefore be due to triggering neuroprotective processes.  
Oestrogen-mediated protection has been well documented in vitro and in vivo, though the mechanisms 
involved are widely unknown. Treatment with oestrogen agonists have demonstrated diverse 
mechanisms of potential neuroprotection, particularly through modulation of neuroplasticity in 
Parkinson’s, Alzheimer’s disease, ischemia and Multiple Sclerosis (Brann et al 2007, Cho et al 2003, 
Garcia-Segura et al 2001, Gold & Voskuhl 2009). Evidence for the pathways through which oestrogen 
may exert neuroprotective effects come from the normal localisation of the enzyme aromatase at the 
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synapse (Balthazart et al 1991, Garcia-Segura 2008, Remage-Healey et al 2011, Zhou et al 2014). 
Aromatase is responsible for the biosynthesis of oestrogen, and is now thought be a key synaptic 
protein in human and mouse tissue. Accordingly, the levels of protein identified are dependent on the 
amount of stimulation at the synaptic compartment (Zhou et al 2014). This provides a direct link 
between stimulation and oestrogen production at the postsynapse, and indicates that neuroprotective 
processes may arise from activity-dependent mechanisms. It is important to note that the timing of 
oestrogen administration is critical for a protective outcome, whereby if used too late in disease it no 
longer confers protective effects (Brinton 2008, Nilsen 2008, Scott et al 2012). An additional caveat 
to the use of oestrogen to potentially restimulate damaged neuronal networks is the unknown actions 
of receptor subtypes during neuroprotection. While oestrogen receptor alpha (ERa) has been most 
commonly linked to neuroprotection during ischemia and injury of CA1 hippocampal neurons, the 
overall application of oestrogen is protective against kainate and NMDA neurotoxicity, and 
accumulating research now implicates both receptors in activity-dependent neuroprotection (Bi et al 
2000, Cordey & Pike 2005, Wnuk et al 2012).  
With evidence here for the ability of oestrogen to potentially enhance the dynamics of the motor cortex 
in disease as a possible method of compensation, the exact time at which application of an agonist may 
be most effective, as well as which receptors require stimulation has yet to be elucidated. For any 
therapeutic treatments utilising oestrogen to be effective in promoting neuroplasticity, these factors 
need to be accounted for to optimise maintenance of normal dendritic spine activity and synaptic 
connections within vulnerable regions.   
4.4.3 Mature spines are selectively altered in the presence of the TDP-43A315T mutation 
In the current Chapter, mature spine turnover rates within the male TDP-43A315T motor cortex are found 
to be severely reduced. Furthermore, TDP-43A315T females experiencing high oestrogen display an 
increase in mature spine gain, whilst females experiencing baseline oestrogen levels display a 
reduction in normal mature spine gain. Together, these findings suggest mature spine types may be 
most affected in the presence of TDP-43 misprocessing in a model of ALS. Mature spine types are 
typically recognised through their larger size and a greater ratio between the spine head and neck, 
creating a ‘mushroom’ morphology featuring a high number of postsynaptic receptors (Holtmaat et al 
2005). Synaptic transmission and neuronal activity play key roles in sculpting neuronal circuits by 
regulating maturation of dendritic spines, and excitatory glutamatergic transmissions are particularly 
key to this through actions at AMPA and NMDA receptors at the dendritic spine head (Lai & Ip 2013, 
McKinney 2010, Ultanir et al 2007). The number of AMPARs in particular has been associated with 
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synaptic strength and the size of the dendritic spine (Anggono & Huganir 2012, Matsuzaki et al 2001, 
Miyazaki & Ross 2017). Localised protein synthesis has also been implicated in modulating dendritic 
spine morphology in an activity-dependent manner, and the trafficking of synaptic mRNAs to the 
postsynapse following activation is critical for neuroplasticity (Fernandez-Moya et al 2014, Mitsumori 
et al 2017, Sutton & Schuman 2006, Swanger & Bassell 2013).  
TDP-43 has been implicated in dendritic spine maturation through the Rac1 pathway of spinogenesis, 
associated with AMPAR insertion at the spine head. Furthermore, TDP-43 forms a translational 
complex with the FMRP protein to process the AMPA subunit GluA1 (Ederle & Dormann 2017, 
Majumder et al 2012, Majumder et al 2016, Udagawa et al 2015). The GluA1 subunit has been termed 
the ‘gatekeeper of neuroplasticity’ due to the phosphorylation of the protein being strongly associated 
with LTP and the role for the subunit in the recruitment of other AMPA subunits following activity 
(Diering & Huganir 2018, Henley & Wilkinson 2013). In the presence of TDP-43 misprocessing, it 
may be that a reduced ability for the protein to traffic and process synaptic mRNAs such as GluA1 at 
the dendritic spine renders the structure unable to mature in response to activity and localised protein 
synthesis. This may then have broader effects on the ability of appropriate synaptic connections to be 
formed and maintained, particularly in the case of dendritic spine maturation. In the current thesis, this 
is particularly salient for the findings here within the motor cortex, whereby the dynamic turnover of 
mature spine types is severely reduced in male TDP-43A315T mice, as well as in females with baseline 
levels of oestrogen.   
4.4.4 Conclusions 
The results here elucidate a previously unknown early disease event occuring in the TDP-43A315T mouse 
model of ALS, whereby neuroplasticity at the dendritic spine is selectively perturbed in the motor 
cortex. Specifically, males display a reduced ability to maintain dynamic populations of dendritic 
spines in the motor cortex, in comparison to the increased dynamics of the region under normal 
conditions. Furthermore, this Chapter indicates the sex hormone oestrogen may be acting to 
compensate for lost dendritic spine dynamics within the female TDP-43A315T; normally associated with 
stability, instead cycling peaks of oestrogen maintain increased dynamic populations of dendritic 
spines within the motor cortex. Together, these findings suggest that the male motor cortex is 
inherently susceptible to activity-dependent insult at the dendritic spine as mediate by misprocessed 
TDP-43, and that this could potentially be protected by the appropriate administration of oestrogen. 
Further studies are required to resolve the mechanism through which TDP-43 may be mediating 
dendritic spine dysfunction, as well as the specific receptor subsets of oestrogen that convey 
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neuroprotective effects. Collectively, these findings support the hypotheses that TDP-43 
misprocessing affects the dynamics of dendritic spine turnover and perturbs neuronal plasticity at an 
early time point.  
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5 GENERAL DISCUSSION 
The preclinical progression of neurodegenerative disease has received increasing attention as one of 
the major obstacles to developing disease-modifying therapies. It is evident that identifying 
pathological pathways that occur prior to disease manifestation is key to developing viable therapeutic 
targets. One such pathway that has been increasingly identified in a range of neurodegenerative 
disorders is that of early synaptic dysfunction, whereby perturbations to synaptic structure and 
functions precede cell death and overt disease symptoms (Bae & Kim 2017, Lepeta et al 2016, Wishart 
et al 2006). ALS features the select vulnerability of the motor system to progressive neuronal loss, and 
is characterised by toxic inclusions within the neuronal cytoplasm (Neumann et al 2006). The RNA-
binding protein TDP-43 has been identified as the primary component of these aggregates in the vast 
majority of disease cases; whilst classically, research has focused on the impact of TDP-43 
misprocessing in the nucleus and the cytoplasm, it is now thought to have more distal roles at the 
synaptic compartment. Early dysfunction at the synapse has been increasingly linked to protein 
dysfunction in ALS, and evidence of normal functions for TDP-43 at the synapse suggest the potential 
for misprocessing to be a pathological pathway in disease.  
Dendritic spines are the primary postsynaptic compartment of glutamatergic neurons and are integral 
to the processes underlying neuroplasticity; encompassing the connectivity of neural circuits and the 
ability of the cortex to reorganise and modulate activity in response to stimulation such as learning 
events (Bosch & Hayashi 2012, Frankfurt & Luine 2015, Woolfrey & Srivastava 2016). Highly motile 
structures, their morphology is tightly linked to functions that dictate the strength of synaptic 
connections (Holtmaat et al 2005). Disease-specific disruptions to dendritic spine shape, size or 
number accompany a range of neurological diseases and disorders within discrete neuroanatomical 
regions, suggesting they may be a common substrate for the select vulnerability of cortical regions. 
TDP-43 has been observed to have normal roles at the dendritic spine, yet it has remained unknown 
as to how the structure may be impacted in disease states such as ALS, and why specific cortical 
regions are so susceptible to pathology at the synapse. The current thesis demonstrates that the 
misprocessing of TDP-43 has implications for the structure and function of the dendritic spine, 
indicative of dysfunctional neuroplasticity within discrete cortical regions. 
5.1 DETERMINING A TIMELINE OF TDP-43-MEDIATED SYNAPTIC DYSFUNCTION 
The first experimental chapter of this thesis sought to investigate whether the synapse is dysfunctional 
over a disease-time course in the Thy1-YFP::prpTDP-43A315T (TDP-43A315T) mouse model of ALS. It 
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was hypothesised that dysfunction at the postsynaptic dendritic spine is an early disease mechanism 
mediated by misprocessed TDP-43 and central to disease progression, due to evidence for early 
synaptic dysfunction in neurodegenerative disease and the normal roles for TDP-43 at the dendritic 
spine (Alami et al 2014, Casas et al 2016, Devlin et al 2015, Fogarty 2018, Fogarty et al 2015, Liu-
Yesucevitz et al 2011, Liu-Yesucevitz et al 2014, Majumder et al 2012, Majumder et al 2016, Sunico 
et al 2011, Wang et al 2008a). The findings revealed reductions in dendritic spine density occurring 
selectively in the motor cortex at a presymptomatic time point, prior to overt cell loss, and occurring 
concomitantly with a reduction in the frequency of mEPSCs. This supports the notion of dendritic 
spine changes mediated by TDP-43 misprocessing being an early disease event in ALS, and further 
reveals mature spine types are specifically vulnerable to progressive alterations in dendritic spine 
density. The findings here evidence the tight link between the function of synapses and the regulation 
of dendritic spines early in disease. Mature spine types form the strongest synaptic connections, and 
feature large spine heads to encompass greater postsynaptic densities (PSD) (Dosemeci et al 2016, 
Rochefort & Konnerth 2012). The failure of postsynaptic receptors and machinery to be anchored at 
the PSD may potentially result in a reduced ability to strengthen synapses, and indeed TDP-43 has 
been linked to dendritic spine maturation through the Rac1 pathway (Majumder et al 2012). The 
specific dysfunction of mature spines mediated by TDP-43 misprocessing may be a result of an 
inability of motor cortical neurons to process activity, and therefore to strengthen synaptic connections.  
Dendritic spines are essential for neuroplasticity, and regulate synaptic transmission through excitatory 
receptors; and indeed, it is well established that altered excitability within the motor cortex is an early 
pathological event in ALS (Burrell et al 2011, Menon et al 2017, Menon et al 2015, Vucic et al 2008). 
Here, the presymptomatic reduction in firing frequency further evidences the role of altered excitability 
mediating disease progression, in conjunction with dendritic spine alterations. The normal functions 
of TDP-43 shed light on the mechanisms that may underlie these functional and structural changes, 
whereby TDP-43 has been associated with the translation and regulation of AMPA receptor subunits 
GluA1 and GluA2 (Majumder et al 2016, Yamashita & Kwak 2014b). Accordingly, disruptions to the 
surface expression of these subunits results in decreased mEPSC frequency and synaptic silencing, 
and directly indicates TDP-43 misprocessing may be mediating the disrupted ability to respond to 
excitation (Liao et al 2001, Noel et al 1999). It is intriguing that the observed reduction frequency 
reflects hypoexcitability, as previous research has more commonly identified hyperexcitability in ALS. 
However, hypoexcitability has been increasingly linked to neuronal death and has been observed in 
iPSCs harbouring various ALS-linked mutations, including those of TDP-43 (Devlin et al 2015). 
Together, the findings from this chapter indicate that the complex regulation of the synaptic 
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compartment is altered presymptomatically in the presence of misprocessed TDP-43, resulting in 
dysfunction at the dendritic spine within the motor cortex. Research has yet to identify the link between 
TDP-43 misprocessing at the synaptic structure and the susceptibility of the motor cortex to disease 
insult; thus it is integral to identify fundamental features of the motor cortices that may render 
susceptible to pathology at the dendritic spine.  
5.2 ESTABLISHING FUNDAMENTAL CHANGES TO DENDRITIC SPINES  
The susceptibility of discrete neuronal networks is a key feature of neurodegenerative disease; 
however, the processes that render these regions vulnerable have yet to be fully elucidated. 
Furthermore, the influence of factors such as age and sex on dendritic spine activity within cortical 
regions is still poorly understood. Thus, the second experimental chapter of this thesis aimed to 
determine whether cortical region, age and sex influence dendritic spine changes in the Thy1-YFP 
mouse model, to establish fundamental dendritic spine activity that may render the motor cortex more 
exposed to activity-dependent insult. It was hypothesised that dendritic spine turnover and 
morphological subsets have a unique pattern of dynamics depending on cortical region, sex and age.  
To quantify changes at the dendritic spine, cranial window surgeries were undertaken in conjunction 
with 2PLSM, to capture snapshots of real-time dendritic spine turnover as modulated by age, sex and 
region. Spine populations were termed stable if present during all imaging rounds, or dynamic if 
gained, lost or matured between imaging rounds. The gain, loss or morphological maturation of a 
dendritic spine was considered a dynamic turnover event. Capturing the real-time changes at the 
dendritic spine build upon approaches classically measuring density, as the motility of the structure is 
essential for neuroplasticity. The findings highlight the dynamic nature of the motor cortex, and 
identify the region as having higher activity demands in comparison to the somatosensory cortex. 
Additionally, the role for cycling oestrogen in regulating dendritic spine changes underlying regional 
neuroplasticity is key to understanding the sexual-dimorphism of cortical development and regulation 
both in health and in disease. 
The shaping of cortical circuits is dependent on dendritic spine reductions, preceded by peaks in 
dendritic spine density that indicate a greater capacity for neuronal plasticity during critical periods 
(Arikkath 2012, Boivin et al 2018, Bourne & Harris 2008, Flurkey et al 2007, Gonzalez-Burgos et al 
2015, Johnson et al 2016, Knott & Holtmaat 2008, Koss et al 2014, Petanjek et al 2011, Poon 2018, 
Selemon 2013). The P60 time point explored in this Chapter represents a period of potentially 
increased plasticity, as evidenced by an increase in dendritic spine density preceding overall spine 
reductions by P90. Cortical regions undergo differential timelines of circuit development whereby 
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higher order regions refine synaptic connections later than lower order regions. The motor cortex is a 
region that consists of vast cortical networks interconnected to frontal and subcortical regions, with 
evidence for high synaptic demands, particularly during periods of heightened plasticity (Barthas & 
Kwan 2017, Brecht 2011, Kolb et al 2012, Lein et al 2006, Meunier et al 2009). The increase in mature 
spine turnover observed here may indeed reflect this, whereby mature spines within the motor cortex 
require greater synaptic inputs to be strengthened (Taft & Turrgiano 2013; Lambert et al 2017).The 
decrease in immature dendritic spine turnover by adulthood further highlights the maturation of the 
motor cortex, where maintained mature dendritic spine dynamics may be required to regulate the dense 
connectivity of the motor region.   
Perhaps one of the more intriguing results from the current Chapter is that of how cycling oestrogen 
regulates dendritic spine populations within different cortical regions. Baseline levels of oestrogen in 
the motor cortex are associated with high dynamic dendritic spine populations, whilst transient peaks 
of high oestrogen are associated with stable dendritic spine populations. Increases in spine density 
have been associated with increased oestrogen levels, and this is thought to be an initiating step in 
forming and stabilising dendritic spines; thus potentially, cycling oestrogen peaks may be initiating 
crucial stabilisation events underlying neuroplasticity (Alexander et al 2018; Wang et al 2018). 
Furthermore, oestrogen within the motor cortices appears to influence mature spine types, with these 
stronger connections associated with greater AMPA receptor recruitment at the dendritic spine head 
(Babayan & Kramár 2013, Kramár et al 2009, Lee et al 2003, Woolley & McEwen 1994). Studies have 
identified that the targeted stimulation of oestrogen receptors is linked to greater recruitment of GluA1 
and GluA2, and it may be that findings in the current thesis are underpinned by the transient 
stabilisation of dendritic spines within the motor cortex by the recruitment of AMPA subunits.  
The somatosensory cortex displays differential trajectories between the sexes for the balance of 
dynamic and stable dendritic spine populations over time, and this may further reflect the oestrogen-
mediated timelines for cortical development (Qiu et al 2018). The evidence here suggests the female 
somatosensory cortex may mature earlier than that of males; maintained dynamic proportions of 
dendritic spines in females may indeed contribute to the strengthening of synaptic connections over 
time, maintaining neuroplasticity. While steady state conditions in the female somatosensory cortex 
have been shown to be unaffected by oestrus cycling, the ability of neurons in this region to respond 
to activity is influenced by oestrogen levels, whereby once more high oestrus is associated with higher 
dendritic spine turnover (Alexander et al 2018). These findings shed further light on the activity profile 
that may define the mature female somatosensory cortex, highlighting that maintained dynamic 
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dendritic spine populations play a role in regional networks through the regulation of synaptic 
connections.  
Collectively, this Chapter identifies the key characteristics of two distinct cortical regions that confer 
vulnerability to one – the motor cortex – in disease states, whilst the other – the somatosensory cortex- 
is spared during the earlier stages of disease progression. The high dynamics of the motor cortex 
suggest the region may be more susceptible to activity-dependent insults, with cycling oestrogen 
playing a critical role in the transient stabilisation of neuroplastic mechanisms. The findings here 
further highlight the distinct differences between lower and higher order cortical circuitry over time, 
whereby lower order regions display distinct timelines of maturation between the sexes. Whilst 
shedding light on some of the normal changes occuring at the dendritic spine, this Chapter also raises 
many questions as to how dendritic spines respond to the presence of a disease linked protein mutation 
within a vulnerable cortical region.  
5.3 IDENTIFYING EARLY ALTERATIONS TO NEUROPLASTICITY AT THE DENDRITIC 
SPINE IN DISEASE 
The results from the first two experimental chapters set the stage for the final study of this thesis, 
observing early synaptic dysfunction within the motor cortex at the dendritic spine that is linked to 
perturbations in fundamental neuroplasticity of the region. Furthermore, the differential stable and 
dynamic dendritic spine proportions between males and females experiencing high oestrogen indicate 
a key role for oestrogen in the response of dendritic spines to activity in disease states.  
The male TDP-43A315T motor cortices display a reduced dynamic proportion of dendritic spines, 
mirrored by the overall reduction of mature spine turnover. The motor cortex is an innately active 
region, being a higher order cortical region and featuring local, intercortical and subcortical networks 
associated with classical motor and cognitive functions (Auer et al 2018, Duncan & Owen 2000, Sanes 
& Donoghue 1997). For the motor cortex to function appropriately, it requires the rapid establishment 
of modifiable synaptic connections – this need for heightened neuroplasticity may indeed be what 
induces activity-dependent susceptibility in the presence of a TDP-43 mutation (Chen et al 1998, 
Ziemann et al 1998). The time point at which susceptibility at the dendritic spine has been identified 
in the current thesis is normally one of increased spine density overall, and should be indicative of a 
vast capacity for neuroplasticity. However, it is during these periods that regions such as the motor 
cortex are most likely to sustain insult from high activity demands in the presence of protein 
misprocessing (Purves et al 1988, Schaefers & Teuchert-Noodt 2016). The evidence here suggests that 
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in TDP-43-mediated disease states, perturbations of the dendritic spine may be contributing to disease 
progression during a preclinical period, particularly in males.  
Conversely, female TDP-43A315T mice display increased dynamics of dendritic spines within the motor 
cortex regardless of oestrogen level. Intriguingly, this is in comparison to normal conditions of cycling 
oestrogen in the female motor cortex whereby high oestrus is associated with stable dendritic spine 
populations. Oestrogen has well-documented neuroprotective effects, and the increased dynamics 
observed in the TDP-43A315T motor cortex may be attributed to compensatory mechanisms aimed at 
maintaining high dynamics in a highly active cortical region. The production of oestrogen at the 
synapse has been directly linked to the stimulation of synapses, and further ties activity-dependent 
mechanisms to functions at the dendritic spine (Zhou et al 2014). Though this provides a potential 
pathway through which to rescue dendritic spine dysfunction, it is important to note that work from 
others demonstrates the need for incredibly targeted applications of oestrogen for neuroprotection; if 
used too late in disease it is ineffective, and it is still unknown which specific oestrogen receptors need 
to be stimulated at what time to exert neuroprotective effects (Brinton 2008, Nilsen 2008, Scott et al 
2012). To effectively target early disease events and potentially halt pathological progression, it is 
crucial to identify the optimal timing of an oestrogen agonist that stimulates the correct receptors in 
order to maintain fundamental neuroplasticity at the dendritic spine. 
The first experimental chapter identified specific alterations to mature spines, shown to be integral to 
fundamental neuroplasticity within the motor cortex in both males and females in Chapter 3. In the 
final chapter, TDP-43A315T females display increases in the gain of mature spines during high oestrogen 
levels, whilst during baseline oestrogen levels there is instead a reduction in the overall gain of these 
spine types. TDP-43 has been implicated in roles in dendritic spine maturation through the negative 
regulation of the Rac1 pathway and the translation of the AMPA subunit GluA1 (Majumder et al 2012; 
Majumder et al 2016). With normal roles in dendritic spine formation and maturity, misprocessed 
TDP-43 may be responsible for dysfunction at this specific spine type in disease states. With roles for 
TDP-43 in trafficking mRNA and RNA to the synapse, dysfunction may result in an inability of AMPA 
receptor subunit mRNA to reach the dendritic spine. A reduced ability to traffic key synaptic proteins 
to the dendritic spine for localised protein synthesis may then result in an inability to respond to 
activity. Thus potential protective effects observed during high oestrogen in the TDP-43A315T female 
may be concentrated on preserving the dynamic turnover of mature dendritic spines specifically, in 
order to maintain strengthened cortical circuits in a highly active region.  
5.4 FUTURE DIRECTIONS AND LIMITATIONS 
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This thesis focused on characterising early disease events mediated by TDP-43 at the synapse, 
establishing fundamental changes at the dendritic spine underlying neuroplasticity. The high activity 
demands of the region may render the motor cortex susceptible to pathology, and the potential for 
cycling oestrogen to protect against dendritic spine dysfunction in the TDP-43A315T mouse model of 
ALS further reveals a mechanism that may explain sexual dimorphism in neurodegenerative diseases. 
For these findings to be translated into new pathways for viable therapeutics aimed at targeting 
preclinical periods of disease, it is crucial to undertake further studies to understand the mechanisms 
underlying the changes observed at the dendritic spine.  
The use of the Thy1-YFP transgene enables high-resolution visualisation of dendritic spines within 
control and pathological conditions. However, as YFP preferentially labels a subset of motor and 
sensory neuronal populations, the reduction of YFP-positive neurons as observed may not correspond 
to overall cell death. To identify the scale of neurodegeneration as a consequence of TDP-43 
misprocessing, further studies may utilise NeuN or Tunel staining in order to quantify total neuronal 
loss. Further, while the measures of dendritic spine density and turnover provide a read-out of changes 
occurring at the dendritic spine and the availability of certain synaptic connections, these cannot 
account for the potentially variable viability of synaptic machinery at dendritic spines both normally 
and in disease; nor can they account for the molecular mechanisms underlying dendritic spine changes. 
To further investigate the processes underlying modifications to dendritic spines, key synaptic proteins 
at the synaptic membrane need to be quantified. The composition of AMPA and NMDA receptor 
subunits at the postsynaptic membrane regulates the function of the dendritic spine, and with TDP-43 
linked particularly to AMPA processing, probing receptor proteins may provide answers as to how 
TDP-43 mediates synaptic alterations. Experimental paradigms that may be utilised to achieve this 
include targeted PCR arrays and identifying splicing targets of TDP-43 in the TDP-43A315T model of 
ALS. Performing PCR arrays on synaptosomes taken from the mouse model will allow for optimised 
protocols to identify receptor subunits or postsynaptic machinery that may be altered in the presence 
of protein misprocessing. Additionally, exon-intron-specific RT-PCR may be used to further determine 
proteins and subunits that undergo alternative slicing in disease states within the PSD. TDP-43 
regulates the alternative slicing of a range of RNAs, yet studies have not targeted this approach to 
specific neuronal targets (Deshaies et al 2018, Tollervey et al 2011). By expanding such an approach 
to measure splice targets within whole-cell samples, synaptosomes and subproteomes of the PSD, the 
differential regulation of synaptic proteins within cellular compartments may be used to elucidate 
where TDP-43 may be exerting toxic effects on key synaptic molecules.  
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The specific alterations to mature spine types in the current thesis - along with evidence for overall 
changes in neuroplasticity mediated by TDP-43 misprocessing – are indicative of the essential role of 
mature spines as strengthened synaptic compartments. As aforementioned, AMPA subunits are critical 
for the maturation of dendritic spines, and regulate processes underlying activity-dependent 
neuroplasticity through continual receptor insertion, anchoring and diffusion events (Anggono & 
Huganir 2012). To establish the potential for AMPA receptor function to be perturbed at specific 
subunits, insertion events may be driven using an optical dimerization system (Kennedy et al 2010). 
This system can be used to locally control the rapid recruitment of AMPA receptors to the PSD 
following activity (Kennedy et al 2010, Sinnen et al 2017). These experiments can then be used in 
conjunction with electrophysiological measurements of mEPSCs, in order to determine whether the 
optogenetic insertion of AMPA subunits such as GluA1 may rescue the hypoexcitable phenotype 
observed in the current thesis. Undertaking this experimental paradigm within layer V pyramidal 
neurons of the motor cortices and other cortical regions may further highlight the mechanisms 
underlying the vulnerability of the motor cortex in the presence of TDP-43 misprocessing.  
The electrophysiological experiments in Chapter 2 were carried out at P30 and P60, with a 
hypoexcitable phenotype identified at P60 and the changes identified in dendritic spine changes in the 
TDP-43A315T  motor cortex further indicative of presymptomatic hypoexcitability. Interestingly, within 
the literature hyperexcitability has been most frequently associated with early ALS pathology (Bae et 
al 2013, Menon et al 2017). To account for these apparently contrasting findings, the current thesis 
may be capturing a specific snapshot of altered excitability in a network that no longer has the capacity 
to regulate activity-dependent neuroplasticity, with excitotoxicity arising from both hyper- and hypo-
mechanisms over time. Indeed, within ALS-patient derived iPSCs, fluctuations in excitability are 
evident with a switch from hyperexcitability to eventual hypoexcitability (Devlin et al 2015, Leroy & 
Zytnicki 2015). To establish a timeline of excitability changes in the TDP-43A315T cortex, it is essential 
to quantify the frequency and amplitude of mEPSCs further over the time course, in order to identify 
how the susceptible motor cortex may be attempting to compensate for the lost ability to modulate 
networks.  
The ability to respond to stimulation and modulate synaptic connections following activity underpins 
cortical neuroplasticity; critical for learning and memory. Though the changes identified in the current 
thesis at the dendritic spine are indicative of altered neuroplasticity, it is still unknown as to whether 
this then impacts the ability to create new synaptic circuits within discrete cortical regions. For future 
studies to capture this process, it would be beneficial to undertake the 2PLSM paradigm of the current 
thesis and use this in conjunction with targeted behavioural experiments. Ensuring these paradigms 
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are optimised to stimulate discrete cortical regions will facilitate further identifying processes 
underlying select vulnerability in disease, and highlight the potential for TDP-43 misprocessing to be 
impacting the maturation and strengthening of synaptic connections during activity. To stimulate the 
motor and somatosensory cortices, rotarod and tactile experiments may be utilised respectively in male 
and female controls and in TDP-43A315T mice, uncovering both the impact of mutated protein and the 
oestrus cycle on the ability to create new synaptic connections within discrete cortical regions.  
The findings in Chapters 3 and 4 regarding the role of cycling oestrogen – particularly in the motor 
cortex – uncover a range of questions as to how oestrogen may be mediating dendritic spine dynamics 
and stabilisation, as well as how it may exert neuroprotective effects. To further utilise 2PLSM 
experiments, another consideration would be to utilise female mice that have undergone an 
ovariectomy, in order to identify whether the loss of oestrogen results in a loss of dendritic spine 
dynamics and synaptic dysfunction. The RT-PCR experiments detailed above may build upon this by 
identifying synaptic compartment-specific changes in distinct oestrogen receptors in the presence of 
TDP-43A315T; agonists of altered receptors may then be used to potentially restore dendritic spine 
dynamics reduced in females that have undergone ovariectomies. 
A number of studies suggest anesthesia commonly used during surgery – such as Ketamine – may alter 
the plasticity of dendritic spines, though findings vary. While the systemic use of Ketamine is 
associated with the increased dendritic spine density of layer V pyramidal neurons in a range of cortical 
regions in rats, hippocampal neurons in vitro exposed to chronic Ketamine demonstrate significant 
reductions in both dendritic spine density and length (Jiang et al 2018, Phoumthipphavong et al 2016, 
Li et al 2011, Li et al 2010). Intriguingly, region-specific alterations at the dendritic spine have been 
identified following ketamine application, whereby acute, low doses increase dendritic spine density 
of layer V pyramidal neurons in the medial frontal cortex with no change in the striatum (Ruddy et al 
2015, Li et al 2011, Li et al 2010). However the majority of these findings are in either juvenile or 
aged mice; indeed, anesthetic use of Ketamine in conjunction with Xylazine has been shown to have 
only transient effects on filopodia in 1 month old mice, with no lasting changes at the dendritic spine 
(Yang et al 2011). Isoflurane, another commonly used anesthesia for surgery, has also been shown to 
impact dendritic spines, particularly at juvenile stages (Yang et al 2011, Briner et al 2010, Head et al 
2009). Though the impacts of anesthesia on the dendritic spine have the potential to present a 
confounding variable, ensuring the parameters of anesthetic use are maintained across all experimental 
groups is crucial for comparable results. The use of Ketamine/Xylazine in the current study for 2PLSM 
was standardized for all experimental groups, with the timepoints employed in Chapter’s 3 and 4 
beyond the age considered most susceptible to alterations associated with Ketamine application.  
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As with many experiments within a specific mutant mouse model of disease, it is essential to undertake 
experimental paradigms in other models of ALS and TDP-43 misprocessing, to understanding whether 
the changes identified are representative of a specific TDP-43 mutation or are a general consequence 
of TDP-43 dysregulation. The use of other TDP-43 mutants – such as the M337V or Q331K mutations 
–may provide a means to answer this question, and indeed studies utilising varying mutations of TDP-
43 have also identified early changes to dendritic spines (Fogarty et al 2016, Fogarty et al 2015). 
Furthermore, the use of mouse models featuring inducible TDP-43 mislocalisation in targeted cortical 
regions may enable the identification of dysfunction that is directly linked to protein aggregation, and 
further elucidate whether this pathology is linked to familial disease forms, or is a wider consequence 
of TDP-43 misprocessing (Spiller et al 2016, Walker et al 2015). The aggregation of TDP-43 is a 
hallmark feature of ALS, and the ability to associate protein aggregation with changes at the dendritic 
spine may provide critical clues as to how sporadic ALS pathology may progress. The use of mouse 
models featuring inducible TDP-43 mislocalisation in targeted cortical regions may enable the 
identification of dysfunction that is directly linked to protein aggregation, and further elucidate 
whether this pathology is linked to familial disease forms, or is a wider consequence of TDP-43 
misprocessing.  
 
As a whole, this thesis has highlighted the changes at the dendritic spine that may be underlying the 
sexually-dimorphic vulnerability of the motor cortex to TDP-43-mediated forms of ALS. The findings 
here also emphasise the critical role of age and sex on the differential development of cortical regions, 
with implications for the susceptibility of neuronal populations to neurodegenerative disease. Changes 
in neuroplasticity at the dendritic spine have been identified at a presymptomatic time point in the 
TDP-43A315T mouse model of ALS, highlighting the need to understand early disease events in order 
to produce viable therapeutic targets aimed at slowing or halting disease progression at the synapse. 
Future studies are required to elucidate the molecular mechanisms underlying these changes, as well 
as the effects this then has on the ability to form new synaptic connections. Undertaking these 
experiments in a range of models of disease, as well as in female mice lacking oestrogen, may shed 
further light on the processes mediating altered neuroplasticity of the motor cortex in the presence of 
dysregulated TDP-43 at the dendritic spine.   
5.5 CONCLUSIONS 
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The select vulnerability of cortical regions to neurodegenerative mechanisms is thought to be a product 
of pathological pathways active well before the clinical manifestation of disease. Synaptic dysfunction 
has been documented as occurring within susceptible regions during early disease stages, and in ALS 
early alterations to excitability may be intrinsically linked to activity at the synapse. This thesis 
provides significant evidence that altered neuroplasticity at the dendritic spine plays an early role in 
the progression of ALS in the TDP-43A315T mouse model, and that TDP-43 itself has key roles in the 
regulation of dendritic spine changes. It also furthers knowledge of the neuroplastic mechanisms 
underlying sexual-dimorphism in both the normal development of synaptic networks within discrete 
cortical regions, as well as how the cycling of the sex hormone oestrogen exerts neuroprotective 
maintenance of these networks in disease states. The findings indicate the male motor cortex is 
specifically vulnerable to TDP-43-mediated dysregulation of neuroplasticity at the dendritic spine, 
occurring early in the disease course within a cortical region primed to fail through activity-dependent 
insults. Understanding the factors influencing the select susceptibility of cortical regions and neuronal 
populations to disease is crucial for targeting early pathological events. Identifying oestrogen as a key 
regulator of neuroplasticity and a potential neuroprotective target provides a therapeutic avenue for 
future studies to optimise the application of oestrogen agonists to restore functions at the dendritic 
spine in ALS. Developing treatments that can successfully target early disease mechanisms is crucial 
to halting or slowing the progression of this devastating disease. 
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